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Summary 
Spray drying provides a rapid route to dry particles from a solution or suspension, and is 
an important unit operation in the food, chemical and pharmaceutical industries.  The 
droplet size distribution produced by the atomization system within a spray dryer is vital 
in defining the output particle size distribution, which in turn can strongly influence the 
subsequent flow, dissolution, ingestion or bioavailability of the final product. 
This thesis explores the capability of a simple atomizing system for the production of 
narrow droplet size distributions within an industrially-relevant spray dryer.  The 
combination of constrained droplet size distribution, defined solute concentration and 
selected processing conditions has been evaluated to determine the influence upon the 
physicochemical properties of a model active pharmaceutical ingredient, and the dosing 
characteristics of formulated products. 
A flow focusing atomizer was demonstrated to be capable of generating narrow droplet 
size distributions for solvents and solutions via the anticipated break-up mechanism.  
  
Laser diffraction studies utilising water, ethanol and 2-propanol were undertaken and 
demonstrated the validity of the postulated control variables of the atomizer, however 
some systematic deviation from the theoretical droplet size proportional to the 
operating pressure was identified.   Sodium chloride solutions up to 5 %w/w, and 
solutions of the corticosteroids fluticasone propionate and mometasone furoate up to 
0.5 %w/w were then evaluated, showing good agreement with the results obtained for 
the solvents. 
The control variables demonstrated to be important for droplet generation under 
quiescent conditions during the laser diffraction experiments were then demonstrated to 
be equally relevant in the dynamic environment within a spray dryer.  A combination of 
target droplet size and sodium chloride concentration was used to produce batches of 
sodium chloride across a range of dry particle sizes.  Subsequent laser diffraction analysis 
identified a linear relationship between predicted particle size and experimental results, 
suggesting the droplet formation mechanism confirmed initially was able to be 
translated to the spray dryer. 
Designed experiments conducted using mometasone furoate indicate that droplet size, 
concentration and drying conditions are important in determining the particle size, 
texture and thermodynamic properties of the output powder.  Average particle size 
results for spray dried mometasone furoate agree well with that anticipated from the 
combination of predicted droplet size and concentration.  A systematic change in particle 
texture with operating conditions, notably inlet temperature and choice of solvent, was 
observed; correlations were also identified between spray drying operating parameters 
and thermal events for the output powder detected during thermal analysis.  Analysis by 
  
X-ray powder diffraction revealed all combinations of spray drying operating parameters 
yielded amorphous particles. 
A capsule-based dry powder inhaler was used to understand the influence of spray dried 
mometasone furoate particle properties upon pharmaceutical performance. Analysis of 
formulations containing spray dried mometasone furoate particles with lactose 
monohydrate defined a clear link between the impaction profile in a cascade impactor 
and spray drying operating conditions. The combinations of droplet size and 
concentration utilised during spray drying, with the resulting differences in API particle 
size, were shown to demonstrate statistically significant relationships with respirable 
mass and emitted dose from the inhaler.  Differences in the blend structure potentially 
attributable to the average size of mometasone furoate particles may have an influence 
on the relationship between emitted dose and airflow for capsule-based inhalers. 
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XRPD X-ray Powder Diffraction 
Introduction 
8 
 
1. INTRODUCTION 
The molecular arrangement within active pharmaceutical ingredient (API) particles and 
the efficiency of their delivery to the site of action are arguably the two most important 
factors in the administration of medicines to patients.  The molecular arrangement 
determines the rate of release, likelihood and extent of physical change or chemical 
degradation, and the balance of adsorption and removal from the body following dosing.  
The molecular conformation and packing within the particle are a function of the 
timescale of particle formation and the rates of heat and mass transfer; the 
characteristics dimensions during particle formation will therefore strongly influence the 
relative position of the constituent molecules forming the particle. 
At the smallest scale of scrutiny the packing of API molecules into a three dimensional 
arrangement will dictate the internal energy of the particle, and so the response of the 
particle to changes in the external environment.  Traditional methods of API particle 
formation have relied upon crystallization from bulk solution, using cooling or the 
addition of a poor solvent to cause formation of a supersaturated solution and 
subsequent crystallization of API once the barriers to nucleation have been overcome 
(Mullin, 2001).  The complexity of fluid flow, heat transfer and the balance of nucleation 
and growth kinetics make prediction of output particle size distribution problematic, 
resulting in the need for additional processes, such as comminution, to provide an 
acceptable particle size distribution for the intended route of delivery.  Reduction in 
particle size by fracture and attrition, whilst undeniably effective, can induce 
inhomogeneities as different particles, and regions within each particle, experience 
varying degrees of stress during processing. Attrition processes can yield disrupted 
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regions that display different characteristics and propensities for chemical reaction or 
physical change when compared to the bulk (Mackin et al., 2002).  The surface of 
comminuted particles are particularly susceptible to disruption, being the focus of 
impact, hence a small structural change characterised by evaluation of the bulk may 
have a disproportionate effect upon the behaviour of the particulate system.  An 
alternative approach is to produce particles at the size of interest by the generation and 
drying of droplets of suitable volume, thus avoiding the deleterious consequences of 
comminution.  Precipitation or crystallization without additional attrition and fracture 
processes will reduce the energetic inhomogeneities across the particle surface, reducing 
the driving force for further unintended modification and limiting the range of 
interactions with other substrates.  Atomic force microscopy studies have revealed a 
two-fold increase in adhesion force with lactose when using amorphous Zanamivir rather 
than the crystalline form (Berard et al., 2002), suggesting variation of up to  ten percent 
between API particle- excipient particle interactions for micronized APIs (Mackin et al, 
2002).  In addition, compartmentalising solution into small volumes offers improved heat 
and mass transfer, constraining the possible particle size and potentially reducing the 
width of the particle size distribution compared to that obtainable by a combination of 
bulk crystallization and comminution. 
The difficulty in obtaining the required particle characteristics from the manipulation of 
bulk quantities of API solution with additional processing has driven research into a 
number of alternative isolation technologies.  The technology required for the 
production of repeatable and reproducible aliquots of matter is typically complex, often 
exploiting an imposed electric field or the regular oscillation frequency of a piezoelectric 
Introduction 
10 
 
crystal as the basis for droplet generation with low population variance (Basaran, 2002).  
Use of vibrating meshes driven by piezoelectric crystals is effective in generating narrow 
droplet distributions, however the average drop size formed is directly related to a small 
multiple of the mesh aperture size and so can lead to fouling issues where small droplets 
are required.  Electrospray systems are widely used as the sample introduction system 
for mass spectrometers and have shown promise for monodisperse droplet formation, 
however the use of the technique is limited to liquids of suitable conductivity, with 
known issues for aqueous solutions (Ijsebaert et al., 2001). 
The drying step necessary to produce solid particles from monodisperse or narrow 
droplet distributions must be able to preserve the distribution throughout the 
evaporation process to be considered effective.  Coalescence of droplets or the 
agglomeration of resultant particles will yield greater polydispersity, negating the 
atomization efficiency.  The gas flow patterns and droplet or fluid ligament trajectory 
within the drying system are key parameters in preserving the distribution variance, 
governing the degree of droplet and particle co-association and wall impaction.  The flow 
pattern and rate are additionally important in the extent of drying able to be achieved, 
and in conjunction with the operating temperature and droplet and solute 
physicochemical properties, are influential in defining the morphology of the dried 
particles. 
Research has therefore centred upon the development of systems suitable for exploring 
fundamental hypotheses and demonstrating the benefits of reduced particle distribution 
widths in small-scale studies representative of potential industrial applications.  
Assuming a narrow particle size distribution confers a benefit to finished product, a 
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decision on cost of process implementation and operation versus the incremental 
product quality benefit will determine the industrial viability.  The costs associated with 
complex atomization systems of narrow applicability and bespoke drying systems may 
prove prohibitive in marginal cases, hence the development of robust atomization 
systems based upon simple operating principles coupled with established drying 
technology would be of value. 
1.1. Objectives 
The primary objective of the studies described in this thesis is the to understand the 
particle property differences able to be obtained for active pharmaceutical ingredients 
by manipulation of spray drying operating conditions when using narrow droplet 
distributions.  Previous research studies (Tajber et al, 2009; Prinn et al, 2002; Chawla et 
al, 1994) have demonstrated a link between operating parameters and output particle 
properties, but the elucidation of effect will inevitably have been compromised by the 
prevailing droplet distribution when using a two-fluid nozzle.  The use of technology 
capable of generating narrow droplet distributions would allow the impact of operating 
conditions to be evaluated without the complicating effects of substantial droplet 
volume variance and the difference in processing pathway this can bring. 
A second objective of the thesis is the evaluation of a simple atomizing technology for 
the production of narrow droplet distributions, and subsequently of the ability to 
translate the droplet distribution into meaningful differences in particle properties and 
dosage form quality using commercially available drying equipment.  A configuration 
able to be readily industrialised would allow for processing benefits offered by the use of 
narrow droplet distribution drying to be rapidly realised, and may offer a path to a 
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relatively simple translation to manufacturing scale via a control framework of few 
impactful variables.  The basis of droplet generation using the atomizer chosen for this 
work has been the subject of a number of studies over the past two decades (Ganan-
Calvo et al, 1998; Ganan-Calvo et al, 2011), however to date no research into the 
possible beneficial effect for imparting preferred particle properties for inhaled delivery 
of pharmaceuticals has been conducted.  The focus of this thesis is therefore to 
demonstrate the suitability of flow focusing for this purpose, rather than a further 
refinement to the mathematical basis for droplet formation. 
The simple droplet formation technique introduced above, based on low pressure 
elongation of a liquid thread, has been explored in conjunction with a commercially 
available, small scale spray drying system to establish the viability of this processing 
approach.  Comparison of experimental results with theoretical predictions has been 
performed to assess the suitability of the chosen atomizer, as described in Chapter 3.  
High speed videography and laser diffraction analysis of the droplet stream produced by 
the atomizer have been used to identify the droplet break-up regime, average droplet 
diameter and droplet distribution width and provide experimental verification of 
theoretical predictions, using solvent and solution properties defined in Chapter 2. 
An inorganic solute, sodium chloride, has been used to validate the ability to translate 
the difference in droplet distribution characterised in a quiescent atmosphere to 
discernible particle differences using the spray dryer.  Sodium chloride is known to 
produce crystals of low aspect ratio, reducing the potential impact of particle shape 
resulting from droplet drying upon analysis of the particle size. Model APIs have then 
been used to demonstrate systematic impact upon particle properties of droplet 
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formation and drying conditions.  Two corticosteroid molecules, mometasone furoate 
and fluticasone propionate, have been spray dried and the physical and thermal 
properties evaluated to ascertain possible effects attributable to drying conditions.   
The subsequent performance variation able to be obtained from a dosage form relevant 
to the particular APIs used, as described in Chapter 4.  The APIs investigated within the 
spray drying experiments are routinely used for the treatment of lung disease and are 
commonly delivered topically using inhalation therapy.  Selected particle batches for 
mometasone furoate have therefore been formulated with lactose monohydrate and 
delivered via a capsule-based dry powder inhaler to an inertial impactor in an attempt to 
link the particle properties imparted during drying to the aerodynamic particle size 
distribution generated via the inhaler.  The formulation, testing and subsequent analyses 
performed are discussed in Chapter 5. 
The following sections of the Introduction summarise the theoretical basis and 
development of the processing technology and formulation approaches used during the 
studies.  The equipment configurational options in spray drying are discussed, with the 
suitability of processing options to particular scales of operation highlighted in order to 
position the choice of operating system used during the experimental studies in this 
thesis.  A summary of the theoretical analysis of droplet drying, with reference to the 
relative movement of solute and solvent during this dynamic process, is then provided to 
frame the observations and subsequent discussion in Chapter 4.  The likely implications 
of the kinetics of drying upon molecular arrangement within the dried particles are then 
outlined, as background to the discussions on thermal analysis and x-ray diffraction in 
Chapter 4.  Droplet formation via the mechanisms relevant to atomizers is summarised, 
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with and additional section specific to flow-focusing – the particular variant of pneumatic 
atomizer employed during the experimental studies. 
The final sections of the introduction provide background to the pharmaceutical aspects 
of the thesis, in particular the field of inhalation delivery using dry powder inhalers.  The 
formulation approaches necessary to allow dispersion of the small API particles are 
summarised, alongside a description of the design of the primary packaging and delivery 
system that play an integral role in generating dose suitable for lung delivery.  A 
description of the analytical systems necessary to identify and quantify the potentially 
inhalable portion of the liberated dose is then provided, to provide context for the 
studies described in Chapter 5. 
1.2. Spray Drying 
Spray drying is a mature technology and is routinely used as part of industrial processes 
to manufacture products in the food, chemical and pharmaceutical sectors.  The 
subdivision of a bulk liquid into droplets facilitates rapid drying and the production of 
particles of desired physical properties when an appropriately designed process is 
operated, providing the means for conversion of solution or suspension to dry solid in a 
single processing step.  The first documented process is commonly recognised to be a 
patent published at the end of the nineteenth century (Percy, 1872), describing a process 
for simultaneously atomizing and desiccating fluid and solid substances to prevent 
destructive chemical change.  The production of dried milk was the first commercial use 
of the technology, and the manufacture of whey powder, powdered milk and baby 
formula remain major spray drying applications.  The need to preserve and reduce the 
transport burden for foodstuffs during World War II resulted in rapid development of the 
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technique, supplemented after the war by the use of spray drying in the development of 
pharmaceuticals (Cal & Sollohub, 2010). At approximately the same time spray drying 
began to be used for the manufacture of APIs and excipients for pharmaceutical 
applications; antibiotics, analgesics and vitamins were some of the earliest spray drying 
processes developed within the pharmaceutical sector (Marshall, 1954).  Spray drying 
remains an important processing route for pharmaceutical materials as it can readily 
form amorphous materials conferring preferential physical properties to excipients for 
direct compression tableting applications, and enhance dissolution rate compared to 
crystalline forms of API.  The low temperatures experienced by APIs within the drying 
droplets and relatively small stresses imposed on molecules compared to milling 
processes have identified spray drying as an ideal process for the processing of 
biopharmaceuticals, with much current academic and industrial interest (Walters et al., 
2014). 
1.2.1. Spray drying equipment 
The design of a spray drying installation is dictated by the characteristics of the feed and 
dry product and the value of the recovered material.  A schematic diagram of a simple 
open-cycle system is presented as Figure 1.1. 
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Liquid feed
(+atomising gas for 
pneumatic nozzles)
Drying gas
Heating system
Cyclone
Drying chamber
Atomiser
Product collection
Gas exhaust
Gas disperser
 
Figure 1.1 Schematic diagram of an open-cycle spray dryer 
 
The majority of spray drying processes use air as the drying gas, drawn in from the 
atmosphere via filters before being heated to the required temperature for use as the 
drying gas.  The exhaust, comprising the inlet air, vaporised solvent and residual product 
with a particle size below that able to be collected by the separator, then passes back to 
atmosphere.  Such open-cycle systems are only able to be used with non-volatile 
solvents and when the solute, when dried, offers little in the way of processing risk.  
When an explosivity risk is present as a result of the liquid used as a solvent/ suspending 
agent or due to the dried product the process will typically be operated using an inerted 
atmosphere, such as the use of nitrogen as the drying gas rather than air.  In some 
instances the solvent or product poses a direct risk to health and so requires both 
containment within the equipment and very efficient removal from the drying gas 
exhaust.  Closed cycle systems are operated where the oxygen content of the drying gas 
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has to be limited due to flammability issues, incorporating a recycle system with a 
scrubbing system to remove solvent from the exhaust gas.   Closed systems are 
constructed to prevent the leakage of gas, vapour or product and are usually operated at 
above ambient pressure to minimise the ingress of oxygen should a leak occur.  If health 
risks are posed by the product or solution closed or semi-closed (powder-tight but not 
necessarily gas-tight) systems are often used; however the onus is really upon effective 
removal of the solvent or powder from the process exhaust so that open-cycle operation 
becomes a possibility.  Semi-closed operation can also be used to reduce drying gas 
solvent content to an acceptable level whilst reusing some of the heat within the exhaust 
gas. 
A number of methods for heating the drying gas are available depending on the 
particular drying application.  Direct heaters, where the incoming gas stream is used to 
burn fuel and provide heat, give high thermal efficiencies by virtue of the high inlet 
temperatures generated.  Directly heated systems can provide a route to an inert 
atmosphere without the need for a nitrogen feed if operated to efficiently consume the 
oxygen in the incoming gas stream.  Semi-closed systems are often operated when the 
flammability risk is from the dried product as this allows efficient operation via heat 
recovery, however this configuration is not used for flammable solvents as solvent 
vapour will be recycled with the drying gas.  Indirect heating is used where product 
would potentially be damaged upon contact with combustion products that will 
inevitably form in the case of direct heating.   Electrical heaters are often used in the 
case of laboratory and pilot scale operations, where thermal efficiencies will inevitably 
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be low but are of low priority, and equipment and associated safety costs prevent the 
use of fired heaters. 
The spray drying configurations outlined above share four common process objectives: 
1. Conversion of the liquid feed into droplets to increase the available liquid surface 
area for evaporation, and to subdivide the liquid into droplets of an appropriate 
size to give the required output dried particle size distribution. 
2. Efficient contact of the droplets and the drying gas of the required temperature 
and flow rate. 
3. Provision of a suitably large drying volume affording sufficient residence time to 
enable the required degree of drying and maximise the fraction of product able 
to be recovered from the dryer. 
4. Separation of the dried product from the fluid stream exiting the equipment 
without adversely impacting the physical or chemical properties of the product. 
Specific considerations will influence the detail design of the equipment, for instance the 
need to operate intrinsically safe processes for dangerous substances and when using 
flammable solvents, or alternatively the need to protect the product when intended for 
consumption will dictate the design philosophy to a large extent.   
1.2.1.1. Atomization systems 
The design of spray drying atomizing systems can be divided into three groups; those 
that utilise the mechanical rotation of the atomizing device to impart the energy 
required to form droplets, atomizers that rely upon the relative movement of fluids to 
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cause subdivision of the liquid feed and the use of pressure in conjunction with a suitably 
sized orifice to form and disintegrate a liquid sheet or thread.  The first group, the rotary 
atomizers, are the mainstay of industrial atomizer systems as they are able to cope with 
both solutions and suspension feedstocks, can accommodate a wide range of feed flow 
rates and the relationship between operating parameters and droplet size distribution is 
well understood.  The second and third groups, the nozzle atomizers, can offer a wider 
range of droplet sizes, and tend to be the norm for small scale spray drying systems as a 
narrower drying chamber is required than for rotary atomizers. 
Rotary atomizers exploit the momentum imparted to the liquid feed by the rotating 
wheel to form droplets by direct break-up of the sheet of liquid formed at the functional 
surface of the wheel, or by collapse of liquid ligaments generated as the liquid sheet 
projects away from the wheel edge.  Simple flat discs are rarely used as slippage 
between the feedstock and disc surface occurs, leading to inefficient transfer of 
momentum from the wheel to the liquid and poor atomization.  This problem can be 
partially overcome by employing a curved rather than flat surface, and distribution of 
feed onto the underside of an inverted-bowl wheel often leads to improved atomization 
as radial forces reduce slippage during wheel rotation.  The most common approach to 
improved momentum transfer is however the use of vanes or channels at the wheel 
surface to minimise relative rotational movement between the wheel and liquid. 
Droplet distributions obtained from rotary atomizers depend upon the combination of 
the properties of the solution/ suspension and atomizer characteristics.   At constant 
operating conditions droplet size is known to be proportional to viscosity, surface 
tension and inversely proportional to liquid density.  Wheel speed and feed rate 
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(inversely proportional and proportional relationships with droplet size respectively) are 
considered the key atomizer operating parameters.  Prediction of droplet size from 
rotary atomizers is problematic, due to the complex droplet formation processes 
responsible for generation of the spray.  Empirical prediction validated by measurement 
of the particle size of dried product has been used, however this approach is necessarily 
situation-specific and has been shown to give results of variable accuracy (Masters, 
1991). 
Two variants of nozzle atomizers are commonly available: pressure nozzles and 
pneumatic nozzles.  Pressure nozzles convert pressure to kinetic energy, usually in the 
form of a swirling conical liquid sheet.  The increase in edge diameter with distance from 
the atomizer results in a reduction in sheet thickness; interaction with the surrounding 
drying medium, surface tension, viscous and inertial forces disrupt the liquid sheet 
resulting in the formation of droplets.  An increase in nozzle capacity is possible by 
reducing the volume occupied by the air core within the spray cone via increased axial 
motion of some of the liquid passing through the nozzle; the increase in capacity comes 
at the price of reduced droplet homogeneity however.  Droplet size produced by 
pressure nozzles are a function of spray angle, pressure, and physical properties of the 
liquid feed.  Wider spray angles result in smaller droplet sizes, however also result in a 
lower discharge coefficient and so less economical operation.  Increasing operating 
pressure results in the transfer in more energy per unit mass to the liquid and leads to a 
reduction of droplet size at all but very high operating pressures.  Liquid viscosity will 
impact upon both droplet size distribution and operating efficiency of the nozzle – 
increasing viscosity will result in a coarser droplet size distribution, but also a reduction 
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in the volume of the air core due to the reduced spray angle of the coarse droplets.  
Surface tension increases will cause an increase in droplet size, however the magnitude 
of the surface tension range possible for successful pressure atomization is small and so 
the effect is small compared to that experienced as a result of changes in viscosity.  
Prediction of average droplet size for industrial systems is subject to the particular nozzle 
design and application, however the correlation given as Equation 1.1 may provide a 
useful approximation (Masters, 1991): 
 
    
       
 
 
  
 
 
 
Equation 1.1 
where Q is the feed flow rate (m3 s-1), µ is feed viscosity (Pa s) and ΔP is the pressure 
drop across the nozzle (Pa).  Pressure nozzles are cheap to manufacture and easy to 
maintain; multiplexing of nozzles is necessary to cope with increased throughput 
however accurate manufacturing of the component parts with small tolerances means 
the impact upon overall droplet size distribution is usually acceptable.  The main 
drawbacks for pressure nozzles are the need for a high pressure feed system, usually 
requiring expensive pressure pumps, and a reduced capability to cope with suspended 
solids when compared to rotary or pneumatic atomizers – a consequence of the narrow 
flow geometries necessary for successful operation. 
Pneumatic nozzles utilise the energy from a pressurised gas stream to impart the 
momentum to the liquid feed necessary for droplet production.  Contacting the liquid 
feed with the high velocity gas stream results in a rapid increase in liquid surface area via 
friction, which subsequently breaks up into droplets from the jet or sheet initially 
formed, or is directly atomized under highly turbulent conditions.  The physical 
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properties of the liquid feed, notably surface tension, viscosity and density, will influence 
the droplet size distribution produced (increase in these parameters will lead to an 
increased droplet size), however given that these properties are unlikely to be able to be 
modified greatly in the industrial setting, the velocity and density of the gas stream is of 
greater practical significance alongside the gas: liquid ratio.  
Contact of the gas and liquid streams can be accomplished using a number of designs.  A 
coaxial gas stream enveloping a jet can be used for low liquid flow rates; the narrow jet 
diameter allows for acceptable atomization when using a sufficiently rapid air flow.  
Increasing the liquid flow rates necessitates the conversion of the liquid bulk into a 
conical sheet to allow penetration of the air stream and efficient energy transfer.  
Formation of the sheet is achieved by rotating the liquid within the nozzle to form a 
liquid annulus, followed by coaxial contact with the gas stream to accelerate the liquid 
and then increase the diameter to reduce layer thickness and disintegrate the conical 
sheet into droplets.  When atomizing using a single gas stream the contact with gas can 
occur within the nozzle (internal mixing), outside the nozzle head (external mixing) or, 
when using mechanical rotation to initially form the liquid sheet (pneumatic cup 
atomization) at the internal – external boundary. 
The majority of the energy transferred from the gas stream to the liquid stream 
accelerates the liquid sheet, with less than 1 % of the energy being employed to cause 
droplet formation (Masters, 1991).  The transfer of energy is maximised when using 
internal mixing nozzles, however independent control of the gas and liquid streams is not 
possible with this design, reducing the operational influence able to be exhibited upon 
the atomization process. 
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The gas: liquid ratio is of greatest importance in controlling the droplet size distribution 
obtained from pneumatic atomizers.  Increasing the relative gas flow will reduce the 
droplet size produced, and also reduce the spray angle of the conical liquid sheet, 
although the variation in spray angle possible across the operating range is not 
appreciable.  Droplet size has been correlated with operating characteristics using 
Equation 1.2 (Nukiyama & Tanasawa, 1940): 
 
         
 
          
   
    
    
 
  
 
Equation 1.2 
Where: urel = initial relative gas: liquid velocity ratio, Mgas/ Mliq = gas: liquid mass ratio; A 
and B are constants reflecting nozzle design and liquid properties, α and β are exponents 
characteristic of nozzle design. 
Gas: liquid ratios of 0.1 to 10 are usual, with incomplete atomization and inefficient 
energy expenditure encountered below and above the ratios indicated.  Increasing gas 
density at constant velocity reduces average droplet size, a consequence of increased 
energy transfer to the liquid feed.  
The contact of gas and liquid streams is normally accomplished using either a single gas 
flow concentrically arranged to envelope a central liquid flow or an annular liquid flow 
with both inner and outer gas flows.  The former arrangement, known as a two fluid 
nozzle, is most commonly used and capable of efficient atomization in the majority of 
applications.  The latter design, the three-fluid arrangement, is beneficial for atomizing 
high-viscosity feeds when penetration of the liquid sheet from one side is problematic, or 
where very fine droplet size distributions are required. 
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1.2.1.2. Droplet and drying gas contact 
The average velocity and velocity distribution of drying gas within a drying chamber of 
fixed volume determine the residence time available to accomplish drying and the extent 
of deposition upon the inner surfaces of the drying chamber and connective pipe-work.  
Recirculation flows will influence the temperature distribution within the drying chamber 
and so affect the drying profile of the droplets whilst passing through the chamber.  
Drying gas enters the drying chamber through the air disperser which induces the initial 
motion and trajectory of the gas stream.  The optimal gas flow pattern is dependent 
upon the required droplet movement, and in turn will depend upon the operating 
characteristics of the atomizer and the atomizer-drying gas flow arrangement.  The 
position of the disperser within the drying chamber depends upon the mode of 
operation.  Entry of drying gas from the chamber roof is commonplace for co-current 
spray and drying gas configurations; this can have the additional benefit of reducing wall 
deposition when using a rotary atomizer if drying gas entry is through the majority of the 
cross sectional area of the chamber roof.  Concentration of the drying gas flow around 
the atomizer has been employed for spray nozzles to give more rapid drying.  Side entry 
of the drying gas results in a rotary gas flow, giving a longer droplet residence time than 
for roof entry gas flow; splitting the gas flow between wall and roof entry to the chamber 
gives a compromise between residence time and wall deposition, allowing the technique 
to be used for optimising rotary atomization. 
Counter-current operation is usually effected using bottom entry of the drying gas flow, 
with the gas entry point being situated at the junction between the cylindrical and 
conical sections of the chamber.  Most counter-current configurations have a plenum at 
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the chamber base imparting a rotary motion to the incoming gas; gas entry via a central 
conduit and wall entry of the drying gas are alternative disperser designs.  Introduction 
of drying gas to mixed flow design dryers depends upon the position of the atomizer and 
the overall flow pattern required; splitting of the inlet gas can be used, particularly in the 
case of mixed flow dryers incorporating a fluidised bed where part of the inlet gas is 
employed to fluidize the powder mass. 
1.2.1.3. Drying chamber 
The drying chamber aspect ratio for small to medium-sized equipment is determined by 
the choice of atomization system and drying gas flow; wide chambers are favoured for 
use with rotary atomizers due to the high radial velocity component imparted to the 
droplets when compared to nozzle atomizers.  Tall form dryers with a relatively narrow 
diameter but substantial length are commonplace industrially and for smaller units when 
using nozzle atomizers with co-current gas flow as spray angles from pressure and 
pneumatic atomizers are usually narrow and the gas flow acts to minimise transverse 
droplet movement. 
The dimensions chosen for the chamber will be based upon estimation of the gas flow 
and droplet movement within the chamber by calculation or modelling.  The chamber 
configuration chosen should provide a droplet residence time sufficiently long to allow 
complete drying but not expose the dry product to excessive heat, whilst maximising 
product collection by minimising wall deposition.  Once the atomizer type and average 
droplet size has been identified indicative calculations can be undertaken to evaluate the 
likely deposition on the chamber wall and so the expected level of product loss.  In 
reality droplets will usually follow the drying gas flow pattern within six diameters of the 
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atomizing wheel for rotary atomizers, so for all but laboratory or pilot scale equipment 
direct impingement of droplets or wet product on the dryer wall is not an overriding 
concern.  Where rotary atomizers are used with small spray drying units the radial 
distance of droplet projection (Sh) expected can be estimated using the relationship 
below (Lapple & Shepherd, 1940): 
 
   
      
    
 
Equation 1.3 
Where D = droplet size (m), uh = initial radial velocity (m s
-1), ρl = liquid density (kg m
-3) μg 
= drying gas viscosity (Pa s). 
Estimation of chamber size to ensure optimum drying time is relevant to all 
configurations, but is complex given the temporal and special variation in chamber 
temperature and humidity, gas velocity and droplet size and density (Langrish, 2007).  A 
simplified approach is therefore typically used which assumes plug flow of drying gas and 
a constant droplet diameter to estimate residence time.  The effect of droplet velocity 
imparted by the atomizer upon residence time is small but the deceleration time for 
droplets to slow to the velocity of the drying gas stream can be estimated for nozzle 
atomizers using Equation 1.4 (Masters, 1991): 
 
    
           
    
 
     
    
 
  
    
     
     
   
    
Equation 1.4 
Where Re1 is the initial droplet Reynolds number, Re2 is droplet Reynolds number at time 
t, D is droplet size (m), s, l and g are solid, feed and atomizing gas densities 
respectively (kg m-3), g is the drying gas viscosity (Pa s), R’ is the drag force per unit area 
acting on the droplet (N m-2) and u is droplet velocity (m s-1).  As the Reynolds number is 
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a function of the droplet velocity, calculation of the time required for the droplet 
Reynolds number to change between known values will give the deceleration rate, hence 
iterative integration will allow calculation of the increased path length required to give 
the necessary drying residence time. 
1.2.1.4. Particle collection 
When the spray drying operation produces large or very dense particles, gravitational 
settling into the base of the drying chamber may form the primary product collection; 
however the small particle sizes often encountered in spray drying usually require a 
purpose-designed particle collection system downstream of the drying chamber.   
Efficient separation of dry product particles from the drying gas stream beyond the 
drying chamber is important to ensure a cost-effective process and to minimise 
particulate exhaust emissions.  The optimal collection system will depend upon the 
aerodynamic size of the particles to be collected, their mechanical robustness and the 
economic value of the product.  The common technologies employed for particle 
collection for spray drying are cyclones, bag filters, electrostatic precipitators and wet 
scrubbers.  Cyclone collectors present the least operationally complex solution, giving 
continuous collection of dry material for up to 99 % of particles in the exhaust air stream.  
Bag filters offer higher efficiencies in terms of collection, however blinding of the filter 
media increases resistance to air flow requiring pulsing of the bag with a reversed air 
flow or vibration to de-occlude the surface.  The additional operational complexity of bag 
filters increases the running costs and unblinding the filter bags causes fluctuations in air 
flow which can increase product variability.  Wet scrubbers have very high collection 
efficiencies and are particularly useful when collecting product that strongly adheres to 
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equipment surfaces, however the product will then require a secondary separation to 
allow recovery from suspension.  Electrostatic precipitators again have high collection 
efficiencies and do not result in gas flow fluctuations, similarly to cyclones.  Installation 
and operating costs are higher than for cyclones, and so would not be favoured over 
cyclones except for expensive or polluting products, or where abrasive products would 
lead to cyclone damage.  Where a spray drying operation has environmental or operator 
safety concerns a secondary collection system may be used in addition to cyclones, 
which form the primary separation system. 
1.2.2. Pharmaceutical applications 
Spray drying has been heavily utilised to produce particles to enhance API targeting and 
control the rate of release (Re, 2006).  The subdivision of bulk liquids into droplets, 
compartmentalising the content has been exploited to generate particle structure at the 
micrometer or nanometre scale, using the relative difference in solute solubility and 
component diffusivity to form layers and voids, or to combine nanoparticles into 
multicomponent particles of larger dimension.  An analysis by Vehring and co-workers 
(Vehring et al., 2007) quantifies the contribution of the diffusivity of each solute to the 
surface enrichment under the conditions of a receding liquid surface, as encountered 
during spray drying.  The Peclet number, defined for each solute as Equation 1.5, is used 
to provide a relative measure of the concentration of each solute at the surface: 
      
 
   
, Equation 1.5 
where  is the solvent evaporative flux (m2 s-1) and Di is the diffusion coefficient of solute 
i (m2 s-1),  An exact solution for Cs,i, the surface concentration of solute i from the bulk 
concentration is possible via Equation 1.6 and Equation 1.7: 
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Equation 1.6 
 
     
    
   
  
   
   
Equation 1.7 
where Cm,i is the average droplet solute concentration and rn is the normalised radial 
coordinate, 
 
  
 , where r is the radial position (m) and rs is the droplet radius (m).  A 
practically useful estimate of the surface enrichment, Ei, as defined in Equation 1.8, can 
however be obtained using Equation 1.9:  
 
    
    
    
 
Equation 1.8 
 
     
   
 
 
   
 
   
 
   
 
    
 
Equation 1.9 
The differential mobility of solutes, and the difference between solute diffusivity and 
solvent evaporation rates provide an insight into the mechanisms of layering and the 
formation of hollow particles.   The low particle density generated by producing hollow 
particles offers advantages for pulmonary delivery, and the interest in this sector is 
illustrated by the body of work conducted using biodegradable polymer and 
phospholipid materials to produce particles with voidage, often in the form of crumpled 
shells (Edwards et al., 1997, Kawakami et al., 2014, Liang et al., 2015, Parsian et al., 2014, 
Vanbever et al., 1999).   
More complex solid foam structures are possible if emulsion systems, rather than 
solutions, are used as the feed liquid.  Voidage can be achieved by producing an 
emulsion where the dispersed phase is of submicron dimension and has a lower 
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evaporation rate than that of the continuous phase containing the solute.  Upon spray 
drying, the continuous phase will evaporate first, precipitating the solute in the form of a 
solid foam with the subsequent removal of the dispersed phase producing the voids.  
This approach to particle formation has been employed for the generation of 
Pulmosphere formulations (Dellamary et al., 2000), using a fluorocarbon in water 
emulsion to produce a phospholipid framework to incorporate API as either a molecular 
dispersion or as embedded nanoparticles. 
Narrow particle size distribution is of primary importance in API delivery for a number of 
dosage forms.  Particle dimension in intravenous therapy is important for both 
therapeutic effect and to avoid harmful side effects, such as formation of embolisms or 
blood clots (Wissing et al., 2004).  Size and monodispersity have been demonstrated to 
be key in providing predictable controlled release from biodegradable polymers for 
ocular delivery (Barzegar-Jalali et al., 2012); similarly predictable increases in the oral 
bioavailability of low solubility APIs by the use of monodisperse polymer matrices has 
been described (Bohr et al., 2011).  Cellular uptake of biopharmaceuticals and the ability 
to cross membranes, such as the blood-brain barrier, are inextricably linked to the 
morphology of particles and much research is underway to further explore and advance 
this therapeutic route (Davis et al., 2008, Panyam & Labhasetwar, 2003). 
The examples provided above exemplify the importance of compartmentalising the API 
or polymer matrix in a reproducible volume to provide consistent particle shape and size, 
however rate of solvent evaporation and molecular mobility of solutes also has 
consequences for particle structure beyond particle morphology.  The molecular 
arrangement of solutes will be a function of the time available for the adoption of 
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preferential conformations, and so the drying conditions used will directly impact the 
crystallinity of the resulting dried particles.  Where evaporative timeframes are short in 
comparison to crystal nucleation and growth an absence of long range molecular order 
can be expected.  The processing pathway and resulting material state can be illustrated 
with reference to Figure 1.2; if the generation of supersaturation occurs at a sufficiently 
slow rate a crystalline phase will be formed at the melting temperature Tm, with a step 
change reduction in enthalpy and volume via heat transfer as a first order transition.  If 
supersaturation is generated at a rapid rate in comparison to molecular relaxation then 
the preferential molecular confirmations necessary for crystallizations are not attained, 
and with the loss of translational molecular movement a supercooled liquid is formed.  
Further reduction in temperature will result in the glass transition temperature (Tg) being 
reached, denoted by the loss of rotational molecular motion with a reduction in specific 
volume; a consequent reduction in heat capacity can be seen as the change in gradient 
of  
  
   
 or 
  
  
, as shown in Figure 1.2 (Hancock & Zografi, 1997): 
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Figure 1.2 Variation in enthalpy or volume with cooling  
 
The value of the glass transition temperature, Tg, identified during analysis is dependent 
upon experimental factors, during both material preparation and measurement.  An 
absolute limit for Tg is the intersection with the crystal enthalpy or volume curve, Tk 
(known as the Kaufman temperature), as this represents enthalpy equivalence between 
the amorphous and crystalline states.  The variable nature of the glass transition has 
been the subject of debate, primarily as to whether this represents separate 
thermodynamic states or a relaxation continuum.  Thermodynamically separate states 
have been postulated previously, however only under widely differing processing 
conditions, such as large differentials in pressure (Angell, 1995).  The range of conditions 
possible in the case of pharmaceutical API isolation is more modest, so differences in the 
properties of amorphous materials are most likely due to differing molecular relaxation 
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resulting from process-related kinetic differences, such as cooling or precipitation rate 
rather than being due to polyamorphic forms.  
An additional effect is also known to influence the experimentally identified glass 
transition.  Trace amounts of solvent retained during precipitation or environmental 
water absorbed during cooling can act as plasticisers, reducing the glass transition 
temperature.  The reduction in glass transition is understood to be proportional to the 
mass fraction of the retained / absorbed liquid, and is described by the Gordon-Taylor 
equation developed during the study of polymer blends (Hancock, 2002): 
 
      
              
        
 
Equation 1.10 
  Where Tg1, Tg2, Tg1,2 are the glass transitions temperatures of component 1, 2 and the 
mixture respectively (K), W1 and W2 are the mass fractions of components 1 and 2, and 
Cp1 and Cp2 are the differences in heat capacity (J kg
-1) above and below the glass 
transition temperature for components 1 and 2.  The term K is defined as presented in 
Equation 1.11: 
 
   
    
    
 
Equation 1.11 
 
The amorphous state can confer therapeutic advantages compared to crystalline forms.  
The higher internal energy of amorphous forms results in more rapid dissolution than for 
the crystalline version, increasing bioavailability giving more effective treatment, or a 
reduction in dosage.  The pharmaceutical industry and regulatory authorities have 
however been reticent to adopt amorphous forms of APIs with preferential adoption of 
crystalline forms usually encountered.  The inherent physical instability may lead to 
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conversion to a crystalline form under suitable environmental conditions, which could 
result in an uncontrolled change in the dosing characteristics of a medicine after 
dispensing.  Whilst thermodynamic instability is necessarily the case for all amorphous 
forms compared to crystals, the rate of transformation varies and for a number of APIs 
the kinetics are sufficiently slow that little risk of conversion within a meaningful 
timeframe is present.  A margin of 50K between storage temperature and glass transition 
has been suggested as appropriate (Hancock & Shamblin, 2001), however, as discussed 
above, the possibility of lowering of the Tg via plasticisation by absorbed water should be 
considered and mitigated. 
1.3. Droplet formation 
The formation of droplets by the atomizer is the key step in defining the particle size 
distribution of the dried product. The droplet size distribution generated depends upon 
the variability in the dimension of the fluid ligaments produced by the atomizer which 
act as precursors to droplets.  Additionally the environment into which the droplets are 
dispersed may influence the final droplet distribution, either by further break up 
(secondary atomization) or by coalescence as a result of differing droplet velocities.  A 
large body of information on droplet formation has been generated by researchers over 
the 180 years since Savart identified the proportionality between breakup length and jet 
velocity at constant orifice diameter, and orifice diameter at constant jet velocity (Eggers 
& Villermaux, 2008).  Plateau’s analysis of 1849 demonstrated that the surface area of a 
cylindrical jet exceeds that of two droplets of equivalent volume if the length of the 
cylinder is greater than the jet circumference; hence the surface energy of the liquid is 
reduced by the formation of droplets.  Rayleigh provided insight into the dynamics of the 
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transition from a jet to droplets, recognising the role of growth of perturbations of the 
jet surface in the eventual breakup of the jet and the defining influence of perturbation 
wavelength in the size of droplets formed. 
Rayleigh showed that the growth rate of the dominant disturbance, qm is dependent 
upon the surface tension as shown in Equation 1.12: 
 
        
 
   
 
 
 
 
Equation 1.12 
 
where  is the surface tension (N m-1) d is the jet diameter (m), and subsequently that 
the dominant wavelength can de defined as per Equation 1.13. 
          Equation 1.13 
 
 Assuming a portion of the jet of this length transforms into a droplet of diameter D (m), 
then  and droplet size D can be predicted using Equation 1.14 and Equation 1.15: 
    
 
       
   
 
 
Equation 1.14 
 D=1.89d. Equation 1.15 
Rayleigh’s description of surface tension-driven breakup was developed further by a 
number of contributors (Lefebvre, 1988).  Weber (1931) included the effects of viscosity 
upon the droplet formation process.  Weber’s analysis defines two characteristic 
wavelengths for an inviscid disturbed cylindrical jet for the minimum wavelength of 
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disturbance able to be propagated and the optimal wavelength of disturbance 
respectively, as given in Equation 1.16 and Equation 1.17: 
         Equation 1.16 
         Equation 1.17 
  
In the case of viscous jets  opt is revised as given in Equation 1.18, with l representing 
liquid viscosity (Pa s), so an increase in liquid viscosity would be expected to increase the 
size of droplets produced at breakup. 
 
            
   
     
 
  
 
Equation 1.18 
 
A number of researchers have investigated the effect of gas friction on the disintegration 
of liquid jets.  Increasing the relative jet to ambient air velocity leads to wave formation 
at the jet surface, augmenting or supplanting the effects of surface tension on the 
breakup process.  Haenlein (1932) described four separate regimes of increasing 
influence as jet velocity increases within a stagnant air environment, ranging from 
surface tension being the dominant factor to disintegration of the jet at the nozzle 
orifice.  Ohnesorge (1936) adopted an analytical approach to the impact of aerodynamic 
forces, using dimensional analysis to characterise operating space.  Ohnesorge defined a 
dimensionless number Z, the stability number or viscosity group, latterly referred to as 
the Ohnesorge number, and plotted this against the Reynolds number to establish the 
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dominant mechanism of atomization.  The Ohnesorge number, Z  
   
  
 , is calculated as 
shown in Equation 1.19: 
   
          
 Equation 1.19 
 Where d0 is the orifice diameter (m), so is constant for a liquid jet issuing from a fixed 
nozzle geometry at constant temperature, with variation in operating parameters being 
reflected in the changing Reynolds number.  Ohnesorge’s classification of jet breakup is 
reproduced as Figure 1.3  
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Figure 1.3 Ohnesorge’s classification of modes of disintegration 
 
Increasing the jet velocity progressively will change the mode of disintegration from 
surface tension-driven axisymmetric as described by Rayleigh, to an air friction 
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dominated non-axisymmetric sinuous wave mode predicted by Weber and observed by 
Haenlein. Increasing the jet velocity further reduces the breakup length to the nozzle exit 
with chaotic droplet formation. 
The approach to characterising jet breakup devised by Ohnesorge has been further 
developed by Reitz (1978) with an increase in the range covered for sinuous breakup, 
and a separation of this mode into two classes.  The first of the two classes, at lower 
Reynolds numbers for a given Ohnesorge number, is characterised by a combined 
surface tension and air friction effect, producing droplets of similar diameter to the jet.  
The second class depicts an increased effect of air friction to give shorter wavelength 
disturbances at the jet surface leading to droplets smaller than the jet diameter. 
1.3.1. Flow focusing 
Flow focusing is the generation of a narrow-diameter liquid jet by use of a fast-flowing 
coaxial fluid stream.  Flow focusing devices consist of a liquid conduit through which the 
focused liquid is introduced into the centre of a chamber, an additional conduit through 
which the focusing fluid is fed, and an exit orifice of circular cross-section through which 
both the focussed and focusing fluids exit.  A diagram of a generalised flow-focusing 
arrangement is shown as Figure 1.4. 
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Focusing fluid
Focused fluid
 
Figure 1.4 Flow focusing arrangement 
 
When operated optimally, a liquid jet with a diameter significantly smaller than that of 
the focussed fluid conduit can be produced under conditions of turbulence sufficiently 
low that subsequent break-up conforms to the Rayleigh ideal, resulting in narrow droplet 
size distributions (Ganan-Calvo, 1998).   
Analysis of the forces during jet generation has led to a description of jet momentum and 
subsequently to an estimate of droplet diameter following break-up.  Energy is supplied 
to the liquid by the fact-moving gas stream as viscous stress and through the pressure 
distribution at the liquid surface, resulting in the generation of additional surface area as 
the jet is produced, coupled with kinetic energy as the momentum of the jet increases.  
The relationship has been described by Equation 1.20, which has been observed to 
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provide accurate results when used to evaluate jet diameters beyond the discharge 
orifice (Ganan-Calvo et al., 2011a): 
   
  
         
 
  
 
    
 
     
   
     
   
      
        
Equation 1.20 
 is the tangential viscous stress on the liquid surface caused by the gas stream (N m-2), 
Pg is the pressure exerted at the liquid surface by the gas stream (Pa), Rj is the jet radius 
(m), Ql is the focused liquid flow rate (m
3 s-1),  is the interfacial tension (kg s-2) and l is 
the liquid viscosity (Pa s). 
The energy dissipation by the interfacial energy increase is considered small, and when 
considering low viscosity liquids the viscous dissipation and viscous stress terms become 
small, hence the three terms can be neglected, as shown in Equation 1.21, to give an 
acceptably accurate estimate of jet radius:  
 
   
    
 
     
        
Equation 1.21 
Integration of Equation 1.21 provides an estimate of the jet radius at the point of break 
up given the low rate of radial change beyond the orifice plate, Equation 1.22: 
 
      
    
 
      
 
 
 
 
Equation 1.22 
Equation 1.22 is also able to be derived with reference to Bernoulli theorem, as can be 
seen from the similarity in form to Equation 1.21.  The two variable terms within 
Equation 1.21 are consistent with the Bernoulli equation, as given as Equation 1.23 
(Coulson & Richardson, 1999),  
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Equation 1.23 
 
The formation of the liquid jet can therefore be described using a conservation of energy 
argument; the acceleration of the liquid jet results in a reduction in pressure within the 
liquid and, by continuity, within the adjacent gas phase.   
The formation of droplets from the jet is driven by surface tension acting upon 
disturbances in the liquid surface generated at the nozzle exit, with resulting droplet size 
predicted by Equation 1.15.  A spectrum of disturbance wavelengths are evident at the 
liquid surface, however only the disturbances with a wavelength greater than the 
circumference of liquid jet are observed to propagate downstream.  The fastest-growing 
disturbance predominates at the point of break-up; disturbances with a circumference: 
wavelength ratio of 0.697 (the ‘Rayleigh mode’) have been observed to have the 
dominant effect on droplet break-up and thus the size of the droplets produced (Eggers, 
1997).   
The flow rates for the focusing and focused fluid, and focused fluid conduit and exit 
orifice diameters and separation are therefore critical process parameters for successful 
operation.  Axisymmetric disturbances are understood to be the precursor to quasi-
monodisperse droplet formation, and the Weber number, as defined in Equation 1.24, 
has been used to describe the limit for formation of axisymmetric disturbances. 
 
    
   
 
 
Equation 1.24 
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An upper limit of We = 40 (Ganan-Calvo, 1998) has been proposed for generation of 
narrow droplet size distributions by growth of the Plateau-Rayleigh instability; outside 
this region sinusoidal (‘whipping’) disturbances increasingly dominate, resulting in both a 
larger droplet size than predicted and increased polydispersity.  A lower limit is also 
evident, due to the formation of a recirculation flow that disrupts the formation of the 
jet surface below a minimum liquid flow rate (Ganan-Calvo et al., 2011b). 
Target operating parameters for the experiments described in Section 3.2 were 
identified using an iterative approach employing the above equations.  Flow rates and 
pressure drops for a required droplet size were identified, and then the Weber number 
was defined to allow comparison with the scientific literature.  An Excel spreadsheet was 
produced to allow calculation of size and associated Weber number across the 
experimental space of flow rate and pressure drop for each of the liquids atomized. 
1.4. Inhaled drug delivery 
The respiratory tract has long been used as a treatment route for a variety of diseases, 
often of pulmonary origin.  Vapours, aerosols and fumes of plant extracts, organic liquids 
and minerals were inhaled from primitive vessels or rudimentary mechanical systems to 
provide relief from a range of conditions including cough and asthma (Anderson, 2005).  
Efficient delivery of API to the lung was first achieved using pressurised metered dose 
inhaler devices (pMDIs) in the 1950s, utilising a combination of chlorofluorocarbon (CFC) 
propellants to aerosolize the formulation upon actuation of a metering valve (Bell & 
Newman, 2007).  Two therapeutic agents were initially delivered, adrenaline and 
isoprenaline, as separate formulated products, using ethanol as a cosolvent to form a 
solution.  The pMDI rapidly became the mainstay of portable inhaled therapy, with 
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industrial quantities of CFC propellants being available as a result of their use in 
refrigerant systems, and metering valves having been developed for the cosmetic 
fragrance sector.  The use of one of three surfactants, oleic acid, sorbitan trioleate or 
lecithin, expanded the formulation space to include micronised particles, reducing 
aggregation and making dispersed, inhalable particles possible rather than relying upon 
droplets to ensure respirable size for the API; use of the surfactants also conferred the 
additional benefit of lubricating the metering valve.  The ozone-depleting potential of 
CFCs was recognised with the ratification of the Montreal Treaty in 1987, requiring the 
eventual replacement of CFC systems with alternatives of lower depleting potential.  
Hydrofluoroalkanes (HFAs) were identified as a suitable replacement to CFCs and have 
become the continuous phase of choice for modern pMDI development, however some 
technical issues remain.  No surfactant system has yet been identified for use in HFA-
based pMDIs, resulting in the need for expensive contingencies, such as coated inner 
valve and canister surfaces, to stabilise suspension formulations.  The two predominantly 
used propellants, HFA134a (1,1,1,2-tetrafluoroethane) and HFA227ea (1,1,1,2,3,3,3-
heptafluoropropane) have low boiling points, requiring the use of expensive pressurised 
manufacturing systems to produce and fill the formulations.  From a patient perspective 
however the lower enthalpy of vaporisation of the propellants compared to the CFC 
systems tends to allow for a more comfortable dose delivery.  The pMDI remains the 
predominant portable delivery system, however difficulty in coordination of dose release 
and inhalation manoeuvre for patients, exacerbated by the technical difficulties 
associated with the CFC to HFA transition has led to the development of alternative 
inhaler variants. 
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Dry powder inhaler devices (DPIs) entered the market in 1971 with the introduction of 
Fison’s Spinhaler, delivering agglomerated sodium cromoglycate from a capsule 
employing a system of blades to spin the capsule ejecting the powder and subsequently 
disrupt the agglomerates to produce a respirable/ fine particle fraction - the proportion 
of the dose considered efficacious with an aerodynamic diameter less than 5 m (Bell et 
al., 1971).  A series of capsule based inhalers have followed, for instance Rotahaler 
(Glaxo), Aerolizer (Novartis), Cyclohaler (Teva) and Handihaler (Boehringer Ingleheim), all 
operating on the same base principle of using the patient’s inspiratory effort to entrain 
and deagglomerate the dose within the capsule (Newman & Busse, 2002; Prime et al, 
1997).  The need to reload the device after each actuation was partially circumvented by 
the Aerohaler (Boehringer Ingleheim), using a magazine of six capsules to reduce the 
frequency of patient intervention, however similar levels of convenience to those 
associated with pMDIs were only realised with the development of reservoir and 
multiple unit dose devices.  Reservoir devices, such as the Turbuhaler (AstraZeneca), 
Twisthaler (Schering Plough), Jethaler (Ratiopharm), Clickhaler (Vectura), Novolizer 
(Meda), Skyehaler (Skyepharma) and Eazyhaler (Orion) use an internal container of API 
or formulation as blend, spheronized API or compressed disk from which an aliquot is 
metered as a dose for the patient upon preparation of the device for actuation.  A 
substantial number of patient doses (up to 200) can be obtained from a single device; 
however concerns around dose reproducibility have hampered entry into some markets, 
primarily the US.  Multiple unit dose devices contain premetered doses filled into 
individual dose units at the manufacturing facility, requiring the patient to advance the 
blister strip (Ellipta and Diskus, GlaxoWellcome) or disk (Diskhaler, GlaxoWellcome) to 
obtain the dose immediately prior to inhalation. 
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All currently marketed DPIs are passive, rather than active devices, utilising the patient’s 
inspiratory flow through the device to provide the energy required to liberate respirable 
particles.  Formulation and device design therefore needs to be carefully considered to 
make best use of the patient’s inspiratory manoeuvre, allowing an efficacious respirable 
fraction to be generated under flow conditions achievable by the target patient 
population. 
1.4.1. DPI Formulation 
The small particle size required for API particles to reach the central and peripheral lung, 
acknowledged to be an aerodynamic diameter of between 1 and 5 m provides a 
technical challenge with respect to dispersion of API particles from the agglomerated 
state.  Deaggregation of API particles within the airflow through a device requires the 
forces acting upon the particles to overcome the autoadhesive forces holding the 
agglomerate together.   The adhesion forces acting between particles in respiratory 
formulations can be subdivided into those arising from interactions between the 
molecules of neighbouring particles at narrow particle separation, referred to as van der 
Waals forces, electrostatic forces imposed during powder transport and handling, and 
capillary forces due to the adsorption of water in the interstices between particles.   The 
relative contribution of each of these adhesion mechanisms will depend upon the 
prevailing environmental conditions.  Van der Waals forces are short range forces, 
resulting from electromagnetic interaction between the protons and electrons of 
molecules in close proximity to the contact zones between the particles.  The quantum 
mechanical nature of this interaction, coupled with the additional complexity of surface 
roughness of interacting particles currently prohibits accurate prediction for real 
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particulate systems, however useful estimates of the magnitude of forces are considered 
achievable by the evaluation of simplified cases. 
Interactions between molecules that leave their chemical identities unchanged arise 
from dipole-dipole (Keesom interaction), dipole-induced dipole and induced dipole - 
induced dipole (London or dispersion) interactions.  The potential, V, of these 
interactions is approximated by Equation 1.25: 
 
    
 
  
 
Equation 1.25 
where S is the particle separation (m).  The constant of proportionality, C, is specific for 
each of the interactions as defined in Equation 1.26, Equation 1.27 and Equation 1.28 
(Atkins, 1998):  
Dipole-dipole: 
   
   
   
 
          
  
Equation 1.26 
Dipole-induced dipole: 
   
  
   
 
   
 
Equation 1.27 
induced dipole- induced dipole: 
   
 
 
  
   
     
     
 
Equation 1.28 
   
where , α’ and I are the dipole moment (D), polarizability volume (m3) and Ionisation 
energies (J) of the two molecules involved in the interaction.  Differentiation of the 
potential provides an expression for the attractive force, presented as Equation 1.29: 
 
   
 
   
 
Equation 1.29 
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The force therefore declines rapidly with intermolecular distance, hence only the 
molecules in very close proximity to those in a neighbouring particle will contribute 
significantly to the intermolecular interaction.  Consideration of the combined effect of 
the molecules in a small spherical particle with the face of a larger faceted particle leads 
to Equation 1.30 (Finlay, 2001), 
 
      
 
    
 
Equation 1.30 
where A is the Hamaker constant for the interacting materials defined by Equation 1.31: 
            , Equation 1.31 
where B describes the interaction energy (J m6) nmp and nm are the molecular density in 
the particle and wall respectively.  D and d represent the interparticle separation and 
particle diameter (m). 
Analysis by Finlay (2001) demonstrates that for a particle with a diameter of five microns 
95 percent of the van der Waals force is contributed by molecules within 0.0005d (2.5 
nm) of the adhesional contact, or 0.00008 percent of the particle mass.  Given the 
sensitivity of the force to such a small area around the contact point, the texture of the 
surfaces of the adhering particles is of paramount importance to adhesion by this 
mechanism. 
Increasing the moisture content of the atmosphere surrounding adjoining particles will 
eventually lead to condensation of liquid water into the interstices.  The Kelvin effect 
predicts that the vapour pressure above a concave liquid meniscus will be reduced 
compared to that above a flat surface, hence preferential condensation will be expected 
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at the contact points of solid surfaces of substances wetted by water (Adamson, 1982).  
The adhesion force attributable to capillary condensation emanates from the surface 
tension of the condensed water acting to oppose increase in the meniscus surface area.  
The increase in adhesion force can be estimated for the adhesion of a particle and flat 
surface of the same material using Equation 1.32: 
                        Equation 1.32 
 where d is the particle diameter (m), 23 is the air-water surface tension (N m
-2), θ is the 
contact angle, and 212 is the work of adhesion (J) resulting from van der Waals forces at 
the particular environmental conditions (e.g. including the presence of water at 
surfaces). 
 Assuming a typical value for interparticle spacing on contact of 0.4 nm, capillary 
adhesion would be expected to occur within inhaled formulations where hydrophilic 
surfaces are present (Finlay, 2001) and capillary forces would be expected to be the 
major contributor to adhesion above 65 percent relative humidity (%RH).  Atomic force 
microscopy (AFM) studies performed at greater than 50 %RH demonstrated increased 
adhesion forces compared to measurements generated using dry atmospheres (Sedin & 
Rowlen, 2000, Xu et al., 2013).  Studies relevant to inhaled API and excipients conducted 
by Podczeck demonstrated an increase in adhesion force beyond 75 %RH for micronised 
lactose particles on a compacted lactose surface, however no similar increase was 
observed when hydrophobic micronised salmeterol xinafoate particles were used 
(Podczeck et al., 1996).  AFM was used to assess the impact of increasing relative 
humidity on lactose-budesonide and lactose-salbutamol formulations (Price et al., 2002), 
demonstrating the dependence of the effect upon the particular molecule used.  Two 
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orders of magnitude difference in interaction energy were encountered between the 
APIs, and differing interaction energy trends were observed.  Capillary adhesion was 
interpreted as being significant for both molecules above 30 %RH, but with a large rise in 
adhesion noted above 60 %RH for salbutamol, compared to a linear increase in adhesion 
force with relative humidity for the less hydrophilic budesonide.  Capillary effects 
became dominant for both APIs beyond 65 %RH.  The effects of capillary condensation 
have been observed to be reversible, however where particles exhibit aqueous solubility 
this may result in dissolution and the formation of permanent solid bridges upon 
removal of the condensate by drying. 
Relative movement of particles during powder handling and transport can result in 
triboelectrification, with a resulting increase in adhesion if dispersion is attempted 
before the charge has decayed sufficiently.    An experimental design was conducted to 
evaluate the charge generated by blending of lactose for 30 minutes in a Turbula mixer 
using an aluminium container then filled into gelatin capsules, compared to that 
imparted during aerosolisation (Chow et al., 2008).  A range of air flow rates and ambient 
humidities were evaluate during inhaler testing, and the impact of repeated use of the 
test inhaler was examined.  Larger charges were seen to be developed upon 
aerosolisation than during processing and filling (of the order of 10 nC g-1 versus 1 nC g-1 
respectively), however an increase in charge with handling was noted.  Increased 
charging was observed when handling or aerosolising powders at low humidities and 
when aerosolising at higher flow rates, and an increased rate of charge dissipation was 
noted at higher relative humidity attributed to increased charge transport in humid air 
and condensed liquid in the particle interstices rapidly dissipating static charge.  The 
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impact of adding API to lactose on the charge developed during blending in a Turbula 
mixer in containers of different materials of construction was considered by Elajnaf and 
co-workers (Elajnaf et al., 2006).  A large change in the charge developed by addition of 
small quantities of API was noted, with polarity of charge developed for each material 
attributed to the relative position in a triboelectrical series of each particulate.  The 
material of construction of the blending container was observed to play a significant role 
in the charge developed, but generation of a powder layer on the surface of the 
container reduced the charge imparted to the powder.  Charge densities of magnitude 
10 nC g-1 were generated for API blends at 20 C / 45 %RH.  The impact of particle size 
and crystallinity on the development of charge was evaluate for lactose monohydrate 
(Carter et al., 1998).  Increased charge was measured on larger particles within the 
particle size range 45 to 180 m, however little impact of crystallinity upon results was 
noted.  Work performed using processing containers made of a variety of materials 
demonstrated a lack of impact upon the aerosolisation of spray dried mannitol, despite 
powder charge differences of -96 nC g-1 for stainless steel to 93 nC g-1 for Teflon being 
imparted to the powder (Adi et al., 2010).  
 The adhesion force attributable to contact of two particles with charged surfaces can be 
estimated by Equation 1.33:  
 
   
       
   
 
Equation 1.33 
 where   is the surface charge density (C m-2) of the adhering particles, and 0 is the 
vacuum permittivity (C2 N-1 m-2).  Studies conducted on the adhesion force for micronised 
salmeterol xinafoate particles on lactose surfaces revealed a mean adhesion force of 2.4 
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x 10-11 N (Podczeck et al., 1997).  An analysis by Finlay based upon the above relationship 
for autoadhesion of lactose particles of diameter 3 m using an adhesion force of 1.5 x 
10-11 N concluded a charge density of greater than 2 nC g-1 would be necessary to have a 
significant impact upon adhesion (Finlay, 2001).  The discrepancy between this value and 
the charges generated during experimental studies on charges generated indicates that 
no observable impact upon triboelectrification by processing should be expected, 
consistent with the findings of Adi et al (2010), where tumbling blending has been used 
to prepare formulations.   
Charging is also possible during powder entrainment upon inhalation by contact with 
inhaler surfaces and other particles within the emitted powder cloud.  Using an electrical 
Next Generation Impactor (eNGI) Hoe and co-workers evaluated the contribution of 
formulation and inhaler components to the charging of the aerosolised powder cloud 
(Hoe et al., 2010).  Charge densities between 100 and 2294 nC g-1 were measured within 
the induction port across the 30 to 90 L min-1 airflow used, orders of magnitude greater 
than that attributed to processing.  The distribution of charge with impacted salbutamol 
sulphate charge was seen to be bimodal, with net negative charge measured below 2.82 
and above 8.04 m; increasing net charge with flow rate was seen, but not proven to be 
statistically significant due to data variability.  The impact of storage humidity on 
aerodynamic particle size distribution and charge was investigated using a Next 
Generation Impactor (NGI) and an Electrical Low Pressure Impactor (ELPI) (Young et al., 
2007).  Results from both impactors demonstrated a similar trend of fine particle fraction 
of salbutamol sulphate with humidity, with a maximum at 60 %RH; results from the ELPI 
showed a consistent decrease in the charge carried by the impacted powder with 
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increasing humidity.  A multifactorial study considering the relative effects of 
formulation ingredients and contact materials on the generation of charge and 
subsequent impact on deposition was performed by (Telko & Hickey, 2014).  Two 
standard entrainment tubes of differing specific resistance were used rather than 
different devices, so effects attributable to materials of construction could be separated 
from that of resistance.  The use of different contact materials to contain the formulation 
prior to actuation had little impact upon the charge profile generated, suggesting 
triboelectrication during blending and subsequent charge exposure upon particle 
separation was the predominant mechanism. Storage effects were observed upon the 
charge profile and stage deposition, with differences in performance apparent for a 
formulation retested after a two week storage interval.  The charges generated upon 
aerosolisation were detected when dosing using the entrainment tubes at up to 95 %RH, 
indicating that charge generation in DPIs is a clinically-relevant phenomenon.  The 
charges developed on the API and excipients were observed to be dependent upon their 
relative position in the triboelectric series, as anticipated, and reducing the drug 
concentration decreased the fine particle fraction (consistent with active site theory, as 
described later in this section) with an increase in charge per particle.  The actuation 
conditions demonstrated an unexpected trend, with the magnitude of charge per 
particle decreasing with increasing specific resistance and turbulence.  The authors 
attributed this counterintuitive trend to the increase in particle collisions likely to occur 
with a higher resistance, as a denser powder cloud is likely to result.  An increase in 
particle collision would promote charge transfer, and provide an opportunity for back 
flow of charge.  The magnitude of charge generated during the study was greater than 
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previously considered likely, with potentially tens of thousands of charges per particle 
possible and therefore a possible influence on particle trajectory and site of deposition. 
Once aerosolised, separation of particle agglomerates containing the API particles is 
necessary in order for a sufficiently small aerodynamic size for lung delivery to be 
achieved.  The lift and drag forces experienced by a particle are proportional to the area 
presented to the laminar airstream, whilst the adhesional force is proportional to the 
particle diameter.  An agglomerate comprised of API particles will therefore be 
inherently difficult to separate using aerodynamic forces, requiring additional energy or 
modification of the adhesion forces to generate a meaningful respirable fraction.  Inhaler 
devices with a means of generating deagglomerating forces other than by patient 
inspiratory effort, known as active inhalers, have been developed however have not yet 
attained acceptance in clinical practice.  Devices such as the Turbuhaler and Twisthaler 
employ formulations containing spheronized pellets of API that are dispersed using a 
tortuous airflow path (Wetterlin, 1988; Yang et al., 2001), however questions have been 
raised regarding the dose reproducibility of such devices (Chrystyn, 2007).  The most 
widely used approach for assuring acceptable respirable fraction is to mix the API with an 
excipient of larger particle size, and exploit the difference in inertia to promote 
separation via drag or during impact with the internal surfaces of the inhaler.  A high 
carrier to API mass ratio is typically used to increase the likelihood of API-carrier 
interactions; the size disparity between API and carrier particles necessitates a high mass 
ratio as the probability of API: API interaction versus API: carrier interaction will be 
dictated by the number, rather than mass, ratio.  The use of dilute API concentrations 
has the added benefit of allowing dosing of milligram quantities of powder blend rather 
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than microgram quantities of API, reducing the impact of nominal dose weight variability 
on the uniformity of delivered API dose.  The use of adhesive mixtures, also known as 
ordered or interactive mixtures, were employed previously in pharmaceutical dosage 
forms to provide an approach to improved blend homogeneity (Staniforth, 1987).  The 
key difference with DPI formulations is the need for the adhesion to be reversible in 
order to generate the respirable fraction of the API within the formulation.  The most 
widely used excipient for inhaled formulations is lactose (4-(β-D-galactosido-)-D-glucose), 
usually in the form of the -monohydrate, however other sugars such as mannitol, 
glucose, trehalose and sorbitol have been evaluated and provide a practical alternative 
(Kou et al., 2012).  The influence of the physical characteristics of the lactose carrier 
upon the aerodynamic particle size distribution and emitted or delivered dose is well 
recognised, and has been the subject of study for numerous research groups over the 
past three decades.  The characterisation of lactose carrier distributions has usually 
employed the median particle size and fines content (defined most frequently as the 
weight percentage of particles with a diameter less than 15 m) as descriptors.  
Manipulation of the fines content has been shown to have a profound effect on the 
respirable fraction of API able to be obtained from a DPI formulation with a proportional 
effect between increasing fines content and increasing respirable fraction (Adi et al., 
2006, Islam et al., 2004a, Kinnunen et al., 2014, Zeng et al., 2001); however the 
mechanism behind this effect remains the subject of debate.  Two theories have been 
proposed: the occlusion of active sites on larger carrier particles, and the formation of 
fine agglomerates of lactose and API particles that enhance the API fine particle mass by 
providing a structure more amenable to separation than single API particles; it is 
considered likely that a combination of the two factors will be important in determining 
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the fraction of API released from the carrier (Jones & Price, 2006).  The level of fines 
necessary to maximise respirable fraction appears to be dependent upon the particular 
system under study; the physical properties of the API and other formulation ingredients 
in combination with the device used will influence the optimal fines content.  
Consideration of the entire carrier particle size distribution has led a number of authors 
to evaluate the optimal median carrier particle size.  A number of factors other than 
dispersibility of API from the carrier surface require consideration, such as good powder 
flow to allow for ease of filling and the ability to retain the dosing characteristics on 
storage (Guenette et al., 2009), hence the ideal distribution will be defined with respect 
to the properties of the API and the formulation process.  Typically carriers with median 
particle size in the range 63 to 90 m have been used for formulation studies employing 
lactose (Jones & Price, 2006). 
Lactose surface properties are an important factor in the generation of the respirable 
dose, and, whilst a degree of modification is possible by lactose processing, research 
groups have been exploring the possibility of using small amounts of alternative 
excipients to change the adhesional contact. Two approaches are possible: the use of 
alternative fine particles to replace or supplant the lactose fines within the formulation 
(Louey & Stewart, 2002, Tee et al., 2000), or the coating of the carrier or API with a 
ternary excipient to modify the surface properties (Begat et al., 2009, Stank & Steckel, 
2013).  Large differences in emitted dose (the dose or fraction of dose released during 
actuation) and respirable fraction (the proportion of the dose considered efficacious, 
generally considered to be fraction with an aerodynamic diameter (Equation 1.34) less 
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than 5 m) are able to be obtained by these approaches, however additional excipients 
and processing steps are required increasing the complexity of manufacture.  
The mixing process employed to produce the formulation can have a profound influence 
upon the behaviour of dry powder formulations.  Two approaches to the formation of 
adhesive mixtures are in general use – the use of tumbling blenders or the use of an 
impeller blade to aerate the blend and induce roping flow (Litster et al., 2002), often 
referred to as low and high shear blending respectively.  The comparatively low energy 
input when using tumbling blending can lead to extended mixing times being necessary 
to achieve suitable blend homogeneity (Zeng et al., 2000), whilst increasing the 
processing time for high shear blending can suppress the available lactose fines (Bridson 
et al., 2007) and increase the adhesion force between API and carrier particles (De Boer 
et al., 2012). 
The physical properties of the API within an inhaled formulation are probably the key 
determinants of the delivered dose.  The aerodynamic diameter (Telko & Hickey, 2005) 
of the liberated API particles is the primary property in deposition within the respiratory 
tract (Biddiscombe et al., 2006), defined in Equation 1.34: 
 
        
  
   
 
Equation 1.34 
 where p and 0 are the particle and unit densities respectively (kg m
-3), and  is the 
dynamic shape factor determined experimentally to account for deviations from 
sphericity.  Particle density therefore has a profound influence upon the site of 
deposition in the respiratory tract, and as modification of the particle density will change 
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the geometric size for a given aerodynamic size, can change the balance of adhesion and 
drag forces.  Single compound crystalline particles offer little opportunity for density 
modification given the repeating molecular motif.  Amorphous or partially amorphous 
particles however, particularly those with multiple components, offer the opportunity 
for density reduction by the incorporation of voids or production of hollow particles.   
Porous Pulmosphere particles, produced using the endogenous lung surfactant DSPC 
(distearoylphosphatidylcholine) are reported to offer a number of related formulation 
approaches, acting either as a carrier for crystalline API or as with the API dissolved 
within the DSPC matrix.  Lung doses of up to 60 percent of label claim have been 
reported, compared to less than 20 percent for conventional API-carrier blends, with 
reduced dose variability (Weers & Tarara, 2014).  Hollow particles, usually produced by 
spray drying, have been used to increase the respirable fraction.  Bosquillon and co-
workers (2001) described increases by using a combination of lactose, DPPC 
(dipalmitoylphoshatidylcholine) and albumin, compared to similar formulation using 
trehalose or mannitol in place of lactose, and highlighted the inclusion of albumin as 
having a large influence upon both particle morphology and fine particle fraction.  The 
same research group used similar formulations to deliver human growth hormone to 
male Wistar rats, demonstrating superior delivery compared to instillation of solution, 
with a threefold increase in adsorption.  The use of DPPC as an excipient, primarily to 
promote formation of low density particles using an endogenous lung material, had the 
additional benefit of acting as a permeation enhancer.  In a study delivering human 
parathyroid hormone (PTH) to Wistar rats using a DPPC-based formulation (Codrons et 
al., 2003) high respirable fractions (c. 60 %) and emitted doses (c. 90 %) were observed 
from a Spinhaler for the low density particles generated by spray drying.  Two 
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formulations were then reported to show improved adsorption over subcutaneous 
injection, and the inclusion of albumin within the formulation allowed a similar in-vivo 
effect with a ten-fold reduction in dose. 
The geometric size of aerosol droplets and particles has been demonstrated to directly 
affect the site of deposition in the lung.  A review conducted by Stahlhofen et al (1989) 
describes the effect of particle size upon the deposition of radiolabelled particles of 
differing size in the lung in the context of inspiratory flow rate and in consideration of 
the rate of clearance, suggesting that and aerodynamic diameter of 6 m gives highest 
deposition for the combination of impaction, sedimentation and diffusion mechanisms 
(Stahlhofen et al., 1989). Studies using salbutamol sulphate solution droplets 
demonstrated an increased improvement in patient FEV1 (forced exhalatory volume in 1 
second) for droplets with an aerodynamic particle size of 6 m compared to 3 and 1 m 
comparators (Usmani et al., 2005), despite greater lung deposition for smaller particle 
sizes.  The evaluation of 1.5, 2.8 and 5 m droplets of ipratropium bromide revealed that 
5 m particles were less efficacious (Zanen et al., 1995).  Narrow distributions of solid 
API particles have also been reported to improve the delivery characteristics of DPI 
devices.  Radiolabelled mannitol delivered from an Aerolizer device of mean particle 
sizes 2.7, 3.6 and 5.4 m showed a doubling of lung dose upon size reduction from 5.4 to 
3.6 m, however little further difference in effect upon reduction in size to 2.7 m 
(Glover et al., 2008).  The particles were not monodisperse however (GSD of 2.6, 2.4 and 
2.7 m with increasing average size) so the distribution width may be partially 
responsible for the lack of change.  Spray dried mannitol (Chew & Chan, 1999) and 
disodium cromoglycate (Chew et al., 2000) were used to understand the effect of 
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increasing flow rate upon respirable fraction of different size fractions from two inhaled 
devices.  An interaction between flow rate, device and API size was noted however a 
clear trend of increased respirable fraction with reducing particle size was observed. 
1.4.2. Delivery system  
The interaction between the delivery system and formulation is of paramount 
importance in determining the proportion of the API within the formulation that is able 
to be delivered to the lung.  Separation of the API particles from the carrier is dependent 
upon the turbulence generated within the inhaler at the point of dose emission (Clark & 
Hollingworth, 1993) characterised by the device resistance, which can be assessed by 
measurement of the pressure difference necessary to maintain a specific air flow 
through the device.  The detail design of the DPI being used will dictate the resistance 
generated at a particular flow rate (Srichana et al., 1998), hence use of a standardised 
pressure difference rather than flow rate has been proposed as a more rigorous basis for 
device comparability (Steckel & Muller, 1997).  
The airstream passing through the DPI first entrains the powder, the mechanism being 
dependent upon the configuration of the primary dose container (Dunbar et al., 1998).  
In the case of static dosing systems, such as blisters and reservoir devices, shear 
fluidization is understood to be the dominant mechanism, whilst mechanical effects are 
the major contributor in DPIs utilising spinning or vibrating capsules.  Shear fluidization 
can occur under either laminar or turbulent regimes, dependent upon the air velocity 
and geometry of the inhaler.  In the case of turbulent shear, the energy for entrainment 
is provided by turbulent eddies generated within the airstream penetrating the boundary 
layer above the powder surface.  The lift force provided by turbulent eddies has been 
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estimated using the relationships presented as Equation 1.35, Equation 1.36 and 
Equation 1.37 (Finlay, 2001): 
  
 
               
  
  
 
 
    
 
Equation 1.35 
 
     
   
 
 
Equation 1.36 
 
     
  
      
 
Equation 1.37 
  
w is the mean shear stress at the wall (kg m
-1 s-2), d is the particle diameter (m),  is the 
kinematic viscosity (m2 s-1) and fluid is the gas density (kg m
-3).  For DPIs d+ is understood 
to be below 100, resulting in estimated lift forces between 10-9 and 10-6 N across the 
particle diameter range 3 to 60 m, compared to adhesional forces of 10-12 and 10-8 N. 
Entrainment by shear fluidization in DPIs is believed to be more likely to occur in the 
laminar regime (Finlay, 2001) as a Reynolds number below 105 is expected for an airflow 
path of cross sectional area larger than 6 mm2.  The lack of turbulent eddies to provide 
the kinetic energy necessary for fluidization indicates reliance on alternative mechanism 
being responsible, with saltation being unlikely due to the short path length for impact-
driven entrainment. 
The lift force provided by a passing laminar airstream is a result of the fluid viscosity, 
causing asymmetry in airflow at the leading and trailing edges of particles.   The lift force 
can be estimated by Equation 1.38 
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Equation 1.38 
 with the coefficient of lift, CL, able to be expressed as functions of the particle Reynolds 
number, Rep, and the ratio of the particle diameter to the boundary layer thickness, 
 
   
; 
AF (m
2) and v (ms-1) are the face area presented by the particle to the airstream and the 
airstream velocity respectively.  In the case of Rep«1 and 
 
   
«1, CL is estimated as 5.87 
(King & Leighton, 1997).  Some doubt exists whether the inequalities stated are satisfied 
for DPIs operating at patient relevant flow rates, and alternative values for CL below 0.4 
have been suggested.  The lift force has been demonstrated to dominate the adhesion 
force and particle weight for carrier particles, however is considered insufficient to cause 
direct entrainment of inhalable particles (Finlay, 2001). 
Following entrainment, the dry powder inhaler influences the deaggregation of powder 
agglomerates via three mechanisms: 
1. Impaction upon the inner surfaces of the inhaler 
2. Particle separation by the direct effect of aerodynamic forces 
3. Differential acceleration experienced by primary particles within the agglomerate 
Most DPIs have features within the device designed to increase the turbulence of the 
inspired air and to provide a structure to promote deagglomerating impacts, either 
directly or indirectly.  Commonly this is in the form of a grid upstream of the entrainment 
point of the powder; however the primary mechanism of deagglomeration attributable 
to such design features may be dependent upon the particular device design.  A study 
conducted by Voss and Finlay concluded that impaction upon the bars of the grid was an 
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ineffective method of deaggregation using a test rig (Voss & Finlay, 2002), however 
alternative studies have suggested the presence of the grid promotes impaction upon 
device surfaces, increasing the respirable fraction (Coates et al., 2004, Suwandecha et 
al., 2014).  The increase in turbulence generated by the grid structure and other air flow 
path features is accepted as having a beneficial effect upon the reduction of 
agglomerates.  The eddies generated within the DPI result in localised differences in air 
velocity which can exhibit stresses across agglomerates, the magnitude of which is 
dependent upon eddy size and energy.  Eddy size in such systems is commonly described 
by categorisation into one of three scales: integral, inertial subrange and Kolmogorov. 
Integral scale eddies are the largest, containing the majority of the kinetic energy in a 
turbulent system and probably are the most effective in terms of agglomerate 
disruption.  A measure of the velocity of integral scale eddies can be gained from 
estimation of the turbulent energy dissipation rate, ,, with an estimate eddy size using 
Equation 1.39 
 
   
  
 
 
 
Equation 1.39 
 where ui is the integral velocity scale (m s
-1) and l is the eddy length scale (m).  Where a 
grid is used to promote turbulence the relationships presented as Equation 1.40 and 
Equation 1.41 can be used with S being values for the spacing between bars of the grid 
(m), u is the mean upstream velocity (m s-1), x0 and x are the grid and turbulence 
measurement positions and c1 and n are constants for the particular arrangement under 
study.   
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Equation 1.40 
  
 
  
    
  
 
 
 
 
  
 
 
   
 
 
Equation 1.41 
 Knowledge of the size and energetics of the integral scale eddies subsequently allows 
extrapolation of the length  (m), time tK (s) and velocities vK (m s
-1) associated with the 
Kolmogarov scale by the relationships given as Equation 1.42, Equation 1.43 and 
Equation 1.44: 
 
 
 
   
   
 
 
 
 
 
 
Equation 1.42 
 
 
  
  
   
   
 
 
 
 
 
 
Equation 1.43 
 
  
  
   
   
 
 
 
 
 
 
Equation 1.44 
  
In the range of Reynolds numbers usually associated with DPI systems, the inertial 
subrange lengths, times and velocities can be considered intermediate between the 
integral and Kolmogorov scales. 
A comparison of forces has been used to estimate the relative contributions of direct 
aerodynamic forces versus stress imposed on agglomerates by integral scale eddies in 
the removal of small particles from carriers (Finlay, 2001).  Assuming an adhesion force 
of 10-11 N, larger forces for drag (10-9 N) and lift (10-10 N) are likely making these viable 
mechanisms (along with impaction of inhaler surfaces) for deaggregation; in contrast the 
forces generated upon agglomerates by the turbulent airstream were calculated as being 
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of similar magnitude to the adhesion forces therefore suggesting this mechanism plays a 
minor role in the generation of the respirable fraction. 
1.4.3. Aerodynamic particle size analysis of inhalation products 
The characterisation of inhaled formulations and devices relies predominantly upon 
techniques that utilise inertial impaction to separate the emitted/ delivered dose into 
size fractions, followed by chemical analysis of the deposited mass.  Test methodology 
has typically used cascade impactors originally introduced for the evaluation of airborne 
dust or contaminant concentrations, however more recently purpose-designed 
impaction systems for inhaled product testing have become available (Marple et al., 
2003).  The use of carrier-based formulations in the majority of dry powder formulations, 
and the dynamic nature of the droplets formed during actuation of metered dose 
inhalers make the use of laser-based systems difficult, given the inability to distinguish 
between particles of different compositions. Sophisticated characterisation systems 
employ laser diffraction in combination with inertial impaction have however been 
described (Mitchell et al., 2006). 
Cascade impaction relies upon inertial forces acting upon particles entrained in the 
airstream to fractionate the particle size distribution. The flow path of particle-laden gas 
within the impactor is arranged to cause changes in direction; with particle inertia 
determining whether the particle remains travelling with the gas stream or deviates on a 
separate path. A series of flow orifices, also known as nozzles, and adjacent impaction 
plates are employed to collect sequentially finer fractions of the overall particle 
distribution from the gas stream.  The combination of orifice diameter and number are 
used to define the gas velocity through the stage, and in conjunction with the orifice 
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stage to collection plate ratio is used to define the aerodynamic size able to be collected.  
A schematic arrangement of a collection stage within a cascade impactor is given as 
Figure 1.5; hashed arrows indicate gas flow streamlines and red and green circles depict 
impacting versus uncollected particles respectively: 
S
d0
Q
Impactor stage
Impaction plate
 
Figure 1.5 Cascade impaction stage and plate arrangement 
 
Flow conditions within impactors are described with reference to Stokes law.  The Stokes 
number (St, the ratio of particle stopping distance to a characteristic dimension) at each 
stage can be calculated using Equation 1.45 (Mitchell & Nagel, 2003) 
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Equation 1.45 
 where d0 is the average orifice diameter for the particular stage (m), Dp and Dae are the 
particle geometric and aerodynamic diameters (m), p and 0 are the particle and 
reference densities (kg m-3), u is the average gas velocity through the impactor nozzles 
(m s-1), Cpa and Cae are the Cunningham slip factors (1 for dp > 1 m) and  is dynamic 
viscosity of air (Pa s) at the test temperature.  The efficiency of collection at the stage is a 
sigmoidal function of St; 50% efficiency is defined as the cut size, D50, of the stage (also 
known as the effective cut-off diameter, ECD), and for simplicity all particles larger than 
D50 are assumed to be collected on the stage with all smaller particles assumed to carry 
over to the next impaction stage.  Considering a volumetric flow Q (m3 s-1) the ECD can 
be calculated using Equation 1.46, where n is the number of nozzles present in the 
impactor stage.
 
      
      
 
       
 
 
 
 
     
    
 
Equation 1.46 
To maximise collection efficiency, the Reynolds number for flow through the nozzle 
orifice of diameter is maintained between 500 and 3000, hence the combination of n and 
d0 is carefully defined across the stages of the impactor to give the required series of cut 
points within the aerodynamic distribution. The ratio of nozzle to plate distance, S, and 
d0 should be between one and 10 for good stage efficiency, and an optimum value of 
0.495 has been suggested for √St50 (Marple et al., 2003). 
The cascade impactors commonly used for characterisation are described in the US and 
European Pharmacopeia, for example the Multi-Stage Liquid Impinger (Apparatus C 
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(USP) and Apparatus 4 (Ph Eur)), Anderson Cascade Impactor (Apparatus D and 
Apparatus 1, 3) and the Marple Miller (Apparatus 2, Ph. Eur only).  The most recently 
developed impactor, the Next Generation Impactor (Apparatus E and Apparatus 5, 6), 
has been designed for ease of analytical work-up and incorporation into automated 
systems.  Example schematics of the impactors are presented as Figure 1.6  (United 
States Pharmacopeia Convention, 2014). 
Marple-Miller  Multi-Stage Liquid Impinger 
 
 
Next Generation Impactor Anderson Cascade Impactor 
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Figure 1.6 Cascade impactors 
 
The impaction systems configuration used depends upon the information required.  
Simple vacuum pumps capable of generating a sufficiently large peak flow rate are 
typically used to distinguish between devices or different formulations, and are the 
mainstay of analysis for the release of commercial or clinical products for human use.  
The pump is usually used in conjunction with a timed switching valve, so a particular flow 
volume can be routed through the inhaler at peak flow.  An example of an equipment 
configuration for this purpose is presented as Figure 1.7 (United States Pharmacopeia 
Convention, 2014). 
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Figure 1.7 Cascade impaction configuration 
 
Stable flow conditions within the impactor are achieved using a flow control valve to 
regulate the pressure ratio P3/P2.  A pressure ratio of 0.5 or lower ensures critical flow 
through the impactor, reducing the impact of flow fluctuations caused by variation in 
pumping rate (Mohammed et al., 2012). 
Coupling the cascade impactor to a more complex actuation system offers the potential 
to increase the patient-relevance of the information obtained.  The Electronic Lung 
(Burnell et al., 1998), as shown in Figure 1.8, uses a computer-controlled servo motor to 
move a piston in response to an inhalation profile previously recorded for a patient.  The 
dose is therefore entrained from the device using a realistic flow profile into the 
sampling chamber; valves then allow the inhaler to be isolated from the chamber.  The 
aerosolised dose is subsequently drawn through the cascade impactor using the 
standard ‘square wave’ flow profile at the required test flow rate to allow fractionation 
of the dose via impaction and derive the aerodynamic particle size distribution of API. 
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Figure 1.8 The Electronic Lung 
 
An alternative to the Electronic Lung system was proposed in the form of a combined 
cascade and virtual impactor combination (CAVIC).  This device, which incorporates an 
anatomical throat profile to mimic the human oropharangeal cavity, uses a similar 
breathing simulator to the electronic lung but pushes, rather than draws the airflow 
through the inhaler and combines this with an additional, larger airstream to remove the 
need for a separate holding chamber (Finlay & Gehmlich, 2000).  Two ‘virtual’ impactors 
are used to reduce the particle size distribution range to 1 to 10 m, and to reduce the 
flow through the cascade impactor to 30 L min-1 to allow impaction and sizing of particles 
in the respirable range.  A schematic diagram of the CAVIC system is presented as Figure 
1.9. 
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Figure 1.9 Cascade and Virtual Impactor Combination (CAVIC) 
 
The complex systems illustrated with the two examples above are typically employed to 
understand the result of device modification, such as a change in specific resistance upon 
the likely deposition in patients.  Assessment of the effect of particle manipulation is 
typically performed using the simpler pharmacopeial systems presented at the beginning 
of this section (Donovan & Smyth, 2010, Young et al., 2011, Zeng, Martin, Marriott, & 
Pritchard, 2001), hence a Next Generation Impactor configured according to Figure 1.7 
has been used to evaluate the API particles generated during the studies presented in 
this thesis.
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2. EQUIPMENT AND MATERIALS 
2.1. Equipment 
2.1.1. Atomizing system 
Atomization by flow-focusing was performed using an FFDryer atomizer (Ingeniatrics 
Tecnologias, Seville, Spain).  The atomizer is designed to fit into the atomizer port of a 
Buchi B-290 spray dryer and provides separate conduits for the focused liquid and 
focusing gas. The body and cap of the atomizer have 6 mm push-fit connectors fitted to 
allow connection to a liquid temperature-regulating circuit using pneumatic tubing.  The 
liquid feed conduit consists of a 1.6 mm feed tube connected to stainless steel capillary 
of internal diameter 150 µm.  The capillary is mounted into a chamber at the end of the 
atomizer body also housing the atomizing gas conduit.  The chamber is closed by a plate 
containing a 150 µm orifice and sealed by a thread to compress an o-ring to give a gas 
tight seal.  Marks on the atomizer chamber external surface and orifice plate are aligned 
to give the required distance of 100 µm between the capillary tip and inner surface of 
the orifice plate.  Gas is supplied to the atomizer via a 6 mm push-fit pneumatic 
connector attached to the entrance of the gas conduit.  The atomizing gas supply is 
regulated using a needle valve (SS-4MG-MH, Swagelok, King’s Langley, U.K.) and digital 
manometer (LEO1, Keller-Druch, Winterthur, Switzerland).  The liquid for atomization is 
supplied by a Syringe pump (Isco 260D, Teledyne Isco, Lincoln, U.S.A.) in order to give 
consistent flow across the range of flow rates evaluated.  The integrated PLC system of 
the Isco pump was used to regulate the liquid flow rates during the droplet size 
distribution and spray drying experiments.  Liquid is drawn into the pump via a non-
return valve connected to the pump piston by 3.2 mm outside diameter stainless steel 
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tubing, and discharged through 1.6 mm outside diameter stainless steel tubing 
connected to the FFD atomizer liquid conduit.  A diagram of the FFD atomizer is 
presented as Figure 2.1. 
Atomizer body
Cap
Push-fit connector
Cooling oulet
Cooling inlet
Liquid feed tube
Gas conduit
Capillary
Orifice plate
Ferrule
 
Figure 2.1 FFD atomizer 
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A liquid-jacketing system connected to a recirculating bath (LTD 6, Grant Instruments, 
Cambridge, U.K.) was used to regulate the temperature of the liquid within the atomizing 
system.   A circuit was assembled using the integral jacket surrounding the pump piston, 
the atomizer body, and a coaxial jacket around the stainless-steel liquid feed tubing 
constructed using 8 mm pneumatic tubing.  A thermocouple was inserted into the 
cooling circuit at the atomizer cooling outlet port and connected to data logger (5100e, 
Eurotherm Ltd, Worthing, U.K.) to allow the temperature within the atomizer to be 
monitored.  The set-point of the recirculating bath was adjusted manually during 
experiments in order to obtain the desired atomizer temperature. 
2.1.2. Spray dryer 
A B-290 spray dryer (Buchi Labortechnik, Flawil, Switzerland) was used to dry solution 
droplets produced by the FFDryer atomizer and collect the resulting solute particles.  
Buchi spray dryers have been extensively used in research, particularly for the evaluation 
of organic compounds.  Langrish and co-workers have used the B-290 extensively in the 
study of sugars during spray drying.  The B-290 was used to compare models describing 
the impact of process parameters on the crystallization kinetics of spray dried lactose 
solutions, identifying inlet air temperature as the dominant parameter (Chiou & Langrish, 
2008).  Langrish also describes a similar impact of inlet air temperature upon crystallinity 
for lactose and sodium chloride, demonstrating that the effects of processing parameters 
upon crystallinity are not limited to organic molecules (Langrish, 2009).  The B-290 was 
used to provide amorphous lactose particles which were subsequently used in the 
validation of rate of change models to describe the transition from the amorphous to 
crystalline state (Das & Langrish, 2012).  The B-290 has also been used with APIs; 
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amorphous salbutamol sulphate particles were produced for use in recrystallization 
studies (Grisedale et al., 2011), and the successful production of composite particles of 
budesonide and formotorol fumarate using the B-290 has been demonstrated (Tajber et 
al., 2009). 
The spray dryer used within this work was fitted with a high efficiency cyclone (Buchi, 
Flawil, Switzerland) to maximise the collection of small particles.  The spray dryer was 
used in open-cycle ‘blowing’ mode given the negligible risk of over-pressurising the spray 
dryer by blinding the outlet HEPA filter.  Air was used as the atomizing and drying gas 
throughout the spray drying experiments.  A diagram of the spray dryer configuration is 
presented as Figure 2.2.  
Aspirator fan
Syringe pump
Recirculating cooler
High efficiency cyclone
Drying chamber
HEPA Filter
Metering valve
Powder collection vessel
Drying gas heater
Atomizer
T1
T2
Compressed 
air
Inlet filter
P
 
Figure 2.2 Spray drying configuration 
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2.2. Materials 
2.2.1. Solute properties 
Fluticasone propionate and mometasone furoate are corticosteroid molecules commonly 
used for the treatment of lung diseases, notably asthma and chronic obstructive 
pulmonary disease (COPD), and are structurally similar as a consequence of both being 
derivatives of cortisol.  Corticosteroids induce relaxation of the smooth muscle that 
forms part of the airway structure when delivered topically (the molecules exhibit low 
oral bioavailability) and are commonly dosed to patients using DPIs and pMDIs (Patton & 
Byron, 2007). 
The molecules share the androstane 3-ring structure common to all steroid molecules, 
however substituent groups differ, most notably at in the ester groups at C-17 but also 
with respect to the halogen at C-9 and the lack of a halogen atom at C-6 for mometasone 
furoate (Crim et al., 2001).  The structures of fluticasone propionate and mometasone 
furoate are presented as Figure 2.3. 
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Figure 2.3 Molecular structures of fluticasone propionate and mometasone furoate 
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The structural difference between the molecules translates to differences in the solid 
state.  Two crystalline forms of mometasone furoate are known; a stable anhydrous form 
designated form 1 and a monohydrate form produced in the presence of sufficient water 
during nucleation.  The monohydrate is able to be converted to a second anhydrous 
form, designated form 2, at temperatures above 130C.  Form 2 readily reconverts to a 
monohydrate form at room temperature with sufficient humidity and shows similar 
crystal packing to the monohydrate.  Form 1 appears to be stable as an anhydrate; no 
presence of a hydrated form was detected following storage at 97 %RH for 3 months.  
The monohydrate is suspected to be the stable form at low temperature with sufficient 
humidity; however the distinctly different molecular packing of the two forms presents a 
significant energy barrier to conversion between forms (Chen et al., 2005). 
Two forms of fluticasone propionate are known to exist, both of which are non-solvated.  
Form 2 has only been produced at elevated pressures using supercritical fluid 
crystallization and has been seen to be metastable at room temperature, converting to 
form 1 in the order of 6 months (Su et al., 2011).   Thermal analysis of form 1 shows no 
events until the melt decomposition commencing at 280C; an exothermic event was 
observed at 150C to 180C for form 2 attributed to conversion to form 1.  The 
exothermic transition was observed to be irreversible during cooling and reheating, 
typical of a monotropic relationship between forms (Cooper, 2003). 
2.2.2. Solvent and solution properties 
The physical properties of the liquid being focused by the FFDryer atomizer will have a 
significant influence on the size and polydispersity of the droplets generated.  The 
density of the focused fluid, in combination with the focusing gas pressure drop, is 
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paramount in determining the liquid jet diameter at the point of break up.  The liquid 
density, in conjunction with the liquid surface tension and focusing gas pressure drop 
defines the balance of inertial and capillary forces that characterise the mode of break-
up, as denoted by the Weber number (Ganan-Calvo & Riesco-Chueca, 2006).   The 
density and surface tension must therefore be known to an appropriate degree of 
precision in order to accurately predict the size of droplets produced.  The identification 
of a value for surface tension can be additionally complicated in the case of solutions 
containing a surface-active solute.  Under these circumstances the value derived for 
surface tension becomes dependent upon the rate at which the surface under 
measurement is produced, as a consequence of differing solvent and solute diffusivity 
(Eastoe & Dalton, 2000).  The surface tension value employed to characterise such 
solutions undergoing dynamic processing will therefore need to reflect the timescale of 
the unit operation in order to reflect the apparent value. 
The characteristics of the solid particles resulting from drying of solution droplets 
produced by the atomizer are a function of the saturation, solute diffusivity and drying 
rate, as described in Section 1.2.2 of the Introduction.  Estimation of the saturation level 
during drying requires knowledge of the solubility of the solute at temperatures relevant 
to the drying process, particularly the saturation concentration.  Studies were therefore 
undertaken to understand the solubility and surface tension of mometasone furoate and 
fluticasone propionate in ethanol and 2-propanol.  The solubility studies demonstrated 
that only low concentrations of solute are possible for the solutes and solvents used, as 
is often the case for relatively large, non-polar organic molecules dissolved in organic 
solvents.  The density of such systems is suitably similar to that of the solvent that the 
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solvent density provides a suitably accurate approximation of the solution density.  The 
solution density was therefore represented by literature values for the relevant solvent 
(Haynes, 2012) at the temperature of interest. 
2.2.2.1. Solubility 
Equilibrium solubility was determined between 30°C and 75°C by the evaluation of 
filtered solution aliquots taken from saturated solutions containing an excess of solute 
(Mullin, 2001).  Two 50 mL vials containing 2 g of API and 20 g of solvent were prepared 
for each solute-solvent combination and placed in a Reaction Station (Stem RS1000, 
Electrothermal, Rochford, UK).  A magnetic stirrer bar was placed in each vial and the 
contents agitated at the required temperature for 48 hours in order to form saturated 
solutions.  10 ml plastic syringes (BD Plastipak, Becton Dickinson, Madrid, Spain) fitted 
with 0.2 µm syringe filters (Millex GV, Millipore, Co. Cork, Ireland) were sealed inside a 
plastic bag and immersed in a thermostatically controlled bath (LTD 6, Grant 
Instruments, Cambridge, U.K.).  The bath was set to the same temperature set-point as 
the Reaction station and the syringes were left to equilibrate for at least 2 hours to attain 
a temperature equivalent to the solution samples.  Once the required time period had 
elapsed a syringe and filter were removed from the bag and the solution vial opened.  
Approximately 2 mL of solution was withdrawn from the vial into the syringe, the filter 
was then removed and the sample was discharged to waste.  The filter was then 
replaced onto the syringe and a further approximate 2 mL of solution was withdrawn.  
The filter was removed and the sample was discharged into a preweighed vial, then 
sealed with a lid and the vial and contents were weighed so the mass of solution could 
be determined.  A second syringe and filter combination were then selected and the 
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sampling process described above was repeated for the second saturated solution vial to 
give a second solution sample.  The lids were removed and the open vials were placed in 
a vacuum oven at 40°C for 24 hours to remove the solvent; at the end of the drying 
period the vials were weighed to allow the mass of dry solute to be calculated.  Solution 
sample concentrations were then calculated and are presented on both a molar and 
mass basis as Figure 2.4 and Figure 2.5. (Note: the final set of sample concentrations was 
evaluated at 70C; insufficient sample remained to allow results for the two APIs in 
ethanol to be generated). 
 
Figure 2.4 Equilibrium molar solubilities of the API-solvent combinations 
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Figure 2.5 Equilibrium mass-fraction solubilities of the API-solvent combinations 
 
A clear difference in the solubilities of the two APIs is evident with higher equilibrium 
concentrations being achieved for mometasone furoate than for fluticasone propionate 
for both solvents used. 
A range of solution concentrations are required during the spray drying experimental 
design study to evaluate the effect of this parameter upon the physical properties of the 
dried particles produced.  A maximum solute concentration of 0.0075 was required to 
complete the spray drying experimental design study described in Section 4.3; hence 
with reference to Figure 2.5 (required concentration signified by dotted line marked as 
‘DoE’) the temperature of the API solutions for spray drying will need to be maintained 
above 50C to avoid possible precipitation of solute before atomization.
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2.2.2.2. Surface tension measurement 
Surface tension data for mometasone furoate and fluticasone propionate in ethanol and 
2-propanol have been generated to aid understanding of the droplet generation and 
drying processes.  Measurements were performed using a T60 bubble pressure 
tensiometer (Sita Messtechnik GmbH, Dresden, Germany).  Maximum bubble pressure 
tensiometry is often used to provide information when liquids are to be used in 
processes with short characteristic timescales, where liquid surface is created at rapid 
rate (Beckett, 1996).  The technique is most beneficial when studying the behaviour of 
surfactant systems, where the speed at which surfactant molecules are able to migrate 
to an expanding interface will have an impact upon the surface tension (Miller et al., 
1994).   Maximum bubble pressure tensiometers utilise the relationship between the 
interfacial tension / surface energy of an expanding bubble and the pressure required to 
cause the expansion.  The maximum pressure will be attained where the bubble radius 
equals the radius of the capillary used to generate the bubble; the dynamic surface 
tension can then be calculated via a modified Young- Laplace equation shown as 
Equation 2.1:  
 
   
  
 
        
Equation 2.1  
 
  
Where P is pressure within the bubble (N m-2), r is the bubble radius (m),  is the liquid 
density (kg m-3),  is the dynamic surface tension (N m-1), h is the immersion depth of 
capillary in liquid (m) and p (Pa) is a correction term for hydrodynamic effects. 
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The characteristic timescale for maximum bubble pressure tensiometry is considered to 
be the lifetime of the bubble, corresponding to the time required for the bubble to reach 
maximum pressure from the commencement of expansion (Fainerman et al., 1994). 
Measurement of surface tension was performed in duplicate for each solution system at 
temperatures of 30°C, 45°C and 60°C.  A solute concentration of 0.5 %w/w was used for 
each solute-solvent system.  A range of bubble lifetimes from approximately 0.1 to 10 s 
were evaluated.  Solutions were contained in clean 20 mm diameter glass tubes and the 
temperature was regulated using a Stem RS1000 Reaction Station (Electrothermal, 
Rochford, UK).  Figure 2.6 to Figure 2.9 show a decrease in surface tension with 
temperature for the four solution systems; in addition a decrease in measured surface 
tension with lifetime is apparent between the minimum lifetime value evaluated and a 
lifetime of approximately 1 second. 
 
Figure 2.6 Effect of droplet lifetime upon the surface tension of Fluticasone Propionate 
in ethanol 
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Figure 2.7 Effect of droplet lifetime upon the surface tension of Fluticasone Propionate 
in 2-propanol 
 
 
Figure 2.8 Effect of droplet lifetime upon the surface tension of Mometasone Furoate in 
ethanol 
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Figure 2.9 Effect of droplet lifetime upon the surface tension of Mometasone Furoate in 
ethanol 
 
Although a reduction in surface tension with lifetime is evident at small lifetime values, 
the change of surface tension with lifetime is not typical of that expected for a solution 
containing a surface active solute.  In the case of surface activity, the maximum surface 
tension (that of the solvent) is the observed at low lifetimes; the surface tension then 
decreases to an asymptotic value as sufficient time is allowed for the surfactant 
molecules to migrate to the emerging bubble surface.    Solution surface tensions for the 
four solution systems approach that of the solvents at longer lifetimes, typically in excess 
of one second, for all three temperatures evaluated.  The higher than expected values 
for surface tension at short droplet lifetimes may be attributed to the measurement 
technique; long, narrow capillaries are used with the Sita T60 instrument and 
measurement geometries such as this have been associated with pressure differences 
between the reservoir in the instrument and the developing bubble.  This has been 
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observed to result in an overestimation of surface tension at short bubble lifetimes 
(Kovalchuk & Dukhin, 2001). 
A comparison of the surface tension results obtained for solutions at 45°C is presented 
below.  Figure 2.10 and Figure 2.11 contain individual values for each of two frequency 
sweeps from >1 to approximately 10 s; surface tension values obtained at droplet 
lifetimes of less than one second have been omitted for the reasons given above.  The 
results for the solutions have been compared with literature values for the respective 
solvents (Azizian & Hemmati, 2003, Haynes, 2012, Hoke & Chen, 1991, Vazquez et al., 
1995, Yaws, 2012) in Figure 2.10 and Figure 2.11.  
 
Figure 2.10  Temperature dependence of surface tension of ethanol solutions 
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Figure 2.11 Temperature dependence of surface tension of 2-propanol solutions 
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experimental sections within this work as this reference provides information for all 
operating temperatures of interest. 
2.3. Conclusion 
Evaluation of equilibrium solubility of the two corticosteroid molecules with temperature 
demonstrates similar trends and concentrations with respect to order of magnitude.  
Mometasone furoate exhibits a consistently higher absolute solubility across the 
temperature range in both of the alcohols, probably as a consequence of the differing 
substituent groups given the similarity in molecular weight and structure between the 
two molecules.  The molar solubilities of each corticosteroid in the two alcohols are seen 
to be equivalent, resulting in an increased mass fraction solubility in ethanol.  The 
equilibrium solubility studies have allowed processing conditions for API spray drying to 
be identified. 
The surface tensions measured for the four solute-solvent combinations are typical of 
non-surface active solutes, as the stable values for solutions are similar to those taken 
from the scientific literature for the solvents used.  Solvent data therefore should 
provide an appropriate basis for calculation of flow focusing parameters.
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3. CHARACTERISATION OF ATOMIZATION 
3.1. Droplet imaging 
The successful production of low-polydispersity droplet distributions using flow-focusing 
is dependent upon the use of appropriate nozzle geometry and suitable operating 
parameters, as described in Section 1.3.1. The FFDryer atomizer has been designed to 
comply with the dimensional requirements necessary for successful flow focusing 
(Rosell-Llompart & Ganan-Calvo, 2008), however to be certain that any trends between 
predicted droplet size and concentration and subsequent dry powder properties are 
genuine, assurance is required that the particular atomizer being used does produce 
droplets by the break-up of a liquid jet by the intended mechanism (Ganan-Calvo, 1998).  
An evaluation of droplet formation was performed using high-speed photography for 
each of the solvent systems intended for use in the spray drying experiments. 
High speed photography is a common technique in the study of atomization, giving a 
clear insight into the process of spray generation.  The key mechanisms responsible for 
formation of droplets are readily identified, allowing additional analytical techniques to 
be selected appropriate to the timescales and nature of the break-up process.  High 
speed photography followed by Phase Doppler Anemometry was used to characterise 
the formation of droplets produced by a twin fluid atomizer (Kufferath et al., 1999).  A 
Nanolite spark system provided illumination; the 20 ns duration was sufficiently brief to 
allow capture of clear images of spray plumes from this dynamic process characterised 
by high Reynolds numbers.  Mayer employed high-speed cinematography and flashlight 
photography to study the atomization of cryogenic propellants, demonstrating 
significant differences between atomization and mixing in under subcritical and 
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supercritical conditions (Mayer, 1994).  The use of magnifying lenses with high speed 
imaging has allowed the study of individual droplets, rather than spray plumes, when 
evaluating liquid jet break-up.  Brenn, Helpio and Durst used a CCD camera fitted with a 
magnifying lens to study droplet formation from a novel, multiple atomizer array 
producing droplets from circular jets via piezoelectric oscillation (Brenn et al., 1997).  The 
authors used an LED-based stroboscope to illuminate the image capture, synchronised to 
the oscillator.  Image processing was then employed to yield information on the droplet 
size distribution produced by the array.  Ganan-Calvo used high speed videography to 
demonstrate the operating principles of a flow-focusing atomizer, employing a 70 ns 
shutter time with an unspecified light source to confirm operating conditions for 
obtaining monodisperse droplets (Ganan-Calvo, 1998). 
An imaging system comprising a high speed videography system, a magnifying lens and a 
high-intensity light source was assembled to evaluate the FFDryer atomizer and used to 
obtain images of droplet formation across and beyond the Weber number range 
postulated to encompass successful operation. 
3.1.1. Equipment configuration 
Images of jet break-up were collected using a high speed video camera (Motionpro 
10000, Redlake, San Diego, USA) fitted with a microscope lens (Linos, Göttingen, 
Germany).  Illumination was provided by an image processing strobe (BVS-II Wotan, 
Polytec GmbH, Waldbronn, Germany) triggered by collection of images by the camera.  
Light from the strobe was directed via a fibre-optic conduit arranged to back-light the 
liquid jet from the atomizer.  The camera was mounted onto a tripod with vertical 
adjustment to allow the point of droplet generation to be accurately imaged; the 
Characterisation of Atomization 
91 
 
distance between lens and droplet stream was maintained throughout the experimental 
runs at approximately 5mm. 
3.1.2. Experimental procedure 
Images were captured using an exposure time of 2 s at a shutter speed of 10000 frames 
per second.  The short exposure time, necessitated by a droplet generation rate of the 
order of 105 droplets per second, requires intense light to obtain a clear image.  The 
strobe unit is able to produce the necessary intensity, however only as a single pulse 
within the timeframe of image capture.  The very short exposure time also made 
synchronisation of image capture and strobe activation challenging, resulting in a 
number of instances of underexposed images if only a single frame was captured.  The 
recording of a sequence of ten frames upon triggering ensured one of the images was 
acceptably clear; the remaining nine underexposed images were discarded. 
Ten acceptable images were obtained for each set of atomizer operating conditions to 
determine whether droplet formation by axisymmetric break-up was taking place.   Each 
image was analysed using ImagePro software (Version 4.5, Media Cybernetics Inc, 
Maryland, USA) to provide a characteristic droplet diameter for each droplet image 
present within the main image.  A graticule (Pyser-SGI Ltd. Kent, UK) was used to 
calibrate the Imagepro software in order that measurements could be performed.  
Larger droplets were observed to be non-spherical in shape, so an average size was 
calculated based upon the maximum and minimum dimensions of the droplet to give a 
more representative characteristic diameter.  Droplet size distributions were then 
calculated from the droplet images to allow comparison of image analysis results to 
those predicted by theory. 
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3.1.3. Experimental conditions 
Droplet images were captured for water, ethanol and propanol across and beyond the 
Weber number range postulated for axisymmetric break-up.  The flow rates, and 
pressure drops used are given in Table 3.1, Table 3.2 and Table 3.3.  
3.1.4. Results and discussion 
 A representative image is presented for each condition for water, ethanol and propanol 
in Table 3.1, Table 3.2 and Table 3.3 respectively.  The remaining images captured are 
presented as Appendix 1. 
Table 3.1 Droplet formation images for water 
Flow rate 
(mL/h) 
Pressure drop 
(mbar) 
Direction of flow:  
Image 
 
200m
 
7 60 
 
10 130 
 
27 60 
 
32 80 
 
40 130 
 
62 60 
 
63 300 
 
80 100 
 
 
Table 3.2 Droplet formation images for Ethanol 
Flow rate 
(mL/h) 
Pressure drop 
(mbar) 
Direction of flow:  
Image 
 
200m
 
10 100 
 
20 25 
 
22 30 
 
28 50 
 
40 100 
 
64 50 
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Table 3.3 Droplet formation images for 2-propanol 
Flow rate 
(mL/h) 
Pressure drop 
(mbar) 
Direction of flow:  
Image 
 
200m
 
5 25 
 
7.5 55 
 
12 150 
 
20 25 
 
24 35 
 
30 55 
 
35 75 
 
40 100 
 
49 150 
 
 
A comparison of median droplet diameter (D50) measured from the images to the droplet 
size predicted by Equation 1.15 is presented as Table 3.4, Table 3.5 and Table 3.6. 
Table 3.4 Droplet size analysis results for water 
Flow rate (mL h-1) Pressure Drop 
(mbar) 
We Predicted D50 
(m) 
Image analysis D50 
(m) 
7 60 3.9 45 38 
10 130 8.3 44 38 
27 60 7.6 88 85 
32 80 10 89 88 
40 130 17 88 93 
62 60 11 133 164 
63 300 39 90 91 
80 100 19 133 141 
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Table 3.5 Droplet size analysis results for ethanol 
Flow rate (mL h-1) Pressure Drop 
(mbar) 
We Predicted D50 
(m) 
Image analysis D50 
(m) 
10 100 23 44 Not recorded 
20 25 11 89 77 
22 30 13 89 74 
28 50 21 88 72 
40 100 43 89 77 
64 50 32 133 129 
 
Table 3.6 Droplet size analysis results for 2-propanol 
Flow rate (mL h-1) Pressure Drop 
(mbar) 
We Predicted D50 
(m) 
Image analysis D50 
(m) 
5 25 6.2 44 50 
7.5 55 14 44 41 
12 150 37 43 50 
20 25 12 88 88 
24 35 17 88 84 
30 55 27 88 97 
35 75 37 88 100 
40 100 50 88 97 
49 150 74 88 91 
 
Weber number values below 40 are understood to be required to ensure axisymmetric 
break-up of the liquid jet and give the narrowest possible droplet size distribution 
(Ganan-Calvo, 1998, Ganan-Calvo, 2008, Rosell-Llompart & Ganan-Calvo, 2008).  The 
critical Weber number has been exceeded for two of the three liquids evaluated and 
axisymmetric break-up has been observed to occur up to Weber numbers of 39, 43 and 
74 for water, ethanol and 2-propanol respectively when operated at conditions 
postulated to generate droplet with a diameter of approximately 90 m.  No evidence of 
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an asymmetric mode of break up was observed above We = 40 during imaging of the 
liquids evaluated which appears in contradiction of the accepted threshold for flow-
focusing, however axisymmetric break-up above this threshold value has been previously 
reported (Gordillo et al., 2001a).  Atomization driven by hydrodynamic, rather than 
capillary forces, has been postulated as the mechanism for axisymmetric droplet 
formation at We > 40.   The authors note that transition to helicoidal (asymmetric) 
break-up is likely to occur with increasing We, however no evidence of this was seen 
during imaging, up to a maximum of We = 74  evaluated for 2-propanol. 
Liquid jet break-up generally occurs too close to the atomizer aperture to make 
identification of the break-up mode possible when operating at a target droplet size 
below 50µm.  Images obtained for 2-propanol at 12 mL h-1 liquid flow, 150 mbar 
pressure drop appear to show axisymmetric break-up;  the similar trajectory of the 
droplets produced at break-up in all images indicates axisymmetric break-up is the likely 
mechanism as transition to a helicoidal, asymmetric mode would be expected to cause a 
wider range of droplet trajectories. 
Larger than predicted droplet sizes are observed at operating conditions encompassing 
relatively high liquid flow compared to pressure drop across the atomizer orifice; this is 
particularly evident when water was used as the focussed fluid at conditions of 62 mL h-1 
liquid flow, 60 mbar pressure drop and 80 mL h-1 liquid flow, 100 mbar pressure drop.  
Given the close proximity of the droplets to the point of break-up in the images, 
coalescence after break-up is unlikely to be the cause of the large droplet size.  A more 
likely explanation is a wider than predicted jet diameter at the point of jet detachment, 
leading to a proportionally large droplet after break-up.  Measurement of the jet 
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diameter at break-up for 62 mL h-1 liquid flow, 60 mbar pressure drop gives a jet radius 
of 77 m, approximating to a droplet size of 145 m compared to a predicted value of 
133 m.   
The short exposure times used necessitated opening the aperture of the lens to the 
maximum extent to best use the light produced by the strobe unit.  The depth of field 
becomes small under such operating conditions, and this combined with the rapid 
movement of the droplets results in some loss of definition of the droplet edge within 
the images.  Measurement using image analysis will therefore be subject to a degree of 
error.  The results and predicted droplet diameter do however agree well, hence it would 
appear that a combination of low pressure drop and high liquid flow may result in 
droplet size being under-predicted.  Effects attributable to flow ratios have been 
observed during previous flow focussing studies (Gordillo et al., 2001a), however were 
attributed to the effect of hydrodynamic forces when operating at We > 40 rather than 
at the low Weber number conditions prevalent at high liquid: gas flow ratios.  
Satellite droplets are evident in a number of the images, a known consequence of this 
mode of droplet formation (Lefebvre, 1988).  These have occurred across the range of 
conditions evaluated; however they are at least an order of magnitude smaller in 
diameter than droplets formed from detachment of the peturbation rather than the 
neck between two peturbations.  Solid material produced from satellite droplets during 
spray drying of solutions should therefore be readily identifiable and their impact on 
subsequent test results should be able to be explained. 
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3.2. Droplet measurement 
Laser diffraction has become established as a key technique for the characterisation of 
particle and droplet size distributions.  The technique exploits the relationship between 
the diffraction angle of a light beam and the particle size of the object causing the 
diffraction to provide an estimate of the particle size.  Modern laser diffraction 
measurement systems employ a collimated beam of laser light and a concentric detector 
arrangement to provide a scattering pattern from a particulate sample which is then 
deconvoluted using Fraunhofer or Mie algorithms to yield a volume-based size 
distribution.  The ability to characterise an entire particulate distribution coupled with a 
sampling rate of up to 2500 s-1 make laser diffraction systems a powerful tool for the 
evaluation of dispersed systems (Mitchell et al., 2006). 
A number of applications of laser diffraction for the study of spray generation are noted 
in the relevant literature. The technique has been used to quantify the output from 
continuous sprays such as fuel injectors and spray dryer atomizers and also transient 
sprays, for example those produced by aerosol devices fitted with metering valves or 
pumps.  The particular laser diffraction system employed during this work, the Malvern 
Spraytec, has been used to evaluate continuous spray generation in a number of 
instances.  An analysis of water mist sprays for fire suppression systems (Santangelo, 
2010) demonstrated the ability of the measurement system when used to characterise 
high velocity droplets. A study of droplet production from a spray dryer atomizer (Thybo 
et al., 2008) notes the changing average droplet size with distance from the atomizer, 
attributed to coalescence within the turbulent spray produced by a two-fluid atomizer.  
The Malvern Spraytec was used as part of an investigation to correlate droplet and 
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resulting particle size distributions for spray pyrolysis (Wang et al., 2008).  Good 
correlation was observed between solution droplet distribution measured using the 
Spraytec and the resulting dry particle size distribution of the solute determined by 
image analysis of scanning electron micrographs. 
Extensive use of the Malvern Spraytec in the charactisation of aerosol device output is 
evident in the literature.  The effect of formulation ingredients upon droplet size 
distribution was investigated for nasal spray devices (Dayal et al., 2004) and use of the 
Spraytec allowed elucidation of the impact of changing physicochemical properties upon 
spray characteristics.   Laser diffraction was used to provide information for a 
computational fluid dynamics (CFD) model describing delivery from a novel liquid inhaler 
(Worth et al., 2009).  The Spraytec was employed to measure the droplet sizes generated 
immediately beyond the inhaler mouthpiece and provide the initial conditions for the 
CFD model, which was subsequently validated using inertial impaction. 
Two notable studies have been conducted to evaluate the measuring capabilities of the 
Spraytec system.  The ability of the Spraytec to evaluate multi-modal droplet 
distributions was investigated (Triballier et al., 2003) and the measurement system was 
observed to successfully characterise the bi- and trimodal distributions used within the 
study.  A second part of this study, also evaluated in a further experiment (Dumouchel et 
al., 2009) challenged the capability of the software algorithm to deconvolute the effect 
of multiple scattering which can lead to under-sizing of dense sprays.  Automotive fuel 
injection systems were used within both studies; multiple injectors and a protecting tube 
were used to change the spray density without changing the droplet size distribution.  
Results demonstrated a narrowing of the distribution when light transmission falls below 
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40% interpreted by the authors as the software algorithm being unable to fully correct 
for the under-sizing of the droplet distribution. 
The droplet distribution produced by flow focusing-based devices is typically monomodal 
(Ganan-Calvo, 1998) and droplet density would be expected to be low given the modest 
liquid flow rates for flow focusing devices compared to spray dryer two fluid atomizers, 
automotive fuel injectors or fire suppression systems.  The Malvern Spraytec should 
therefore be capable of determining droplet size distributions produced by the FFD 
atomizer. 
3.2.1. Equipment configuration 
Droplet size distribution measurement was performed using a Spraytec laser diffraction 
instrument (Malvern Instruments, Worcestershire, UK) fitted with a 300 mm lens.  The 
lens has a minimum working distance of 150 mm and is capable of measuring droplets 
within the range 0.1 to 900 m (Malvern Instruments, 2005).  The FFDryer atomizer was 
suspended directly above the laser beam, maintaining a defined gap between the lowest 
point of the atomizer orifice plate and the top of the beam.  A retort stand and clamp 
were used to suspend the FFDryer atomizer in order that the atomizer could be removed 
from the vicinity of the beam during the background measurement step that preceded 
each droplet distribution measurement.  A distance of 50 mm between the centre of the 
atomizer orifice plate and the Spraytec detector window was used for all experimental 
runs to avoid vignetting (Triballier et al., 2003).  An illustration of the experimental set up 
is presented as Figure 3.1. 
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Figure 3.1 Spraytec set up 
 
3.2.2. Experimental conditions 
A standard operating procedure (SOP) was written based on the default continuous 
spray SOP provided within the Spraytec software in order to ensure measurements of 
different experimental runs were performed under similar conditions. Refractive indices 
specific to each of the liquids under test were used for data analysis; refractive indices 
for solutions were assumed to be identical to those for the solvent as a result of the low 
concentration of solute present.  A curve-fitting model was not selected for use with the 
data analysis software as no knowledge of the droplet size distribution produced by the 
atomizer was available prior to the Spraytec evaluation (Triballier et al., 2003).   
Background measurement was performed before each measurement run, once 
completed the FFDryer atomizer was aligned as detailed in section 3.2.1 and the flow 
rate and pressure drop set as required.  Droplet production from the atomizer was then 
allowed to stabilise for five minutes before commencing measurement.  The droplet 
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distribution was then measured for five minutes, capturing a scattering pattern every 
second during this period.  
Droplet generation was characterised for water, ethanol and propanol, and also for 
solutions of sodium chloride in water and mometasone furoate and fluticasone 
propionate in ethanol and 2-propanol.   
Three groups of measurements were undertaken to demonstrate the suitability of the 
FFDryer atomizer and measurement configuration for investigating the API behaviour 
during spray drying: 
1. Data generated to define the atomizer-to-beam distance to be used during 
characterisation. 
2. Data generated to establish the effect of atomizer operating parameters upon 
droplet size distribution and agreement of data with control theory. 
3. Evaluation of the impact of inclusion of solute on droplet size distribution 
compared to solvent only. 
3.2.2.1. Atomizer to beam distance 
The dried particle size generated during spray drying is dependent upon the droplet size 
at the point of atomization; hence an accurate measurement of droplet size is essential 
to understand drying behaviour.  The laser beam used for droplet size measurement is 
collimated to a width of approximately 10 mm so a change in droplet size during 
measurement is possible if the drying kinetics under the conditions of measurement are 
sufficiently rapid, resulting in the detection of an artificially wide droplet distribution. In 
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addition, coalescence of droplets will change the droplet distribution; if this were to 
occur beyond the point of measurement the droplet size distribution collected would 
underestimate the true droplet sizes being produced.  Jet break up was observed to 
occur at less than 3mm from the orifice plate of the FFDryer atomizer during droplet 
imaging experiments; measurement at intervals beyond this range should therefore 
allow coalescence to be identified by an increasing droplet size with increasing distance 
(Thybo et al., 2008).  Droplet size measurements were performed at atomizer to beam 
distances of 5, 10 and 15 mm for the same droplet generation conditions using 2-
propanol to determine the impact of droplet age upon size at ambient conditions. 
3.2.2.2. FFDryer atomizer characterisation 
Evaluation of atomizer parameters was performed to define sets of operating conditions 
relevant to use with the Buchi B-290 spray dryer.  The small length of the drying chamber 
within the Buchi unit results in a short droplet residence time, hence droplet diameters 
less than 100 µm for water are required in order to allow drying of droplets to 
completion.  Pressure drop and flow rate values postulated to give droplet sizes of 10 to 
100 µm were identified using the relationships established by Ganan-Calvo (1998) for 
water, ethanol and 2-propanol.  Initial experiments were conducted at room 
temperature employing as low a pressure drop as possible in order to operate at the 
minimum Weber number, and therefore to operate as close as possible to the preferred 
operating region postulated in the literature.  Further runs were then performed using 
higher pressure drops of 150 to 400 mbar for ethanol and 2-propanol, and 150 to 900 
mbar for water, to evaluate maximising the atomizer throughput and therefore 
maximising the yield of solute upon spray drying for a fixed period.  
Characterisation of Atomization 
103 
 
Additional experiments were then conducted on ethanol and 2-propanol using a 
jacketing temperature of 50C to determine the impact of the change of operating 
temperature upon droplet generation.  Solution temperatures in excess of 50C are 
necessary to ensure operation below the saturation limit for mometasone furoate and 
fluticasone propionate solutions in ethanol and 2-propanol at the solution concentration 
chosen, as defined in Section 2.2.2.1. 
Finally runs were conducted with solute at a representative concentration – 5 %w/w for 
sodium chloride in water at 25°C, and 0.5 %w/w for mometasone furoate and fluticasone 
propionate in ethanol and 2-propanol at 50C – in order to confirm consistency between 
operation using solvents and associated solutions. 
 
3.2.3. Results and discussion 
To allow comparison of the effect of operating parameters within a complex 
experimental space, droplet size information obtained during the atomizer evaluation is 
represented using the normalised values described below.  Summary graphs of the input 
data, detailing droplet size versus liquid flow rate at fixed pressure drop, are presented 
in Appendix 8. 
 the ratio of measured median droplet diameter to predicted droplet size - 
 
   
          
  
 The measured average span, calculated as the difference between the ninetieth 
and tenth percentiles divided by the median size -  
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Both values have been calculated as the mean of the value recorded at intervals of one 
second over the measurement period.  An additional graph has been included for data 
sets where outlying results have necessitated a large ordinate scale and made 
interpretation of the remaining data difficult; in this case the additional graph has a 
reduced scale excluding the outlying results.  Additional summary figures are given 
defining the impact of increasing Weber number upon droplet size.  
To allow comparison of data the solvent / solution flow rate though the atomizer has 
been expressed using the predicted droplet size, which appears as the ordinate in many 
of the following figures.  The jet diameter at the point of break-up can be estimated 
using Equation 3.1 and Equation 3.2 below, with resulting droplet size given by Equation 
1.15: 
 
    
 
  
 
 
 
 
   
    
  
 
 
 
 
Equation 3.1 
 
 
    
     
    
  
Equation 3.2 
 
  
At a defined pressure the predicted size will therefore reflect the liquid flow rate, as all 
other variables will be constant for a particular solution/ solvent and operating 
temperature.  The actual droplet size produced during the experiment is represented as 
the ratio of the median size (D50) to the predicted size to again allow cross comparison of 
data where numerous of variables are subject to change. 
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3.2.3.1.  Atomizer to beam distance 
The impact of varying atomizer to beam difference upon average droplet size and span is 
presented as  
Figure 3.2 and Figure 3.3: 
 
Figure 3.2 Effect of atomizer to beam distance on droplet size distribution (150mbar, 2-
propanol) 
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Figure 3.3 Effect of atomizer to beam distance on span (150mbar, 2-propanol) 
 
Close agreement is observed between measurements made at atomizer to beam 
distances of 5, 10 and 15 mm with respect to both particle size and span.  Two of the 
three measurements for 5 mm distance at a target droplet size of 80 µm yielded a 
significantly lower size than the remaining measurement and those for 10 mm and 15 
mm runs.  Poor reproducibility between runs at target size of 80 µm and greater was 
evident throughout the evaluation using the Spraytec, hence the difference in results at 
80 µm is likely to be as a result of poor reproducibility rather than atomizer to beam 
distance.  The high value for span at 10 mm atomizer to beam distance, target size 30 µm 
is caused by a high 90th percentile value, frequently observed during measurement of 
droplet generation using low flow rates at relatively large pressure drops.  This effect is 
either a consequence of coalescence subsequent to initial jet break-up, or possibly as a 
result of periodic helicoidal-type break-up of longer wavelength than for the 
axisymmetric mode (Gordillo et al., 2001a).  
The results indicate a stable droplet size distribution over the distance evaluated, 
consequently 10 mm atomizer to beam distance was chosen for subsequent Spraytec 
evaluation experiments. 
3.2.3.2. Atomizer operation characterisation 
3.2.3.2.1. Water and aqueous sodium chloride atomization 
Comparison of a dimensionless actual: predicted median diameter over the predicted 
droplet diameter range for water at pressure drops between 200 and 300 mbar is 
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summarised in Figure 3.4; the associated span is presented as Figure 3.5.  A minimum of 
two runs per flow rate at a pressure drop were undertaken. 
 
Figure 3.4 Effect of pressure drop and liquid flow rate on droplet size for water 
 
 
Figure 3.5 Effect of pressure drop and liquid flow rate on span for water 
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Some evidence of a trend of reducing  
   
          
 with increasing pressure can be 
observed, however the inherent variability between runs at nominally the same 
operating conditions results in the relationship being difficult to discern.  Substantial 
between-run variability when using water is apparent in the span values in Figure 3.5; it 
would appear that the width of the distribution as well as the midpoint is subject to 
significant variability when using water as the focussed fluid. 
Little difference in span or median size standard deviation is observed for water over the 
range 200 to 300 mbar pressure drop, corresponding to We = 7 to 38.  Further 
experiments were conducted up to a 900 mbar pressure drop in an attempt to maximise 
process efficiency for a required droplet size, however no deterioration in performance 
with regard to span and 
   
          
  was observed.  Operational issues were encountered 
at pressure drops above 500 mbar; leakage occurred at the joint between the atomizer 
capillary and solution feed tube so a pressure drop of 300mbar was chosen for further 
evaluation. 
Sodium chloride solutions at 5 % w/w were used to evaluate the atomizer further as this 
is the maximum concentration proposed for spray drying runs to characterise the in-situ 
performance of the atomizer with the Buchi B-290 spray dryer.  Repeat runs (n=3) were 
undertaken at the flow rates evaluated previously for water,  
   
          
 and span with 
increasing predicted droplet size are presented as Figure 3.6 and Figure 3.7. 
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Figure 3.6 Effect of liquid flow rate on droplet size for 5%w/w aqueous sodium chloride 
solution 
 
 
Figure 3.7 Effect of liquid flow rate on span for 5%w/w aqueous sodium chloride 
solution 
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Figure 3.6), corresponding to a flow rate of 41 mL h-1, so the larger of the two solution 
flow rates was restricted to at or below this threshold.  An increase in actual droplet size 
compared to predicted droplet size with increasing droplet size was again observed for 
the sodium chloride solution runs, as noted in previous experiments, hence the 
operating conditions to be used were chosen on the basis of experimental data.   25.8 
and 7 mL h-1 flow rates were selected for the spray drying experiments as they 
correspond to droplet diameters of approximately 70 and 35 m respectively and should 
produce an acceptable difference in droplet size whilst giving a reasonable spray drying 
run time.  Droplet size distributions for the selected conditions are shown as Figure 3.8, 
with error bars representing the standard deviation. 
 
Figure 3.8 Droplet size distributions for 5%w/w sodium chloride solutions 
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3.2.3.2.2. Atomization of ethanol and 2-propanol 
A wide pressure drop range was explored to define suitable operating parameters for 
atomization alcohols and associated solutions.  Initially pressure drops from 70 to 400 
mbar, with flow rates of 2 to 80 mL h-1 were evaluated at 25C to identify an acceptable 
compromise between distribution width and spray drying run time.  
   
          
 and span 
relationships with predicted droplet diameter across the pressure drop range are 
summarised in Figure 3.9 to Figure 3.12. 
 
Figure 3.9 Effect of pressure drop and liquid flow rate on droplet size for 2-propanol, 
25C 
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Figure 3.10 Effect of pressure drop and liquid flow rate on span for 2-propanol, 25C 
 
 
Figure 3.11 Effect of pressure drop and liquid flow rate on droplet size for ethanol, 25C 
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Figure 3.12 Effect of pressure drop and liquid flow rate on span for ethanol, 25C 
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capillary forces at We > 40.  The wavelength of the perturbations formed as a result of 
the action of the gas stream is shorter than that predicted for capillary action; hence a 
smaller droplet size will result.  Droplet size is expected to be inversely proportional to 
pressure drop under such circumstances, as has been seen during the characterisation 
studies performed to characterise the FFDryer atomizer.  Additionally, the applicability of 
Bernoulli theory to the operation of the atomizer, as described in Section 1.3.1, suggests 
that the viscous drag imparted by the high velocity gas stream is not considered within 
the control theory.  The shearing effect at the liquid surface is likely to additionally 
elongate the liquid thread, thus providing an explanation for the offset in droplet size 
noted. 
Instances of increased span are observed when operating at conditions chosen to give a 
predicted size below 40 m resulting from high average ninetieth percentile values 
observed at low liquid flow rates.  The root cause of the high values is unclear; either 
coalescence is occurring before the point of sizing, or disruption to axisymmetric break-
up results in the droplet formation mechanism deviating from that expected.   
Additional runs were conducted at 50C, the jacketing temperature to be used in the 
spray drying runs; the data from these runs is summarised in Figure 3.13 to Figure 3.18. 
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Figure 3.13 Effect of pressure drop and liquid flow rate on droplet size for 2-propanol, 
50C 
 
 
Figure 3.14 Effect of pressure drop and liquid flow rate on droplet size for 2-propanol, 
50C 
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Figure 3.15 Effect of pressure drop and liquid flow rate on span for 2-propanol, 50C 
 
 
Figure 3.16 Effect of pressure drop and liquid flow rate on droplet size for ethanol, 50C 
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Figure 3.17 Effect of pressure drop and liquid flow rate on droplet size for ethanol, 50C 
 
 
Figure 3.18 Effect of pressure drop and liquid flow rate on span for ethanol, 50C 
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general pattern of under-prediction of droplet size at higher pressure drops is again 
evident, similarly to the 25C data, however at the higher temperature inter-run 
variability is seen to increase over that observed previously.  Span values at low 
predicted droplet sizes show large values, similarly to the low temperature data, 
however span values below one are observed across the droplet size range at pressure 
drops above 150 mbar. 
Further characterisation of the variability over the pressure drop range at the two 
operating temperatures is possible by evaluating the variance of the 300 D50 
measurements taken over the course of the five minute duration of each of the 
measurement runs.  Figure 3.19 to Figure 3.22 summarise the predicted size standard 
deviation values for the experimental runs performed at the pressure-drop – 
temperature combinations. 
 
Figure 3.19 Variation of median droplet size standard deviation with average median 
droplet size for 2-propanol, 25C 
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Figure 3.20 Variation of median droplet size standard deviation with average median 
droplet size for 2-propanol, 50C 
 
 
Figure 3.21 Variation of median droplet size standard deviation with average median 
droplet size for ethanol, 25C 
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Figure 3.22 Variation of median droplet size standard deviation with average median 
droplet size for ethanol, 50C 
 
Consistent with the observations for the D50 and span values, a pattern is evident 
between the alcohols for standard deviation.  Standard deviation of less than 3 m is 
apparent at 25C with a pressure drop of 200 mbar or less for both alcohols at predicted 
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seen to give larger standard deviations the 2-propanol at the higher pressure drops, and 
an increase in standard deviation with predicted droplet size is seen.  Increasing the 
operating temperature to 50C causes an increase in standard deviation, however for 
both alcohols standard deviations less than 4 m are able to be obtained when operating 
at 100 to 200mbar pressure drop at predicted droplet sizes below 80 m.  Outside this 
range standard deviations between 5 and 9 m can be experienced, particularly at 
higher pressure drops.  The increase in standard deviation for droplets would translate to 
an increased variance of the dried particle size distribution, hence an upper limit of 80 
m was imposed during the particle formation activities described in Chapter 4.  
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Interestingly the standard deviation appears to reach a maximum in the vicinity of 100 
m median size, corresponding to Weber numbers in excess of 50.  The increase in 
standard deviation at this point is in agreement with the accepted theory for flow 
focussing; however the subsequent decrease in standard deviation with increasing liquid 
flow indicates that the Weber number may not be the only parameter of interest when 
atomizing liquids by this method. 
3.2.3.2.3. Atomization of mometasone furoate and fluticasone propionate solutions 
An evaluation of the reproducibility for repeat runs was conducted for solvent and 
solvent with solute.  The difference between maximum and minimum average D50 was 
used as the basis for a t-test, and a 95% confidence interval constructed using the 
associated standard deviations (Mason, 2003).  Standard deviations were assumed to be 
unequal between samples and standard errors calculated accordingly.  Significant 
difference is observed between the repeat runs in almost all cases; the few exceptions 
are due to large standard deviations rather than close similarity between median sizes.  
As noted earlier a degree of polydispersity was observed for all experimental runs and is 
apparent in the median droplet size standard deviation data presented as Figure 3.19 to 
Figure 3.22.  The significant difference between runs is therefore not a result of a very 
small standard error but due to real difference in the droplet distribution produced 
between experimental runs conducted under nominally identical conditions.  As optimal 
operating conditions were unable to be identified using statistical analysis, evaluation of 
the span and median size standard deviation and process efficiency was used to identify 
operating conditions for spray drying experiments.  The observed effect of operating 
Characterisation of Atomization 
122 
 
pressure upon both span and reproducibility of droplet production resulted in a limit of 
150 mbar pressure drop being employed for use in subsequent API solution experiments 
Two distinct droplet distributions are required to characterise the behaviour of the two 
APIs during spray drying, as was the case for aqueous sodium chloride solutions.  The 
need to maintain the solution temperature at 50C also limits the minimum predicted 
droplet size to 40 m in order to avoid increased span and consequent issues with wide 
particle size distributions.  Three liquid flow rate and pressure drop combinations were 
selected at each of two target predicted droplet sizes for evaluation with API solutions.  
   
          
 and span data produced by the experimental runs are summarised in Figure 
3.23 to Figure 3.26. 
 
Figure 3.23 Effect of pressure drop and liquid flow rate on droplet size for 0.5%w/w API 
solutions in 2-propanol, 50C 
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Figure 3.24 Effect of pressure drop and liquid flow rate on droplet size for 0.5%w/w API 
solutions in ethanol, 50C 
 
 
Figure 3.25 Effect of pressure drop and liquid flow rate on span for 0.5%w/w API 
solutions in 2-propanol, 50C 
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Figure 3.26 Effect of pressure drop and liquid flow rate on span for 0.5%w/w API 
solutions in ethanol, 50C 
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runs.  Analysis of the droplet distribution data (as shown in Figure 3.28) reveals a 
bimodal distribution for We = 35 conditions with two distinctly separate modes at 
approximately 40 and 200 m.  The distribution around the 40 m mode is narrow and 
gives a good droplet distribution for generation of spray dried API.  Material produced as 
a result of droplets drying from the mode at approximately 200 m should be readily 
recognisable during characterisation of dried material and so the impact of such particles 
upon analytical results can be accounted for.  We = 35 conditions of 12 mL h-1 solution 
flow and 150 mbar pressure drop were therefore selected for use in API spray drying 
studies. 
Very similar values for span are observed for the three sets of operating conditions 
evaluated for generation of the larger droplet size.  The We = 20 condition produced the 
largest median droplet size, however some lateral movement of the jet was observed 
during measurement, raising concerns regarding the jet stability when used within the 
spray dryer.  Operating conditions used to give We = 57 resulted in the generation of a 
smaller median droplet size and poorer reproducibility as evident in Figure 3.23 and 
Figure 3.24.  The We = 35 operating condition of 26 mL h-1 liquid flow rate and 100mbar 
pressure drop producing approximately 80 m diameter droplets was therefore selected 
for the API spray drying evaluation.  A comparison of the average droplet diameters 
produced at the target sizes is presented for the solvents and solutions as Figure 3.27, 
with minimum and maximum bars for the mean values indicated. 
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Figure 3.27 Comparison of solvent and solution droplet sizes 
 
The average droplet size distributions with standard error bars generated for 
mometasone furoate and fluticasone propionate solutions at the chosen spray drying 
conditions are shown as Figure 3.28 and Figure 3.29 respectively.   
 
Figure 3.28 Droplet size distributions for 0.5%w/w mometasone furoate solutions in 
ethanol and 2-propanol 
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Figure 3.29 Droplet size distributions for 0.5%w/w fluticasone propionate solutions in 
ethanol and 2-propanol 
 
3.3. Conclusion 
The high speed imaging demonstrates that the FFD atomizer, under appropriate 
operating conditions, is capable of generating a droplet train of narrow polydispersity.  
Additionally the operating window within which reproducible droplet generation is 
possible encompasses a droplet size range of substantial volume difference.  The Weber 
number calculated for the particular experimental conditions effectively describes the 
important operating characteristics of the system, however the liquid: gas ratio would 
also appear to be important, with images suggesting increasing variance with increasing 
relative flow of liquid.  Reduction in the liquid: gas flow ratio beyond a critical value is 
known to induce changes in the droplet formation mode, attributed to meniscus 
instability recognisable by changing position of the meniscus with time. The meniscus of 
the liquid thread appears relatively stable for the liquid: gas flow ratios evaluated, with 
no large change in position with time, however at the more extreme conditions chosen 
for imaging some movement of the meniscus is evident.  A transition to dripping from 
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however no information is available regarding the stability of droplet formation at high 
ratios.  At some point the required droplet formation mechanism will become 
unsustainable and formation may be taking place at the limits of stability for the extreme 
cases evaluated here, however continuous droplet formation is observed at liquid: gas 
flow ratios as high as 0.01, demonstrating the wide operating range of the atomization 
technique. 
Successful flow focusing beyond the postulated Weber number limit of 40 would also 
appear possible from the perspective of preserving axisymmetric break-up of the liquid 
stream.  Droplet formation under conditions encompassed by the Weber number range 
6 to 74 is observed to occur with apparently stable liquid thread, with no evidence of 
helicoidal motion.  Some difference in the nature of droplet formation is however 
apparent, identified by the use of laser diffraction.  A systematic variation in the droplet 
size predicted by Equation 3.1, Equation 3.2 and Equation 1.15 is observed with pressure 
drop; an increase in pressure drop results in a progressively smaller droplet size 
compared to the value predicted.  An additional trend of over-prediction then under-
prediction of droplet size is seen with increasing droplet size at a single pressure drop, 
with some evidence of an over-prediction minimum within the range.  This may indicate 
additional factors or interactions being important in the control of droplet formation, 
worthy of further exploration. The effect is partially explained by the work of Gordillo 
(Gordillo et al., 2001b), which accounts for the impact of higher pressure drops and 
increasing Weber number, however the under-prediction at lower pressure drop and 
Weber number remains unexplained. 
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Atomization of water or aqueous sodium chloride solutions yielded results with greater 
variability than for alcohols or alcoholic solutions, particularly at small droplet sizes with 
an average coefficient of variation of 4.5% for aqueous sodium chloride compared to 
2.8% for mometasone furoate in 2-propanol.  The wider spread may be indicative of 
additional factors attributable to either the increased surface tension or viscosity 
unaccounted for in the current control theories.  Repeatability of atomization from the 
nozzle used was also observed to be poorer than expected, with a statistically significant 
difference in median droplet size apparent between nominally identical runs. An 
appreciable range of median values for the droplet size distributions was observed for 
both sodium chloride and mometasone furoate solutions; as with the within run results 
aqueous sodium chloride solutions were observed to be more variable than 
mometasone furoate in alcohol. Average median droplet sizes for nominally identical 
runs ranged from 29.3 to 38.7 m and 67.0 to 74.0 m for the 35 and 70 m sodium 
chloride solution droplet sizes, compared to 38.4 to 40.5 m and 81.9 to 84.7 m for 
0.5% w/w mometasone furoate in ethanol at the 40 and 80 m droplet sizes 
respectively. Whilst still being able to produce the difference in droplet size distribution 
and subsequent particle size distribution required within this work, the variability may 
make the differences in output particle properties more difficult to discern.  A robust 
analysis of the repeatability of flow focussing systems is not available, hence it is not 
possible to determine whether the observations made are generic or a feature of the 
particular atomizer used.
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4. SPRAY DRYING 
4.1. Drying gas flow calibration 
Drying gas flow on the Buchi B-290 is regulated using a fan speed controller incremented 
in percent, rather than being described using linear or volumetric gas flow.  In order to 
define the drying gas flow rate range described by the scale, and to check the linearity of 
the response, calibration was performed across the flow rate range at two temperatures.  
A hot wire anemometer (Testo AG, Lenzkirch, Germany) was used to measure air velocity 
within the measurement pipe recommended by the manufacturer (Buchi Labortechnik, 
Flawil, Switzerland) connected to the cyclone oulet.  The velocity was measured across 
the control range of the aspirator (50 to 100 %) in increments of 10 %.  The rate was 
measured in ascending aspirator setting, and repeated a further two times at each 
measurement temperature.  Velocities were measured at 30 and 110°C (the maximum 
operating temperature of the anemometer) and converted volumetric flow rate to 
understand the impact of temperature on flow and linearity.  Results for the calibration 
are presented as Figure 4.1. 
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Figure 4.1 Aspirator calibration 
 
Linear regression analysis was performed using Statistica 8 (Statsoft Inc., Tulsa, USA) for 
volumetric flow rate data at each temperature.  The correlation coefficient of 0.99 for 
both temperatures demonstrates good linearity of response of volumetric flow rate with 
the aspirator scale, and shows the linearity is unaffected by operating temperature 
across the range evaluated. 
4.2. In-situ atomizer validation using sodium chloride 
The operating conditions optimised for droplet size and distribution width identified in 
Chapter 3 were defined for jets issuing into stagnant air, however the environment 
within the spray dryer involves a drying gas stream.  A number of runs were therefore 
conducted using sodium chloride solutions to evaluate the impact of droplet production 
within a dynamic environment.  Two sets of operating conditions were defined in section 
3.2.3.2.1 capable of producing droplets with average sizes of approximately 35 and 70 
m; use of solutions of different sodium chloride concentration should produce a range 
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of dried sodium chloride particle sizes that can be correlated to droplet size and 
concentration assuming the atomizer performs similarly within the spray dryer.  Sodium 
chloride was chosen as the solute as it is known to produce solid crystals of low aspect 
ratio when spray dried (Tang et al., 2006).  The high growth rate relative to nucleation 
rate (Mullin, 2001) of small inorganic molecules increases the likelihood of a single 
crystal being produced under the range of conditions evaluated (Langrish, 2009); if 
multiple viable nuclei did grow the drying droplet would ensure agglomeration, resulting 
in a single particle of low aspect ratio  being formed from the spherical droplet at the 
latter stages of evaporation. 
Solution concentrations of 0.01, 0.03 and 0.05 mass fraction sodium chloride were spray 
dried using an inlet temperature of 160C and an aspirator setting of 100 %.  The 
temperature of the atomizer, feed tubing and syringe pump was regulated at 25C to 
ensure droplet generation conditions were as intended.  Run times of between ninety 
minutes and six hours were necessary to produce sufficient material for laser diffraction 
analysis to be performed and to allow scanning electron micrographs to be collected.  
Spray drying runs and subsequent laser diffraction sizing were performed as defined 
below. 
4.2.1. Methods 
4.2.1.1. Spray drying 
The required mass of sodium chloride was weighed into a beaker using a 4 decimal place 
analytical balance to a 0.1 % weight tolerance.  The required mass of deionised water 
was added to the beaker and the contents agitated for 30 minutes to ensure dissolution.  
The pump was flushed twice with deionised water and the solution drawn into the pump 
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by withdrawing the piston.  The atomizer was located into the top of the drying chamber 
and connections were made to the pump outlet and atomizing gas regulation valve.  The 
temperature regulation circuit was connected and the bath was switched on to circulate 
the regulation fluid.  The Inlet temperature and aspirator set points were entered and 
the aspirator fan was switched on.  Once the aspirator was operational the heating 
element was switched on and the outlet temperature was allowed to stabilise.  The 
pressure indicated on the atomizer gauge was noted, and the needle valve adjusted to 
approximately 60 mbar below the target pressure value.  Once the pressure reading had 
stabilised, with further adjustment of the needle valve if necessary, pumping of solution 
was commenced.  An abrupt increase in pressure was noted as liquid atomization 
commenced, at which point the needle valve was adjusted iteratively to reach a pressure 
within 5 mbar of the setpoint.  Initial atomization was of water only, as the remainder of 
the rinse was present within the tubing at the pump outlet.  A brief drop in pressure was 
observed prior to atomization of solution, attributed to an empty portion of tubing at the 
pump outlet emptied when the cylinder was withdrawn prior to refilling with solution 
after the second solvent flush.  Upon atomization of solution the atomizer pressure, 
atomizer temperature, spray dryer inlet temperature and outlet temperature were 
recorded, and subsequently recorded at 15 minutes, 30 minutes and at 30 minute 
intervals until completion of the spray drying run.  At completion of spray drying the 
pump was stopped and the atomizing gas flow stopped by closing the needle valve.  The 
spray dryer heater was switched off, but the aspirator left running at setpoint until the 
outlet temperature had fallen below 70°C, at which point the aspirator was stopped.  
Particles were recovered by disconnecting the cyclone collection pot and pouring the 
recovered sodium chloride into a pre-weighed collection vial via a powder funnel, with 
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gentle tapping of the side of the collection pot to encourage flow.  The vial was weighed 
to determine the mass of powder recovered and the vial was covered with a filter paper 
secured with a cable tie and placed in a sealed desiccator containing 4A molecular sieve 
to minimise exposure to moisture until analysis was able to be performed.  The product-
contact components of the spray dryer were disassembled and washed down to remove 
any adhered sodium chloride, and the pump, connecting tubing and atomizer liquid 
conduit were thoroughly flushed twice with deionised water. 
4.2.1.2. Particle size measurement 
Laser diffraction analysis was performed using a Sympatec Helos instrument, fitted with 
Vibri feed and Rodos/M dispersion systems (Sympatec GmbH, Claustal, Germany).  The 
pressure drop used to ensure dispersion of the sample was selected by evaluating a 
range of pressures whilst maintaining a gap of 2 mm.  A plateau region was identified in a 
plot of pressure against median particle size of spray dried sodium chloride for a single 
batch of spray dried material, the midpoint of the plateau (3 bar pressure drop) was 
selected for measurements to provide the best compromise between dispersion and 
particle attrition.  Measurements were performed using the R2 lens (working range 0.25 
to 87.5 m); the R1 lens was evaluated initially however the upper limit of the working 
range of the lens is 35 m which may be insufficient to fully characterise all of the 
sodium chloride batches generated.  Samples were measured in duplicate and were fed 
using a Vibri feed rate setting of 50 % until 5 seconds after the optical concentration fell 
below 1.0 %.  A template was used to ensure a similar mass of powder was aligned 
optimally for feeding.  The template consisted of a steel plate of 3 mm thickness with a 
55 mm x 3.5 mm rectangular slot removed from the centre.  The template was placed on 
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the vibrating platform of the feeder, powder loaded in and smoothed using a steel 
spatula until the slot was full with a powder surface level with the top of the plate.  The 
plate was then removed to leave a loose compact ready for sizing. 
4.2.2. Results and discussion 
Results of the sizing are summarised in Figure 4.2.  The X50 value obtained from 
Sympatec analysis is plotted against the predicted particle diameter, X, based on the 
diameter of a sphere produced from the mass of sodium chloride present within a 
droplet of the target particle size, calculated using Equation 4.1: 
 
       
       
  
 
 
 
 
Equation 4.1 
Where d is the target droplet diameter (m), Y is the mass fraction of solute within the 
solution, and d and s are the droplet and solute densities respectively.  Linear 
regression analysis was performed using Statistica 8 (Statsoft Inc., Tulsa, USA).  The 
correlation coefficient (R2) of 0.9384 shows a good relationship between expected and 
actual particle size.  Median sizes measured using laser diffraction are consistently 
smaller than predicted so either the droplet size produced within the spray dryer is 
smaller than that generated when generating jets in stagnant air, or the dimension 
evaluated by laser diffraction is not consistent with that used to characterise the droplet.  
Electron micrographs are presented for the spray-dried sodium chloride batches in 
Appendix 2; two micrographs representing the extremes of solute concentration and 
droplet size are shown as Figure 4.3 and Figure 4.4. 
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Figure 4.2 Comparison of measured median particle size to predicted size. 
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Figure 4.3 Electron micrograph of sodium chloride produced at 1%w/w, c. 35µm 
droplet size 
 
Figure 4.4 Electron micrograph of sodium chloride produced at 5%w/w, c. 70µm 
droplet size 
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The predominantly cuboid morphology observed may present challenges with respect to 
deconvolution of the scattering pattern during laser diffraction.  The deconvolution 
algorithm used to provide dimensional data from the intensity of light at the detector of 
the laser diffraction instrument is based upon Fraunhofer theory, and assumes 
diffraction of light by a sphere to be the source of the diffraction pattern (Xu & Di Guida, 
2003).  Deviations from sphericity could therefore make the derived particle size 
measurement less accurate, however spheres have been shown to approximate cuboids 
well for laser diffraction analysis (Heffels et al., 1996, Yamamoto et al., 2002).  An 
alternative explanation is that the offset between actual and predicted particle size is as 
a result of the inter-run variability when atomizing aqueous solutions observed in section 
3.2.3.2.1.  The reproducibility was however observed to be random about the predicted 
target value for the operating pressure employed for this work; hence the systematic 
over-prediction of size observed during sodium chloride spray drying would be unlikely. 
The consistently low value for measured median size of spray dried sodium chloride with 
no obvious cause other than processing conditions indicates a reduction in predicted 
droplet size when operated under the conditions experienced within a spray dryer.  A set 
of experimental runs was conducted at reduced drying gas flow to compare the impact 
of aspirator settings of 100 %, 80 % and 60 %.  Normalised dried particle median sizes 
measured by laser diffraction analysis for these runs are presented as Figure 4.5. 
Spray Drying 
139 
 
 
Figure 4.5  Median size of sodium chloride produced at reduced dry gas flow rate 
 
A clear trend is difficult to identify given that the difference in normalised particle size is 
similar across the change in aspirator rate due to the variability at the 100% setting; 
however there appears to be evidence of an increase in dried particle size with a 
decrease in drying gas flow.  If the drying gas stream is responsible for reduced droplet 
size, then subsequent calculation of relationships between operating parameters and 
dried particle characteristics will be difficult to establish in absolute terms.  The strong 
correlation between measured and predicted size shown in Figure 4.2 demonstrates 
however that the impact of operating parameters upon output particle characteristics is 
likely to be able to be elucidated on a relative basis.   
The spray drying studies using sodium chloride have therefore established that the flow 
focusing atomizer is producing droplet populations that are aligned to the operating 
conditions and consistent with the relationships between droplet population and 
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and actual dried particle X50 for sodium chloride gives confidence that the atomizer is 
capable of producing similar droplet distributions to those apparent in Chapter 3 when 
used for spray drying in the Buchi B-290. 
4.3. Spray drying of active pharmaceutical ingredients 
The operating parameters of the spray dryer and the attributes of the solution to be 
spray dried have a direct impact upon the physicochemical properties of the recovered 
dry particles, as described in the Introduction.  In order to evaluate the magnitude of the 
effect of the processing variables a two-level factorial experiment was devised using 
Design Expert 7 (“DX7”, Stat-Ease Inc., Minnesota, USA).  Five factors - droplet size, 
solution concentration, drying gas flow and inlet temperature as numerical variables and 
solvent type as a categorical variable were investigated in the spray drying study; a full 
factorial experiment would require a minimum of 32 runs so a fractional factorial design 
was adopted as an efficient way of obtaining the information.  A half-factorial (resolution 
V) design was chosen to allow identification of main effects and two-factor interactions 
without confounding of factors or interactions.  A similar design has been used 
previously to successfully investigate the impact of spray drying process variables upon 
the formation of composite particles (Tajber, Corrigan, & Healy, 2009). 
Inclusion of centre-points, typically used to estimate curvature and experimental error, 
was not possible given the lack of an intermediate droplet size condition so repeat runs 
were conducted at selected experimental points.  Experimental ranges employed are 
shown in Table 4.1 and a graphical representation of the design is given as Figure 4.6.  
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Table 4.1 Factors and ranges for experimental design 
Factor Type Minimum Maximum 
Droplet size (µm) Numeric 40 80 
Solution concentration 
(%w/w) 
Numeric 0.375 0.75 
Aspirator setting (%) Numeric 50 100 
Inlet temperature (C) Numeric 100 160 
Solvent Categoric Ethanol 2-Propanol 
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Figure 4.6 Experimental design - Gas flow value for each run are detailed within 
solvent identifier 
Assignment of the statistical significance and relative importance of effects was 
performed using the analysis of variance (ANOVA) technique (Mason, 2003).   
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4.3.1. Operating parameter ranges 
The maximum solution concentration value was chosen with reference to the solubility 
data presented in Chapter 2, and is the saturation concentration at the chosen operating 
temperature for the solvent and solute combination with the lowest saturation 
concentration.  The minimum concentration was selected to allow sufficient material to 
be generated for characterisation whilst maintaining achievable run times.  Aspirator 
maximum and minimum values encompassed the operating range for the spray dryer.  
The maximum inlet temperature was restricted to 160C to ensure temperatures in the 
cyclone collection system were sufficiently below the reported glass transition 
temperature of mometasone furoate (Cacela et al., 2012) to avoid morphological 
changes after collection.  The minimum inlet temperature of 100C was selected to 
provide an outlet temperature sufficiently high to minimise residual solvent content. 
Following identification of a relationship between solute concentration and dried particle 
properties (see section 4.3.3.1) supplementary runs were undertaken using higher solute 
concentrations to further explore the relationship and examine any additional change in 
shape and texture.  The concentrations used were above the solubility limit at the 
temperature of operation.  Mometasone furoate solutions of 1 %w/w concentration 
were observed to show good stability when allowed to cool to ambient temperature; 
hence operation in the metastable state was undertaken given the likelihood of API 
remaining in solution until atomized and dried.  A further run, 31Z, was performed using 
a concentration intermediate between the low and high concentration used in the 
experimental design, primarily to provide an additional particle size for use in the 
formulation studies.  The supplementary spray drying runs are detailed in Table 4.2. 
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Table 4.2 Additional spray drying runs 
Solvent Droplet size (m) Concentration 
(%w/w) 
Inlet temperature 
(C) 
Drying gas flow 
(m3 h-1) 
Ethanol 40 1.0 100 35 
Ethanol 80 1.0 100 35 
Ethanol 40 1.25 100 35 
Ethanol 80 1.25 100 35 
Ethanol 40 0.56 160 35 
 
4.3.2. Methods 
4.3.2.1. Spray drying 
100 or 150 g of solution of the appropriate composition was manufactured for each 
spray drying run, depending on solution flow rate.  The required amount of API was 
weighed into a 50 mL beaker using a 4 decimal place analytical balance to a 0.1 % 
tolerance.  The correct quantity of solvent was then weighed into a 200 mL beaker and 
used to wash the API from the beaker into a suitable Duran bottle.  The bottle was then 
sealed with the screw lid and placed into the preheated water bath incorporated in the 
jacketing circuit of the pump and atomizer.  Once all solute had dissolved the solution 
was drawn into the syringe pump by withdrawal of the piston.  The syringe pump was 
cleaned by twice flushing with solvent before each run (the solvent chosen was the one 
to be used for the subsequent run); this left the tubing at the outlet of the pump filled 
with solvent which was used to set operating parameters prior to atomization of 
solution.  The same process was then employed as for atomization of sodium chloride 
solutions (section 4.2.1.1).  The collection pot was removed from the spray dryer at the 
end of the run, closed using a screw cap and transferred to a safety cabinet for powder 
recovery.  The spray dried API was transferred into a pre-weighed vial using a stainless 
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steel spatula.  The powder was predominantly adhered to the side of the collection pot, 
particularly so for powder produced from 40 m droplets, necessitating scraping down 
from the sides of the vessel using a spatula.  Once all possible material had been 
removed the vial was closed with the lid and weighed to determine the amount of 
powder recovered; the collection vessel was washed thoroughly with ethanol to remove 
the remaining API particles.  The pump and connecting tubing were rinsed twice with 
ethanol or propanol consistent with which was being used as solvent for the current run 
on the solution; initially a volume of solvent 5 mL greater than that of the solution was 
used, then a volume 10 mL greater was employed.  The atomizer liquid conduit was 
flushed twice with 10 mL of ethanol or propanol from a syringe.  The lid of each vial was 
replaced with filter paper and the collected batches of spray dried mometasone furoate 
were stored in a desiccator with 4A molecular sieve. 
4.3.2.2. Characterisation of API particles 
Spray dried API particles were characterised using thermal analysis, X-ray powder 
diffraction, laser diffraction and scanning electron microscopy.  X-ray diffraction was 
used as the primary measure of crystallinity; thermal analysis was then employed to 
provide information on the thermodynamic state of the particles via the interpretation 
of thermal events detected during evaluation.  Laser diffraction was used to give 
geometric size distribution data, and scanning electron microscopy provided an 
understanding of prevailing particle morphology and an additional measure of particle 
size. 
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4.3.2.2.1. Thermal analysis 
Two thermal analysis techniques were used to identify energetic events potentially 
attributable to spray drying operating parameters.  Differential scanning calorimetry 
(DSC) was used to detect latent heat effects, such as those characteristic of 
crystallization, melting and phase transition.  DSC analysis was performed using a Q2000 
instrument (TA instruments, New Castle, Delaware, USA) with each sample being run in 
duplicate.  Approximately 3mg of sample was used per run for DSC analysis, and was 
accurately weighed into a standard aluminium pan and lightly crimped with a lid.  An 
empty standard pan with a crimped lid was prepared and used as the reference for 
measurement.  A temperature ramp of 10ºC per minute between 0ºC and 220ºC was 
used; mometasone furoate degrades (rather than melts) above 230C, so an upper 
temperature of 220C was chosen to avoid contamination of the equipment with 
thermal degradation products. 
 Thermogravimetric analysis (TGA) was used to evaluate weight loss from powder 
samples with increasing temperature.  A Q500 instrument (TA instruments, New Castle, 
Delaware, USA) was used to evaluate weight loss from approximately 5 mg of sample 
within an open aluminium pan, using a temperature ramp of 10ºC per minute between 
25ºC and 300ºC. 
Universal Analysis software (TA instruments, New Castle, Delaware, USA) was used to 
determine onset temperature and enthalpy of thermal events identified during analysis 
by DSC, and to quantify weight losses observed in the course of TGA runs. 
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4.3.2.2.2. X-Ray Powder Diffraction (XRPD) 
XRPD analysis was performed using an X’pert Powder diffractometer (PANalytical BV, 
Almelo, Netherlands) fitted with a copper anode and X’celerator detector.  A variable 
divergence slit was fitted on the incident beam side.  Silicon wafers were cleaned using 
acetone and allowed to dry.  The surface of each wafer was coated with a thin layer of 
silicone grease and a small amount of powder was scattered onto the grease layer.  Once 
prepared the wafers were loaded into a sample holder and loaded onto the 
diffractometer.  Each sample was analysed over the range 2 - 40 2 and the diffraction 
pattern analysed using proprietary software (PANalytical BV, Almelo, Netherlands). 
4.3.2.2.3. Laser Diffraction 
Particle size analysis of spray dried mometasone furoate was performed using a similar 
Sympatec Helos instrument with Rodos/M dispersion system to that used previously for 
analysis of sodium chloride, however the smaller quantity of powder generated by 
mometasone furoate spray drying runs necessitated the use of an alternative feed 
system.  The Aspiros system doses dry powder into the Helos from a glass vial, and is 
able to be used with milligram quantities of powder.  A dispersion pressure of 1 bar was 
found to be sufficient to ensure particle deaggregation when used with a feed velocity 
(rate of advancement of the Aspiros feed tube into the powder vial) of 30 mm s-1.  The 
R2 lens, capable of measuring particles with a diameter of up to 80 m, was used as it 
spans a measurement range well beyond the anticipated dry particle size. 
10 mg of powder per run was loaded into a clean Aspiros glass vial, the vial capped and 
transferred to the Aspiros unit.  The cap was removed and the vial was loaded onto the 
transporting sled and the unit cover closed.  Dispersion pressure and injector depression 
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were optimised automatically for each run before feeding.  Measurement was triggered 
once the optical concentration exceeded 0.1 % and stopped after 5 seconds or when the 
optical concentration had remained below 0.2 % for more than 3 seconds. 
4.3.2.2.4. Scanning Electron Microscopy (SEM) 
Representative images of the spray dried particles were obtained using a Supra 25 
scanning electron microscope (Carl Zeiss Microscopy, Jena, Germany), employing an 
element potential difference of 5 kV.  A small amount of powder was dispersed onto an 
adhesive graphite disc mounted on an aluminium stub for each batch of spray dried 
mometasone furoate.  A clean, disposable brush was used to disperse each sample onto 
the stub, and the powder was then coated with a thin layer of palladium using a sputter 
coater (AGB7341, Agar Scientific, Stansted, UK).  Images of a population of particles 
considered representative were obtained at three levels of magnification, in order to 
assess both within-batch consistency and surface detail. 
4.3.3. Results and discussion 
The materials generated by the spray drying runs were individually assigned a batch 
number as detailed in Table 4.3 with associated operating parameters.  The experimental 
design detailed in Table 4.1 and Figure 4.6 was successfully completed for mometasone 
furoate solutions however difficulties were encountered when fluticasone propionate 
solutions were used, resulting in the generation of a single batch of dried API 
(EE636926/32A).  Severe pressure fluctuations were observed on the pressure gauge 
connected to the atomizer gas supply during spray drying runs using fluticasone 
propionate, with deposition of API around the outlet orifice of the atomizer and eventual 
blockage. 
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Table 4.3 Spray drying batch identities 
Batch number Droplet size 
(m) 
Concentration 
(%w/w) 
Inlet 
temperature 
(C) 
Drying gas flow 
(m3 h-1) 
Solvent 
Mometasone Furoate – experimental design runs 
EE686926/31C 80 0.38 100 35 2-propanol 
EE686926/31E 40 0.75 100 35 2-propanol 
EE686926/31F 80 0.75 100 17.5 2-propanol 
EE686926/31G 40 0.75 100 17.5 Ethanol 
EE686926/31H 80 0.38 100 17.5 Ethanol 
EE686926/31I 80 0.75 160 35 2-propanol 
EE686926/31J 80 0.75 100 35 Ethanol 
EE686926/31K 40 0.38 100 35 Ethanol 
EE686926/31L 40 0.75 160 35 Ethanol 
EE686926/31M 40 0.38 160 35 2-propanol 
EE686926/31N 80 0.38 160 17.5 2-propanol 
EE686926/31P 40 0.75 160 17.5 2-propanol 
EE686926/31Q 80 0.75 160 17.5 Ethanol 
EE686926/31R 80 0.75 160 17.5 Ethanol 
EE686926/31S 80 0.75 160 35 2-propanol 
EE686926/31T 40 0.38 100 17.5 2-propanol 
EE686926/31U 40 0.38 100 17.5 2-propanol 
EE686926/32J 40 0.38 160 17.5 Ethanol 
EE686926/32K 80 0.38 160 35 Ethanol 
EE686926/32I 40 0.38 100 35 Ethanol 
Mometasone Furoate – additional  runs 
EE686926/31V 40 1.00 100 35 Ethanol 
EE686926/31W 80 1.00 100 35 Ethanol 
EE686926/31X 40 1.25 100 35 Ethanol 
EE686926/31Y 80 1.25 100 35 Ethanol 
EE686926/31Z 40 0.56 160 35 Ethanol 
Fluticasone Propionate 
EE686926/32A 80 0.38 160 17.5 Ethanol 
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Saturation solubility, in terms of mass fraction, was determined to be lower for 
fluticasone propionate in comparison to mometasone furoate, however the pronounced 
difference in the ability to be spray dried is unexpected.  The two APIs are structurally 
similar and although there is a difference in saturation solubility all spray drying runs 
attempted using fluticasone were below the solubility limit at 50C, the jacketing 
temperature of the pump, atomizer and feed hoses.  The cause of the rapid formation of 
solid material in the case of fluticasone propionate is therefore likely due to differences 
in the dynamic behaviour of the two APIs during atomization and drying beyond the 
scope of this thesis.  The explanation may lie in a diffusivity difference between the APIs; 
a lower diffusivity in the case of fluticasone propionate would lead to earlier formation 
of solid possibly resulting in the blockage observed.  The molecular masses of the two 
APIs are similar (501 Da in the case of fluticasone propionate and 521 Da for 
mometasone furoate) so any differences would most likely be due to the different ester 
groupings attached to the steroid nucleus and/ or substituents on the nucleus.  A 
comparison of SEM images for batch EE686926/32A to those for mometasone furoate 
generated using similar droplet size and concentration reveals a spherical morphology 
for fluticasone propionate versus crumpled particles for mometasone furoate.  This 
suggests a mechanically robust layer is formed early in the droplet lifetime for 
fluticasone propionate, consistent with precipitation of relatively large quantities of 
solute.  Examination of particle size results given in Table 4.5 shows a larger median 
particle size was generated for the batch of spray dried fluticasone propionate than for 
batches of mometasone furoate produced under similar conditions, again consistent 
with the formation of solid material early in the droplet lifetime. 
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4.3.3.1. Mometasone furoate particle morphology 
Electron microscope images, summarised in Table 4.4 and presented in full in Appendix 
3, reveal a range of surface textures and morphologies.  When produced from the 
smaller droplet size, spherical particles with a smooth surface were observed exclusively 
when 2-propanol as the solvent, regardless of solute concentration, inlet temperature or 
drying gas flow rate.  Smooth spherical particles were in general produced using ethanol 
as solvent when spray drying with the higher inlet temperature, however one run at the 
lowest solute concentration produced spherical particles at the lower temperature.  At 
the lower inlet temperature increasing the solute concentration appears to cause the 
particle surface to buckle/ crumple, with the size of the corrugations apparently being a 
function of the solute concentration used. An ‘open’ buckled or crumpled texture (large 
corrugations at the surface) resulted from processing at 0.75 %w/w mometasone furoate 
concentration; increasing the solute concentration further causes the frequency of 
corrugations to progressively increase, with the resulting smaller corrugations forming a 
tightly-crumpled ‘closed’ surface texture of increased roughness. 
Spray drying from 2-propanol at the larger droplet size produced either spherical or open 
crumpled particles depending upon the inlet temperature used.  High inlet temperatures 
are associated with spherical particles; reducing the temperature yields an increased 
instance of open crumpled particles.  Solute concentration appears to have little effect, 
acknowledging the small number of batches being available to perform the comparison.  
Switching the solvent to ethanol has a similar impact on the range of morphologies 
possible to that seen for the smaller droplet size.  The lower inlet temperature generated 
tightly crumpled particles for all solute concentrations evaluated (0.375 to 1.25 %w/w), 
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whilst at the higher inlet temperature open crumpled particles are prevalent with some 
instances of spherical particles. 
The effect of solvent choice and inlet temperature upon particle morphology indicates 
that precipitation of solute early within the drying period leads to a smoother surface 
and therefore spherical morphology.  The lower mass fraction at saturation for propanol 
is likely to translate to earlier deposition that is the case for ethanol, and a higher inlet 
temperature will lead to more rapid drying, and therefore a higher rate of increase of 
solute concentration at the droplet surface.  As the driving force for drying is decreased, 
and the saturation concentration is increased, the dry particles recovered become 
increasingly buckled.  Similar tightly-buckled morphologies to those observed here were 
produced during spray drying experiments using the polymer Eudragit L100 (Raula et al., 
2004), attributed to entanglement of polymer molecules in the solidified outer shell of 
the droplet with polymer molecules precipitating in the interior if the droplet.  The 
postulated mechanism for crumpled particle formation is unlikely to be responsible for 
the formation of similarly crumpled mometasone furoate particles as precipitation of 
solute within the bulk of the droplet is likely to lead to crystallization; no evidence of 
crystallinity was apparent from x-ray diffraction of the relevant batches.  Two possible 
hypotheses were proposed by Vehring and co-workers (Vehring, Foss, & Lechuga-
Ballesteros, 2007).  One hypothesis notes that surface active molecules will accumulate 
at the surface thus driving supersaturation; the lack of surface activity for mometasone 
furoate (see section 2.2.2) indicates this mechanism is unlikely to be of importance in the 
current scenario. The alternative hypothesis, in the case of low solubility, proposes that 
the diffusivity difference between solvent and solute leads to an accumulation of solute 
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at the droplet surface that rapidly exceeds the solubility limit resulting in formation of a 
thin solid layer.  Depending on the mechanical properties of the surface layer it may then 
crumple as a result of stresses generated by the retreating droplet surface.  This 
hypothesis provides an explanation to why small molecule solutes do not always produce 
solid, spherical particles when dried from droplets, contrary to theoretical considerations 
of the relative diffusivity.  That the argument for the formation of buckled or crumpled 
shells is based upon low solubility of the solute in the solvent would indicate that 
additional factors must be partially responsible in the present case as the lower solubility 
solvent, 2-propanol, exhibits a reduced tendency to produce crumpled particles 
compared to the higher solubility solvent, ethanol.  As noted by Vehring et al, the 
evaporation rate does remain a factor even for high solubility molecules, hence for 
mometasone furoate the greater volatility of ethanol would appear to have more of an 
impact upon particle formation that the low solubility in 2-propanol.
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Table 4.4 Summary of spray dried mometasone furoate batches 
Particles produced using 40 m droplets 
40 µm  droplet, 0.375% w/w Ethanol, 
100C inlet temperature 
40 µm  droplet, 0.75% w/w Ethanol, 
100C inlet temperature 
40 µm  droplet, 0.375% w/w 2-propanol, 
100C inlet temperature 
40 µm  droplet, 0.75% w/w 2-propanol, 
100C inlet temperature 
   
 
40 µm  droplet, 0.375% w/w Ethanol, 
160C inlet temperature 
40 µm  droplet, 0.75% w/w Ethanol, 
160C inlet temperature 
40 µm  droplet, 0.375% w/w 2-propanol, 
160C inlet temperature 
40 µm  droplet, 0.75% w/w 2-propanol, 
160C inlet temperature 
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Particles produced using 80 m droplets 
80 µm  droplet, 0.375% w/w Ethanol, 
100C inlet temperature 
80 µm  droplet, 0.75% w/w Ethanol, 
100C inlet temperature* 
80 µm  droplet, 0.375% w/w 2-propanol, 
100C inlet temperature 
80 µm  droplet, 0.75% w/w 2-propanol, 
100C inlet temperature 
    
80 µm  droplet, 0.375% w/w Ethanol, 
160C inlet temperature 
80 µm  droplet, 0.75% w/w Ethanol, 
160C inlet temperature 
80 µm  droplet, 0.375% w/w 2-propanol, 
160C inlet temperature 
80 µm  droplet, 0.75% w/w 2-propanol, 
160C inlet temperature 
    
* - Note: a 20 micron scale bar has been used for image EE696926/31J; the magnification (500x) is the same as for the other images in Table 4.4 
Spray Drying 
155 
 
4.3.3.2. Particle size 
Laser diffraction sizing results for spray dried batches are presented as Table 4.5.   Good 
agreement between repeat samples was observed, as denoted by the small standard 
deviation for the median particle size.   
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Table 4.5 Particle size results for spray dried API batches 
Batch number 
Droplet 
size 
(m) 
Concentration 
(% w/w) Solvent 
Average percentile (m) 
X50 
SD 
Predicted 
size 
(m) X10 X50 X90 
EE686926/31C 80 0.38 Propanol 2.3 9.0 16.2 0.2 8.92 
EE686926/31E 40 0.75 Propanol 3.3 6.2 9.0 0.1 5.62 
EE686926/31F 80 0.75 Propanol 5.2 15.5 25.4 0.1 11.24 
EE686926/31G 40 0.75 Ethanol 3.7 6.5 9.7 0.1 5.62 
EE686926/31H 80 0.38 Ethanol 7.0 11.8 16.8 0.0 8.93 
EE686926/31I 80 0.76 Propanol 5.3 11.7 17.4 0.0 11.27 
EE686926/31J 80 0.76 Ethanol 7.5 13.8 19.8 0.0 11.27 
EE686926/31K 40 0.38 Ethanol 3.6 6.9 10.1 0.0 4.46 
EE686926/31L 40 0.75 Ethanol 2.8 5.9 8.5 0.0 5.62 
EE686926/31M 40 0.38 Propanol 1.6 4.5 6.2 0.0 4.47 
EE686926/31N 80 0.38 Propanol 6.6 11.2 16.8 0.1 8.93 
EE686926/31P 40 0.75 Propanol 3.3 6.3 9.0 0.0 5.63 
EE686926/31Q 80 0.75 Ethanol 4.5 11.4 22.6 0.2 11.25 
EE686926/31R 80 0.76 Ethanol 4.0 10.2 19.0 0.1 11.26 
EE686926/31S 80 0.75 Propanol 5.4 11.7 17.5 0.0 11.25 
EE686926/31T 40 0.38 Propanol 2.8 4.8 6.9 0.0 4.46 
EE686926/31U 40 0.38 Propanol 2.8 5.0 7.3 0.0 4.46 
EE686926/31V 40 1.01 Ethanol 4.3 8.6 13.0 0.1 6.20 
EE686926/31W 80 1.01 Ethanol 9.7 16.3 23.0 0.1 12.39 
EE686926/31X 40 1.25 Ethanol 5.7 15.9 23.7 0.0 6.66 
EE686926/31Y 80 1.25 Ethanol 8.3 16.9 24.1 0.1 13.32 
EE686926/31Z 40 0.56 Ethanol 1.8 5.4 7.4 0.0 5.11 
EE686926/32A 80 0.38 Ethanol 7.4 14.3 21.3 0.0 8.93 
EE686926/32I 40 0.38 Ethanol 2.9 4.8 7.0 0.0 4.46 
EE686926/32J 40 0.38 Ethanol 2.6 5.0 7.3 0.0 4.46 
EE686926/32K 80 0.38 Ethanol 2.5 8.3 15.0 0.2 8.92 
 
Evaluation of the results via ANOVA using Design Expert 7 is summarised in Table 4.6.  
Droplet size (P<0.0001) and concentration (p=0.0062, 0.0065 and 0.0027 for X10, X50 and 
X90 respectively) as significant factors in dried particle size, as is intuitively expected. 
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Table 4.6 Significant processing factors for particle size distribution of spray 
dried mometasone furoate. 
Batch characteristic Significant factors F ratio P value 
X10 Droplet size 230.73 0.0001 
Concentration 27.75 0.0062 
Inlet temperature 23.24 0.0085 
Drying gas flow 22.67 0.0089 
X50 Droplet size 92.72 <0.0001 
Concentration 10.19 0.0065 
Inlet temperature 4.95 0.043 
X90 Droplet size 147.80 <0.0001 
Concentration 13.24 0.0027 
 
Inlet temperature was also observed to be significant (p=0.0085 and 0.043 respectively) 
for X10 and X50.  In addition, drying gas flow (p=0.0089) is seen to be an important factor 
in determining the fine end of the distribution denoted by X10.  An increase in the inlet 
temperature results in a reduction in the tenth percentile (X10) size, and may be 
associated with the differences in morphology for dried mometasone furoate apparent 
at the two inlet temperatures discussed in section 4.3.3.1.  The impact of drying gas flow 
upon X10 is greater for particles produced from 2-propanol than for ethanol.  A negative 
correlation between X10 and drying gas flow is observed for propanol, with a larger 
gradient apparent at 160C inlet temperature.  A similar gradient observed for ethanol at 
the higher inlet temperature however little difference is observed at 100C.  An increase 
in drying gas flow is likely to lead to more rapid drying, and the diffusivity difference 
between solvent and solute should have a greater impact under conditions of rapid 
drying to give early formation of a solid shell and so a larger particle size should be 
expected, unlike the observations made as a result of analysis of the experimental 
results.  The droplet size produced by the atomizer appears to be affected by the gas 
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flow (see section 4.2), with increased gas flow giving potentially smaller droplets; the 
effect on droplet size would therefore appear to be more important than drying kinetics 
on the finer end of the droplet distribution. 
The high level of significance probability for droplet size and concentration as factors in 
output particle size indicates that the atomizer produces the expected droplet 
distributions when used within the dynamic environment of a spray dryer. 
4.3.3.3. Crystallinity 
No reflections were determined during XRPD analysis of the spray dried mometasone 
furoate batches, denoting a lack of long-range molecular order consistent with the 
generation of amorphous, rather than crystalline material.  Diffractograms for all batches 
produced are presented as Appendix 5.  Molecules with a degree of conformational 
flexibility are often difficult to crystallize (Yu et al., 2000) and isolation of steroid 
molecules in the amorphous state following spray drying has been previously reported in 
the scientific literature (Sakagami et al., 2002, Tewes et al., 2013).  Evaluation of the 
spray dried batches by DSC revealed an exothermic event for each batch with an onset 
between 128°C and 154°C attributed to recrystallization of mometasone furoate (Cacela 
et al., 2012); thus confirming the non-crystalline particle structure for all batches. 
Recrystallization of mometasone furoate in the region of 150°C is understood to be as a 
result of exceeding the glass transition temperature (Tg) of the amorphous state (Cacela 
et al., 2012).  The heat of crystallization and onset temperature of the exotherm are 
noted to vary between batches and, assuming the onset temperature is indicative of Tg, 
may be evidence of variation of the properties of the amorphous API consistent with the 
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processing history of each batch.  Onset temperature and enthalpy of crystallization for 
the experimental design batches are presented in Table 4.7. 
Table 4.7 Thermal events for experimental design batches 
Batch number Droplet 
size 
(m) 
Concentration 
(% w/w) 
Solvent Drying 
gas flow 
(m3 h-1) 
Inlet 
temperature 
(C) 
Onset 
temperature 
(C) 
Enthalpy 
(J g-1) 
EE686926/31C 80 0.38 Propanol 35 100 121.1 11.7 
EE686926/31E 40 0.75 Propanol 35 100 109.1 14.4 
EE686926/31F 80 0.75 Propanol 17.5 100 120.4 12.9 
EE686926/31G 40 0.75 Ethanol 17.5 100 142.0 19.3 
EE686926/31H 80 0.38 Ethanol 17.5 100 171.2 26.4 
EE686926/31I 80 0.76 Propanol 35 160 137.8 7.9 
EE686926/31J 80 0.76 Ethanol 35 100 149.0 21.7 
EE686926/31K 40 0.38 Ethanol 35 100 151.3 23.6 
EE686926/31L 40 0.75 Ethanol 35 160 134.8 34.0 
EE686926/31M 40 0.38 Propanol 35 160 130.6 20.9 
EE686926/31N 80 0.38 Propanol 17.5 160 129.0 24.3 
EE686926/31P 40 0.75 Propanol 17.5 160 132.1 29.5 
EE686926/31Q 80 0.75 Ethanol 17.5 160 173.4 29.8 
EE686926/31R 80 0.76 Ethanol 17.5 160 173.9 29.0 
EE686926/31S 80 0.75 Propanol 35 160 138.2 13.0 
EE686926/31T 40 0.38 Propanol 17.5 100 143.3 33.6 
EE686926/31U 40 0.38 Propanol 17.5 100 169.7 35.0 
EE686926/32I 40 0.38 Ethanol 35 100 136.0 33.4 
EE686926/32J 40 0.38 Ethanol 17.5 160 146.4 40.3 
EE686926/32K 80 0.38 Ethanol 35 160 137.7 23.1 
 
The number and nature of the thermal events observed during DSC analysis showed 
some variation over the entirety of the experimental design, as can be seen in Appendix 
4.  Common to all thermograms is a broad endotherm below 100C.  Similar endotherms 
have been observed during the thermal analysis of crystalline forms of mometasone 
furoate and were attributed to the loss of water of crystallization from the monohydrate 
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(Chen et al., 2005).  The mometasone furoate particles produced by spray drying were 
amorphous, so no stoichiometric solvation is possible, and were spray dried from 
alcohols, excluding water from the immediate molecular environment during drying and 
solidification.  The endotherm could be as a result of retained solvent dispersed within 
the amorphous dried mometasone furoate particles rather than as a ‘true’ solvate; a 
correlation between weight loss during TGA experiments and Tg suppression is noted 
later in this chapter hence this explanation does fit with the experimental evidence 
gathered. 
The crystallization exotherm is predominantly monomodal across the batches, however 
bimodality of varying modal ratio is observed for runs 31E, 31I, 31S, 31T, 31V, 31W, 31X 
and 31Y, and an endotherm preceding the exotherm is observed for 31H.  Runs 31E, I, S 
and T were performed using propanol as solvent employing concentrations of 0.75 
%w/w or below.  Ethanol was used a solvent for runs 31V, W, X and Y, and bimodality is 
associated with high concentrations in excess of 1.0 %w/w.  Exotherm bimodality has 
been observed in the case of crystalline particles amorphised by milling or cryomilling 
(Chattoraj et al., 2012, Trasi et al., 2010) and has been attributed to the separate 
exothermic contributions of surface and bulk crystallization.  The increased mobility 
possible for molecules at the surface compared to those within the bulk results in surface 
crystallization at a lower temperature than crystallization of the remaining amorphous 
solid in the mass.  Evaluation of amorphous APIs generated by quenching melts showed 
a single exotherm in comparison to the bimodal exotherms obtained for the same 
materials produced by milling; the difference was attributed to the presence of small 
crystalline regions in the predominantly amorphous milled APIs acting as nuclei initiating 
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surface crystallization.  The bimodality observed in the exotherms generated for some of 
the experimental runs may be attributed to a similar phenomenon.  With the notable 
exception of run 31T the bimodal exotherms are produced at high concentrations, and in 
the case of runs 31V to 31Y at concentrations above the saturation limit.  Operation at 
conditions close to or above the saturation limit may allow small crystalline regions to be 
produced either during spray drying or during the feed of solution to the atomizer, which 
become incorporated at the surface of the dried particles and produce the bimodality 
reminiscent of that observed for milled materials.  The endotherm observed for run 31H 
at an onset of 171C may be a relaxation endotherm, given that the thermal event 
occurs above the glass transition temperature.  Relaxation endotherms are believed to 
have two potential causes (Craig et al., 1999): 
1. There is a difference in the cooling / solidification rate experienced by the 
material in the process compared to the heating rate in the DSC.  The API 
molecule relaxation is relative to the slower cooling rate, so when exposed to a 
relatively rapid heating rate in the DSC the molecules are unable to dissipate the 
thermal energy by conformational or translation movement so the material 
heats, resulting in the endotherm.  Once the material enters the rubbery state 
the energy dissipates. 
2. Further energetic relaxation occurs following solidification of the material and, 
similarly to the first cause, the molecules are unable to gain sufficient movement 
at the rate of heating in the DSC to dissipate the thermal energy supplied.  The 
glass superheats, giving an endotherm. 
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The rapid cooling and solidification rate experienced in the spray dryer compared to the 
heating rate employed during DSC analysis make the first explanation unlikely.  The 
residence time within the Buchi B-290 is believed to be of the order of one second, 
during which time droplets are dried to finally yield solid particles.  The final part of 
drying, where the molecules are ‘frozen’ into their relative positions will take a fraction 
of this time, hence the required mismatch of rates necessary for the first hypothesis to 
explain events is unlikely to occur.  The second hypothesis requires either a long storage 
time or sufficient molecular movement to allow relaxation to occur.  The storage to test 
time for sample 31H was within the range described by the other samples, for which no 
similar endotherm was observed. 
Multimodal exotherms are observed for the fluticasone propionate run 32A; under 
similar conditions mometasone furoate is characterised by a monomodal exotherm.  The 
complexity of the exotherm indicates a non-uniform energetic state within the particles.  
The processing difficulties observed when spray drying fluticasone propionate were as a 
result of early solidification of material during atomization; the unstable processing 
behaviour observed may result in regions within the particles of differing processing 
history, and therefore varying energetics. 
Evaluation of the data using analysis of variance identified statistically significant 
relationships between the thermal event and processing parameters, as summarised in 
Table 4.8. 
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Table 4.8 Significant processing factors for recrystallization exotherm position 
and enthalpy 
Batch characteristic Significant factors F ratio P value 
Enthalpy of crystallization Concentration 4.73 0.0473 
Droplet size 11.26 0.0047 
Solvent 10.49 0.0060 
Drying gas flow 10.28 0.0063 
Onset temperature Solvent 7.59 0.0155 
Drying gas flow 5.40 0.0357 
 
The onset temperature and enthalpy of the exotherm varies systematically with the 
spray drying conditions used and the solvent chosen.  Drying gas flow and the choice of 
solvent have a significant impact upon the onset temperature of the exotherm (p = 
0.0388 and 0.0073 respectively).  Increasing the drying gas flow results in a reduced 
onset temperature, and higher onset temperatures were seen when analysing particles 
generated using ethanol as the solvent in comparison to 2-propanol.  The glass transition 
temperature of a material is known to be dependent upon the thermal history (Craig et 
al., 1999, Matsuda et al., 1992) and is sensitive to the levels of residual solvent within the 
amorphous solid.  Further evaluation of selected samples by thermogravimetric analysis 
(TGA) revealed a general trend of increased weight loss over the exotherm temperature 
range (130°C to 170°C) for samples demonstrating a lower onset temperature, as 
summarised in Table 4.9 with experimental data presented as Appendix 6. If the onset 
temperature is indicative of the position of the Tg, suppression would appear to result 
from retained solvent acting as a plasticiser.  Comparison of the experimental values to 
values predicted by the Gordon-Taylor equation reveals that the concentration of 
retained solvent at the time of measurement would not account for the degree of Tg 
suppression measured, however the general trend of measured and predicted values 
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does indicate a correlation.  TGA analysis occurred following a prolonged storage period, 
hence the measured values may not be representative of the initial solvent levels.  
Assuming the loss of solvent from the different spray dried MF batches occurs at a 
similar rate, not an unreasonable assumption as storage was under identical conditions, 
and the relevant physical properties of the compared batches was appropriately similar 
giving similar diffusion rates, then the data does support the hypothesis that the 
differences in Tg is due to differing amounts of retained solvent. 
Table 4.9 Comparison of DSC exotherm onset and TGA weight loss 
Sample identity Exotherm onset (C) Weight loss (%) Predicted Tg (C) 
31C 121.4 0.2830 147.7 
31F 120.4 0.3477 147.1 
31G 142.0 0.3500 146.8 
31H 171.2 0.0325 149.7 
31I 137.8 0.4620 146.2 
31J 149.0 0.0768 149.3 
31M 130.6 0.5025 145.9 
31R 173.9 0.0923 149.2 
 
Intuitively a proportional relationship between drying gas flow and onset temperature 
might be expected, assuming a higher drying gas: liquid ratio results in a lower 
equilibrium solvent content.  It should be noted however that a larger drying gas flow 
will also result in a shorter residence time in the drying chamber, and this would appear 
to have been more impactful in terms of particle solvent content than the increased 
equilibrium driving force provided by the larger drying gas flow.Assuming the exotherm 
observed during thermal analysis is crystallization as the Tg is reached, then the enthalpy 
observed can be used as an estimate of the ‘excess’ internal energy of the amorphous 
material compared to the thermodynamically stable crystalline state.  In addition, a 
minimum energy state for the glass will exist, so the differences in enthalpy between the 
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runs can be considered reflective of the differences in energetic state resulting from the 
drying conditions.  A smaller enthalpy should therefore result when the solute molecules 
have the opportunity to relax into a lower energy state during spray drying, due to a 
reduced drying rate.  Droplet size, solvent choice, drying gas flow and concentration 
were observed to be statistically significant factors in the enthalpy of the exotherm (p = 
0.006, 0.015, 0.015 and 0.029 respectively).  A larger enthalpy is evident when reducing 
the droplet size, gas flow or concentration and when using ethanol as solvent. An 
increase in the gas: liquid ratio within the spray dryer is known to lead to more rapid 
drying, which should in turn cause a more disordered molecular state for the resulting 
dried particles.  An increase in concentration should lead to earlier precipitation during 
drying, which should be reflected in an increase in enthalpy, assuming relaxation state of 
the amorphous solid is dependent upon relative supersaturation.  The gas flow and 
concentration relationships with enthalpy therefore appear counterintuitive.  Increased 
levels of retained solvent have been noted for particles produced using high gas flows, 
which may also have consequences for the enthalpy-gas flow relationship.  The reasons 
behind the inversely proportional relationship between concentration and enthalpy are 
unclear; the early solidification likely to be encountered when drying higher solute 
concentrations may result in a larger mass of retained solvent, as the solid layer is likely 
to present a greater barrier to evaporative loss of solvent.  If the mixed system resulting 
from increased solvent content does decrease the enthalpy measured during thermal 
analysis then this may provide some explanation of the phenomenon. 
Ethanol, being a more volatile solvent than propanol, is likely to dry more rapidly at the 
same temperature resulting in early solidification of mometasone furoate and a higher 
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free energy.  Smaller droplets will evaporate to dryness more rapidly than droplets with 
larger diameters as a result of the increased surface area: volume ratio; hence 
precipitation of solid will occur within a higher temperature zone, and therefore at a 
higher evaporation rate when using a co-current spray dryer as used in this study. 
The difference in drying kinetics produced by changes in operating parameters appears 
to have resulted in differences in energetic state of the mometasone furoate particles; 
such differences have been noted previously for materials which, similarly to the 
situation described here, have been isolated in the amorphous state below the glass 
transition temperature, however systematic attribution to spray drying conditions was 
not possible (Tajber, Corrigan, & Healy, 2009).  The study in question used a similar Buchi 
spray dryer, however a conventional two-fluid atomizer was used; the wide droplet size 
diameter likely may have made clear elucidation of trends problematic. 
There has been debate previously in the academic literature about the existence of 
separate amorphous states, analogous to the polymorphic forms often encountered with 
materials in the crystalline state, and whether there is any relevance to pharmaceutical 
systems (Craig et al., 1999, Hancock, 2002, Hancock & Zografi, 1997).  The trends 
observed during the spray drying experiments performed here may be characteristic of a 
material in the glassy state isolated at different stages of relaxation, with the enthalpy 
being indicative of the degree of molecular rearrangement possible before relative 
positions and conformations of the molecules become fixed.  The evaluation of DSC 
results is open to a degree of interpretation, given the necessarily manual nature of 
attributing onset and end of complex thermal events against an often non-linear 
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baseline.  It is therefore acknowledged that the trends identified during this study are 
tentative, and subject to further confirmation. 
4.4. Conclusion 
The relationship between operating conditions and droplet size appears to be preserved 
when operating the atomizer in the dynamic environment of the spray dryer.  Systematic 
variation of gas and liquid flow rates previously demonstrated to lead to a progressive 
change in droplet diameter, coupled with the use of suitable solute concentrations is 
observed to correlate with a proportional increase in output sodium chloride particle 
size.  Good linearity is observed, as demonstrated by the correlation coefficient 0.94 for 
the relationship between predicted and measured particle size.  Absolute proportionality 
between results generated for the atomizer during droplet measurement by laser 
diffraction and the output particle size distribution obtained by laser diffraction for 
sodium chloride was not preserved however, and given the widespread use and 
acceptance of the measurement systems employed it seems reasonable to conclude that 
generation of droplets in the spray dryer is subject to additional processing variables. 
Structured experimentation has revealed a direct impact of droplet size, solute 
concentration and spray drying conditions upon the energetics and physical attributes of 
collected mometasone furoate particles; an enthalpy range of 7.9 to 40.3 J g-1 was 
measured by DSC for spray dried mometasone furoate over the twenty runs conducted.  
Statistically significant relationships have been defined between the processing variables 
and the exothermic event attributed to crystallization of mometasone furoate once the 
glass transition temperature has been attained.  Use of small droplet sizes and more 
volatile solvents, likely to lead to rapid evaporation of solvent from the droplets were 
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observed to result in an elevated enthalpy at glass transition being detected during 
thermal analysis, consistent with an interrupted relaxation process during solidification. 
Drying gas flow and concentration demonstrated unexpected trends with enthalpy, with 
increased gas flow and concentration resulting in a reduction in enthalpy change at 
crystallization.  The reasons for this are unclear, however may be associated with an 
increase in retained solvent resulting from use of these conditions, assuming a 
relationship between processing conditions and particle energetics exists.  Further 
investigation of the energetics of amorphous mometasone furoate – alcohol systems 
may provide insight into these unexpected trends, and confirm whether the enthalpic 
relationship with processing conditions exists.  
The temperature of the glass transition for spray dried mometasone furoate has also 
been observed to vary systematically with differing manufacturing conditions, with a 
suppression of up to 41C from the postulated value of 150C.  Interpretation of the 
relationships between processing conditions and suppression suggests the suppression is 
due to incomplete drying rather than there being a direct link between Tg and thermal 
history. 
The texture of the spray dried mometasone furoate particles was observed to be a 
function of droplet size, solvent and inlet temperature.  40 m droplets showed an 
increased tendency to produce smooth particles, particularly when using 2-propanol as 
the solvent, however use of 100C inlet temperature and 0.75% w/w concentration with 
ethanol as solvent caused the particle surface to crumple.  At the 80 m droplet size an 
increased tendency to form corrugations was observed, with the depth of the 
corrugations increasing with decreasing concentration consistent with a thinner, less 
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mechanically robust layer precipitating when using low solution concentrations.  
Corrugated particle formation was again associated with low inlet temperature, 
consistent with the trend seen at the smaller droplet size. 
The inability to successfully spray dry fluticasone propionate, a molecule with a high 
degree of structural similarity to mometasone furoate, is unexpected and may present a 
limitation to the general applicability of flow focussing in the controlled generation of 
API particles.  If, as discussed, the differing substituents of the androstane nucleus are 
responsible for the large difference in spray drying behaviour then the difference in ester 
group between the two APIs may be a large factor.  Evaluation of fluticasone furoate, a 
commercially available API, by flow focused spray drying may provide a route to 
understanding as successful processing of this molecule would indicate the relative 
significance of the ester group compared to the differences in halogen substituents 
between fluticasone propionate and mometasone furoate.  
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5. FORMULATION STUDIES 
5.1. Introduction 
Mometasone furoate and fluticasone propionate are often delivered by oral inhalation, a 
treatment route for which API particle size is of paramount importance in defining the 
effectiveness of the formulated product.  The majority of current research relating to 
hand-held inhalation dosage forms is undertaken to increase the understanding of dry 
powder inhalers, as this variant offers a preferential combination of ease of use and 
broad applicability across particle and compound classes.  Research groups have typically 
investigated API characteristics (Chow et al., 2007, Crowder et al., 2002, Le et al., 2012, 
Lobo et al., 2005, Weers et al., 2007), carrier particle size distributions (Jones & Price, 
2006, Ooi et al., 2011, Smyth & Hickey, 2005, Zeng, Martin, Marriott, & Pritchard, 2001) 
and interactions between the formulation and device using dry powder inhalers as the 
delivery system (Chew, Bagster, & Chan, 2000, Chew & Chan, 1999, De Boer et al., 
2004a, De Boer et al., 2004b, Donovan et al., 2012, Kubavat et al., 2012, Ngoc et al., 
2013, Srichana, Martin, & Marriott, 1998).  Capsule based inhalers are generally the 
device of choice for experimentation to avoid the use of complex primary packaging 
systems and the need for appreciable amounts of API. 
A number of studies have investigated the influence of API particle size on the emitted 
dose and respirable fraction able to be obtained from passive dry powder inhalers.  
Micro-moulded cross-linked polymers were used in a recent study to determine the 
influence of particle size and shape upon respirable fraction (Fromen et al., 2013).  The 
fabrication technique results in monodisperse particles of predefined shape; differing 
size particles of similar shape were delivered unformulated using two different devices 
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into a cascade impactor resulting in a clear relationship between particle size and 
impaction profile.  Louey et al (2004b) prepared spray dried fluticasone propionate 
particles across the range 1.3 to 9.6 m and delivered both unformulated and as 2 %w/w 
blended particles with lactose into a cascade impactor.  Aerosolisation from capsules 
using Inhalator and Rotahaler devices led the authors to conclude a general trend of 
increasing emitted dose and fine particle fraction with decreasing particle diameter for 
both API alone and blends, however some device dependency is noted.  A clear trend for 
emitted dose is apparent for the Rotahaler, however no real trend is discernible for the 
Inhalator.  Increasing the API particle size within the formulated blends resulted in a 
trend of decreasing fine particle fraction, when expressed as a percentage on the loaded 
API using the Inhalator, with no similar trend for the Rotahaler.  A further publication by 
the same research group (Louey et al., 2004a) explored the use of mannitol particles 
across the size range 1.4 to 10.3 m prepared using air-jet milling and spray drying 
techniques, again delivered from a Rotahaler and Inhalator.  An increase in fine particle 
fraction was observed with increasing size within the 1 to 5 m range for both particle 
generation techniques, with a progressive reduction with further increase in particle size.  
No clear trend of emitted dose with mannitol particle size was apparent for either of the 
test inhaler devices.  A similar trend of increasing fine particle fraction with increasing 
particle size within the respirable range was identified for jet milled amiloride HCl 
delivered unformulated from an Aerolizer inhaler; additionally a trend of increasing 
emitted dose with API particle size was observed (Djokic et al., 2014). 
The lack of an unequivocal relationship between API particle characteristics and the mass 
of API emitted and delivered to the test impactor or impinger in these studies highlights 
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the dependence of the result upon the test conditions employed.  The specific device 
used, as noted in the Introduction chapter, will have large effect upon the results 
obtained – the internal geometry of the inhaler will define the aerodynamic and 
mechanical forces experienced by the formulation upon actuation, and the size 
distribution, morphology and texture of API and carrier particles (if present) will in turn 
determine the balance of shear and impact-generated fractions of the respirable dose.  It 
is therefore difficult to develop an insight into the behaviour of particles produced using 
a new processing route by examination of previous studies.  An evaluation of the 
aerosolisation behaviour of spray dried mometasone furoate particles of differing size 
has not been reported elsewhere in the relevant scientific literature, hence the 
experiments described in this chapter could provide a useful insight into the importance 
of API characteristics in determining the emitted dose and resulting aerodynamic particle 
size distribution.  
An oral inhalation formulation and a passive dry powder inhaler delivery system were 
chosen as the representative case to investigate whether the physicochemical particle 
differences able to be produced using the flow focussing atomizer had an impact upon 
patient-relevant dosing characteristics.  Twelve batches of spray dried mometasone 
furoate particles were selected to compare the impact of particle size and surface 
texture upon aerosolisation performance; representative electron micrographs of 
particles from the chosen batches are presented in Table 5.1 and API particle size 
percentiles are detailed in Table 5.2.  
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Table 5.1: Spray dried mometasone furoate batches 
EE686926/31F: 80 µm  droplet, 0.75% w/w Ethanol, 
160C inlet temperature 
EE686926/31J: 80 µm  droplet, 0.75% w/w Ethanol, 
100C inlet temperature* 
EE686926/31I: 80 µm  droplet, 0.75% w/w 2-propanol, 
160C inlet temperature 
EE686926/31Y: 80 µm  droplet, 1.25% w/w Ethanol, 
100C inlet temperature 
    
EE686926/32K: 80 µm  droplet, 0.375% w/w Ethanol, 
160C inlet temperature 
EE686926/31H: 80 µm  droplet, 0.375% w/w Ethanol, 
100C inlet temperature 
EE686926/31W: 80 µm  droplet, 1.0% w/w Ethanol, 
100C inlet temperature 
EE686926/31X: 40 µm  droplet, 1.25% w/w Ethanol, 
100C inlet temperature 
    
EE686926/31D: 40 µm droplet, 0.375% w/w Ethanol, 
160C inlet temperature 
EE686926/31Z: 40 µm droplet, 0. 5% w/w Ethanol, 
160C inlet temperature 
EE686926/31E: 40 µm droplet, 0. 75% w/w 2-propanol, 
100C inlet temperature 
EE686926/31V: 40 µm droplet, 1.0% w/w Ethanol, 
100C inlet temperature 
    
* - Note: a 20 micron scale bar has been used for the image of EE696926/31J; the magnification (250x) is the same as for the images of compared batches 
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A Cyclohaler was used as used to deliver formulated spray dried mometasone furoate 
particles to a next generation impactor (NGI) so aerosolisation characteristics for the 
chosen batches could be evaluated.  The Cyclohaler device (and the closely related 
Aerolizer) has been extensively used in experimental studies as a capsule is used to 
contain the formulation, allowing for easy preparation at laboratory scale. 
A series of publications by Coates et al describe a thorough characterisation of the 
contributions of the device and capsule to powder dispersion and resulting respirable 
dose.  Initially the impact of grid structure and mouthpiece was investigated by use of 
computational fluid dynamics, with the models being validated by Laser Doppler 
Velocimetry (Coates et al., 2004).  Simulation of emitted particle trajectory was then 
undertaken to understand the effect of the changing flow pattern.  Two modified grid 
configurations were compared to the standard design, to evaluate the difference in 
airflow, and the resulting impact upon turbulence and aerodynamic particle size 
distribution of the delivered dose.  Additionally, the influence of the mouthpiece length 
upon the emitted dose was explored, comparing ¾ and ½ length versions of the inhaler 
to the standard mouthpiece length.  Good agreement between simulated and measured 
flow rates were observed, giving confidence in subsequent predictions of the flow field 
at the grid and within the mouthpiece.  The main effect of the grid was to straighten the 
airflow and reduce the swirling airflow generated by the tangential air entry and 
resulting capsule rotation; additionally the standard low voidage grid was predicted to 
generate high integral scale strain rates which are understood to aid deagglomeration.  
Increasing the grid voidage had a significant impact upon straightening of the flow, with 
increased tangential flow predicted.  The fraction of particles impacting the grid 
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decreased with increasing voidage, however the number of collisions with the inner 
surface of the mouthpiece is predicted to increase, consistent with the difference in flow 
field.  The similarity in fine particles fraction of the emitted dose for the different voidage 
grids indicates a compensatory effect – the reduction in grid collisions and lower 
turbulence experienced with lower grid voidage being offset by an increasing incidence 
of collisions between particles and the inside of the mouthpiece.  The increase in particle 
– mouthpiece interactions with lower voidage was observed to lead to a lower emitted 
dose, demonstrating that although an effective deagglomeration mechanism for the ex-
device dose, use of mouthpiece collisions will result in a lower emission of respirable 
particles when expressed in terms of the nominal dose compared to a more effective 
grid.  The length of the mouthpiece was seen to have a much smaller influence upon 
dosing characteristics, with no impact upon respirable fraction observed.  A second 
publication (Coates et al., 2006) explored the influence of changing the size of the air 
inlets on the inhaler device, and unlike the previous work, evaluated the influence of test 
flow rate upon dose emission.  When considering the standard inhaler device, as used in 
the present work, increasing the test flow rate from 30 to 60 L min-1 results in an 
increase in fine particle fraction of the loaded dose from 15.0 % to 44.7 %.  A smaller 
increase of 40.1 % to 56.0 % was noted when considering the fine particle fraction of the 
emitted dose, denoting a lower mass being emitted at the lower flow rate which was 
attributed to retention within the capsule, rather than upon the inner surfaces of the 
inhaler. 
Particle impact velocities upon collision with the interior surface of the lower regions of 
the device were estimated at the test flow rate; predicted velocities of 8 and 14 m s-1 at 
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30 and 60 L min-1 were obtained.  Capsule rotation rate, determined by high speed 
photography, increased from 1340 to 2620 revolutions per minute with the increase in 
flow rate.  Both factors were initially considered important in generating both emitted 
dose and fine particle fraction and were investigated further in a later series of 
experiments.  A third study (Coates et al., 2005a) investigated the impact of flow rate 
upon the aerosolisation of mannitol, exploring wider range of airflows than the other 
studies performed by the research group.  Three regions of the inhaler were considered 
using a combination of computer modelling and empirical methods, and their respective 
roles in deagglomeration of the formulation were examined.  The grid of the device was 
observed to be the key element of the device with regard to deagglomeration, in terms 
of both the creation of turbulence which causes the stress required to cause 
deagglomeration, and in providing the surface with the highest energy particle impacts.  
An increase in dispersion performance was observed from 30 to 75 L min-1, but no 
further increase was apparent up to 120 L min-1.  Further interrogation of this 
relationship revealed a maximum, for fine particle fraction of the emitted dose, at 65 L 
min-1.  Relationships were defined between the flow rate and level of deposition in the 
USP throat used with the multi-stage liquid impinger, and also the time required to 
empty the capsule against the test flow rate.  The authors note that at 30 L min-1 
incomplete emptying of the capsule occurs, which reduces the level of device deposition, 
but at flow rates beyond 60 L min-1 the increased air velocity leads to a reduced level of 
deposition as re-entrainment of deposited particles is possible. 
The role of the capsule in deagglomeration was explored in a further study (Coates et al., 
2005b).  High speed photography, computational fluid dynamics and dispersion of 
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mannitol formulations into a four stage liquid impinger were used to define the 
importance of capsule size and the presence of a capsule in aerosolisation from the 
device.  The authors concluded that the size of the capsule and particle-capsule impacts 
were of little importance in determining performance, however the size of the hole 
pierced in the capsule strongly influenced performance with superior dispersion 
observed using smaller diameter holes.  The authors note that smaller diameter holes 
increase emptying times, with the hole size produced by the marketed device helping to 
ensure flow through the inhaler is fully developed and turbulent at the point of dose 
emission. 
In a study similar to the second study conducted by Coates et al, Shur et al investigated 
the design features of the Cyclohaler, constructing modified versions to match the 
performance of a reference inhaler (Shur et al., 2012).  Using commercial Spiriva 
capsules containing tiotropium bromide, the authors studied the impact of modified 
Cyclohaler air inlets upon the aerodynamic particle size distribution of the emitted dose 
using computerised fluid dynamics, high speed videography and cascade impaction.  The 
flow field and pressure gradients within both the chamber and capsule were defined, 
indicating the maximum pressure gradient within the capsule is present across the 
hemispherical ends.  The effect of test flow rate was shown to be lower for the low 
resistance Cyclohaler than the higher resistance reference Handihaler over the range 20 
to 55 L min-1, with little change in the key aerosolisation parameters noted for the Spiriva 
formulation at the extremes of the flow rate range. 
Donovan et al (2010, 2012) evaluated the Cyclohaler whilst studying the interactions 
between device and formulations, with particular reference to the characteristics of the 
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carrier particles in the formulation (Donovan, Kim, Raman, & Smyth, 2012, Donovan & 
Smyth, 2010).  The authors investigated the relative importance of aerodynamic forces 
and those generated during impact upon the generation of respirable API particles from 
carrier based formulations.  Anhydrous (smooth) and granulated (particles containing 
asperities) lactose particles were compared when used as the carrier for budesonide, 
with the particle size of the carrier forming an additional variable.  The authors 
concluded that impaction was an important mechanism in the generation of the 
respirable dose, particularly in the case of the type of inhaler used within the present 
study, and the magnitude of effect increased with the greater momentum associated 
with larger carrier particle sizes. 
The emitted dose and aerodynamic particle size distribution obtained from a DPI are 
therefore strongly correlated to the particular formulation and device employed.  A 
lactose-carrier based formulation has been employed to remain consistent in approach 
with the majority of studies, and the particle size distribution of lactose used has been 
similarly selected to be consistent.  The Cyclohaler used for the experiments described in 
Chapter 5 has been selected as a consequence of prevalence of this variant of inhaler in 
the studies described in the academic literature, and the depth of knowledge generated 
on the mode of operation.  A good comparison should therefore be possible between 
results at produced by the studies described in this thesis and those generated by the 
work of the research groups summarised in the preceding paragraphs, at equivalent flow 
rate and pressure drop by using a similar device.  The similarity of trends identified 
during these studies with published results will form part of the discussion of results 
presented in section 5.3. 
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5.2. Methods 
5.2.1. Manufacture of inhalation blends 
5 %w/w blends using lactose as a carrier/ diluent were produced using a tumbling mixer 
(Turbula T-2C, Glen Creston, UK) employing a rotation speed of 42 rpm for 60 minutes.  
Blends were manufactured at 200 mg scale, using a 20 mL vial and lid to contain each 
blend.  Filled vials were packed into a larger cylindrical container in a common 
orientation and the free space in the container was packed out with tissue to prevent 
movement of the vials relative to each other or the container.  Lactose monohydrate 
from a single manufactured batch with a median particle size of 77 m, and fines 
content (% < 5 m by weight) of 5 % was used for all formulated mometasone furoate 
blends to ensure consistency.  As described in Section 1.4.1  the optimum lactose particle 
size distribution for use in inhaled blends has been the subject of much debate and 
research, with little in the way of consensus.  A 1:1 ratio of API particles to lactose fines 
has been suggested (Islam et al., 2004b) and the lactose used was selected to 
approximate this ratio for the chosen API content within the blends.  Aliquots of blend 
were hand filled into size 3 gelatin capsules.  Each capsule shell was tared on an 
analytical balance and 10.5  0.5 mg of blend was transferred into one half of the shell 
using a small stainless steel spatula.  The capsule was then closed and stored for 
between 24 and 48 hours between 35 and 60 %RH before dosing into the NGI.  The spray 
dried batches formulated as blends and the corresponding blend batches are detailed in 
Table 5.2.  
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Table 5.2: Blend batch identities 
Input spray dried 
MF batch 
Intended 
droplet size 
(m) 
Solution 
concentration 
(%w/w) 
API Particle Size Distribution 
undersize percentile (m) 
Blend batch 
number 
X10 X50 X90 
EE686926/31E 40 0.75 3.3  6.2 9.0 EE758544/2 
EE686926/31D 40 0.375 3.3  6.5 9.4 EE758544/3 
EE686926/31F 80 0.75 5.2 15.5 25.4 EE758544/4 
EE686926/31H 80 0.375 7.0 11.8 16.8 EE758544/5 
EE686926/31I 80 0.75 5.3 11.7 17.4 EE758544/6 
EE686926/31J 80 0.75 7.5 13.8 19.8 EE758544/7 
EE686926/31V 40 1.00 4.3  8.6 13.0 EE758544/8 
EE686926/31W 80 1.00 9.7 16.3 23.0 EE758544/9 
EE686926/31X 40 1.25 5.7 15.9 23.7 EE758544/10 
EE686926/31Y 80 1.25 8.3 16.9 24.1 EE758544/11 
EE686926/31Z 40 0.5 1.8  5.4 7.4 EE758544/12 
EE383926/32K 80 0.375 2.5  8.3 15.0 EE758544/13 
 
5.2.2. Cascade Impaction 
Each batch was evaluated at 20 and 60 L min-1 flow rate using a next generation 
impactor; the same impactor components and Cyclohaler device were used for all tests.  
Three tests were performed for each blend at each flow rate and two capsules were 
actuated into the NGI for each impaction test.  One impaction test was performed for 
each blend during a single impaction session to ensure the twelve blends were evaluated 
under similar conditions.  The Cyclohaler was washed in distilled water and blown dry 
with compressed air at least 48 hours before being used to deliver the blends to the NGI, 
and blown clean until visibly free of powder between evaluation of different batches. 
A next generation impactor with a preseparator and USP induction port was used to 
evaluate the mometasone furoate blends; a diagram of the impactor is given as Figure 
5.1 (United States Pharmacopeia Convention, 2014).   
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Figure 5.1 Next Generation Impactor 
 
 
 
Air flow through the impactor was induced using a vacuum pump ( HCP5, Copley 
Scientific, Nottingham, UK ) connected to a critical flow controller (TPK, Copley Scientific, 
Nottingham, UK); a diagram of the experimental configuration used is presented as 
Figure 5.2: 
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Figure 5.2 Cascade impaction configuration 
 
Each impaction cup was washed with acetone, coated with 19.25 % PEG200 solution in 
acetone, and the acetone allowed to evaporate to provide an adhesive layer to minimise 
impactor bounce.  2 mL of PEG200 solution was used to coat the impaction cups for 
stages 2 to filter; 4 mL of solution was used to coat the stage 1 cup.  Once assembled, the 
preseparator reservoir was filled with 15 mL of deionised water and the air flow rate 
through the impactor was adjusted using the controller on the pump to give the required 
volumetric flow as indicated by a calibrated rotameter connected to the induction port.  
The P3/P2 ratio was checked at this point to ensure it was below 0.5 and that sonic flow 
was being achieved; the test flow time was then set to give an inspiratory volume of 4 L. 
One capsule was selected and inserted into the chamber of the Cyclohaler using steel 
tweezers.  The Cyclohaler was closed and the capsule pierced using the integral pins by 
depressing the buttons on the side of the device.  The Cyclohaler was connected to the 
NGI induction port using a purpose-designed polymer connector, the vacuum pump 
switched on and the inspiratory air volume was route through the device by switching 
the flow controller valve.  A second actuation period of equivalent air volume was then 
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directed through the inhaler to ensure full emptying of capsule contents.  The capsule 
shell was removed from the Cyclohaler, visually checked for residual powder and the 
second capsule of the same batch was placed into the chamber.  Two further actuation 
periods were then used to entrain and deposit the contents of the capsule into the NGI.  
The second capsule shell was checked for residual powder, removed and the Cyclohaler 
was blown with filtered compressed air until visibly clean within a safety cabinet. 
The NGI was disassembled and the material present upon each impaction plate was 
washed into 50mL volumetric flask using 65:35 acetonitrile: water as a dissolving solvent.  
The contents of the induction port and the preseparator were washed into separate 
100mL volumetric flasks using the same dissolving solvent.  Flasks were allowed to stand 
overnight and then the contents were made to volume and shaken approximately 1 hour 
before a 1 – 2 mL aliquot of solution was transferred to a clean HPLC vial and capped. 
Analysis of the samples was performed by HPLC (Agilent 1100, Agilent technologies, 
Santa Clara, CA, USA) employing UV detection at 250nm wavelength; two standard 
solutions of 7.5 mg  1.0 mg L-1 were prepared and run with the sample solutions to 
allow quantification.  A Zorbax SB-C18 column (4.6 x 50 mm, 3.5 µm packing) maintained 
at 40°C was used for separation of a 50 L injected volume of solution.  Gradient elution 
of two mobile phases over a 6 minute run time was used to aid separation; mobile phase 
identities, phase ratio changes and associated run time points are detailed in Table 5.3. 
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Table 5.3 HPLC run parameters 
Mobile phase A: Water acidified with 0.05% TFA 
Mobile phase B: Acetonitrile acidified with 0.05% TFA 
  
Time A:B volumetric flow ratio 
0 90:10 
5 5:95 
5.5 90:10 
6 90:10 
 
Linearity of response for the HPLC method has been demonstrated up to a column 
loading of 880 ng, well in excess of the highest concentration produced during analytical 
work-up in the current study.  
5.2.3. SEM characterisation 
Electron micrograph images were obtained for each of the blends prepared for 
evaluation by cascade impaction.  Images of lactose and API particles within the 
formulation were obtained using a Supra 25 scanning electron microscope (Carl Zeiss 
Microscopy, Jena, Germany), employing an element potential difference of 5kV.  A small 
amount of powder was dispersed onto an adhesive graphite disc mounted on an 
aluminium stub for each batch of spray dried mometasone furoate.  A clean, disposable 
brush was used to disperse each sample onto the stub, and the powder was then coated 
with a thin layer of palladium using a sputter coater (AGB7341, Agar Scientific, Stansted, 
UK).  Images of a population of particles considered representative were obtained at 
three levels of magnification in order to assess both within-batch consistency and 
surface detail. 
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5.3. Results and discussion 
The spray dried mometasone furoate particles appear unaffected by the blending 
operation, as good comparability is observed between the particles seen in Table 5.1 and 
API particles within the blends in the electron micrographs presented as Appendix 7.  
Cascade impaction analysis results are summarised as Emitted Dose (ED, the sum of API 
mass deposited on the inlet port, preseparator and stages 1 to filter), Impactor Size Mass 
(ISM, sum of API mass deposited on stages 2 to filter) and Respirable Mass (RM, sum of 
API deposited on stages 3 to filter at 20 L min-1, and 2 to filter at 60 L min-1) as Figure 5.3, 
Figure 5.4 and Figure 5.5.  Mean values for the three results at each flow rate are 
represented by columns with error bars indicating the standard deviation. 
 
Figure 5.3 Batch comparison of average mometasone furoate emitted dose 
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Figure 5.4 Batch comparison of average mometasone furoate impactor sized mass 
 
 
Figure 5.5 Batch comparison of average mometasone furoate respirable mass  
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The proportion of the dose emitted from the Cyclohaler is dependent upon the test flow 
rate, with higher ex-device deposition observed for all batches at the 60 L min-1 air flow 
rate.  Emitted dose also exhibits a flow-rate dependent trend with mometasone furoate 
particle size, as shown in Figure 5.6, with higher values obtained for the batches 
containing relatively large mometasone furoate particles at 60 L min-1.  Higher ex-device 
masses are however produced by blends containing smaller mometasone furoate 
particles at the lower flow rate of 20 L min-1, suggesting a complex relationship between 
powder physical properties and entrainment of the dose.  Increased ED values with 
greater flow rates have been observed previously when using the Cyclohaler (Srichana, 
Martin, & Marriott, 1998), however the magnitude of difference observed with the spray 
dried mometasone furoate formulations is larger than has been observed with 
formulations containing crystalline APIs.  It should be noted that the API particle sizes 
used within this study are larger than those typically used within inhaled formulations; 
the low particle formation rate for the equipment configuration used made the 
generation of sub-five micron particles unachievable within a practical timeframe.  The 
trends identified here may represent those present for smaller particles but are possibly 
easier to define with the greater range of API particle sizes evaluated.  Flow rate 
dependence of emitted dose was observed for formulations containing micronised and 
SEDS generated budesonide particles (Lobo et al., 2005), again without the absolute 
differences observed for spray dried mometasone furoate particles.  Jet milled amiloride 
HCl particles of median particle sizes ranging from 1.7 to 3.0 m demonstrated a trend of 
increasing ED with particle size for unformulated API particles delivered from an 
Aerolizer device (Djokic et al., 2014 ).  The authors attributed the difference in ED to an 
increased agglomeration with smaller particle size, indicating a difference in 
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agglomerative tendency between the two lower median size batches (1.71 and 2.07 m) 
and the larger batches of jet milled API (2.62 and 2.94 m).  Whilst this provides a 
possible explanation of the ED difference between the two groups of materials the 
categorisation seems arbitrary, with little physical reasoning as to why the size range 
2.07 to 2.62 m should produce a difference in agglomerative behaviour to that of the 
larger sized particles.  The ED data presented may be indicative of a general trend of 
increasing emitted dose with particle size, as seen for spray dried mometasone furoate 
particles at the higher test flow rate.  A study conducted using spray dried fluticasone 
propionate revealed a trend of decreasing emitted dose with increasing API particle size 
for lactose blends delivered from two devices of differing resistance at 60 L min-1 (Louey, 
Van Oort, & Hickey, 2004b).  Drug-alone dosing showed a device dependent ED trend, 
with a directly-proportional relationship seen with API particles size when delivered from 
an Inhalator, and the opposite trend observed when using a Rotahaler, a lower 
resistance device.  A second study by the same research group, this time using 
unformulated spray dried mannitol with the same two devices revealed no trend of 
emitted dose with particle size (Louey, Van Oort, & Hickey, 2004a).  The impact of 
particle size upon emitted dose appears therefore to be dependent upon the particular 
API used, and is influenced by the interaction between API, device resistance and test 
conditions.  Of the work referenced, the evaluation of formulated spray-dried FP most 
closely matches the present study, however the trend at 60L/min is the opposite of that 
seen for spray dried mometasone furoate.  Electron micrograph images of the 
fluticasone propionate blends in the referenced work indicate an adhesive mixture was 
created upon mixing, however similar images taken of the mometasone furoate blends 
(Appendix 7) show interactions between API and carrier particles that are dependent 
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upon the API particle size.  Mometasone furoate particles with median particle sizes 
below 10 m form an adhesive mixture, whereas those above 10 m show in general a 
decreasing tendency to adhere to the carrier with increasing API median size.  The 
emitted dose trends illustrate the relative ability of API particles of different sizes to 
avoid deposition on the surfaces of the Cyclohaler during actuation.  Emission from the 
capsule during actuation is by a combination of aerodynamic and centrifugal forces; 
avoidance of deposition on the Cyclohaler is then reliant upon the entraining air flow to 
be sufficiently large for the particles momentum to relax into the prevailing airflow 
direction.  At the higher flow rate this would appear to favour the largest API particles – 
the increased adhesion of the smaller particles to large carrier particles may result in 
enhanced impaction for the proportion of mometasone furoate particles remaining 
attached to the carrier.  A reduction in flow rate reduces the air velocity but has a 
smaller impact upon the ejection velocity from the capsule, resulting in a higher level of 
deposition upon the Cyclohaler device.  Smaller API particles will relax into the airstream 
more rapidly, so for the fraction able to be separated from the carrier a lower incidence 
of deposition will be experienced resulting in an inversion of the trend seen at 60 L min-1 
for the 20 L min-1 flow condition. 
Comparison of the emitted dose results with those for impactor sized mass and 
respirable mass shows a greater proportion of the API emitted at 20 L min-1 is able to 
reach the lower stages of the impactor than at 60 L min-1 flow rate, regardless of particle 
size.  By observation (occasional incidence of the capsule shells splitting and fragmenting 
upon piercing in the Cyclohaler made weighing impractical) only trace amounts of 
powder remained associated with the capsule shells after use, hence sufficient energy 
Formulation Studies 
190 
 
was provided at either flow rate to allow entrainment and aerosolisation of the powder 
charge.  A greater proportion of the powder entrained at 20 L min-1 must therefore 
impact upon the Cyclohaler device, as shown by the smaller emitted dose values in 
Figure 5.3.  A larger fraction of the remaining powder cloud is then able to penetrate into 
the impactor, thus the inhaler device would appear to preferentially classify for smaller 
particle sizes at the lower flow rate.  
The data indicate that the increased energy supplied at the higher flow rate provides 
sufficient momentum for larger particles to exit the capsule, become entrained in the air 
flow and deposit within the impactor.  Larger particles with greater mass develop more 
momentum, hence are less likely to be retained within the device by wall adhesion, 
resulting the proportional relationship between API particle X50 and emitted dose.  
Conversely at the lower flow rate of 20 L min-1 smaller particles with lower mass are 
more likely to be entrained in the air stream and avoid impaction upon the inner 
surfaces of the inhaler than more massive particles, resulting in the inversely-
proportional relationship between size and emitted dose.  The trends are illustrated by 
Figure 5.6: 
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Figure 5.6 Effect of mometasone furoate X50 on Emitted Dose 
 
Inter-batch comparison of emitted dose using a pairwise T-test to determine statistical 
significance (α = 0.05) between particles formed using large and small droplets and at 
varying solute concentration is presented as Table 5.4, with statistical significance 
denoted in red.  Significant difference in emitted dose between the two droplet sizes is 
shown for both air flow rates when considering all concentrations, however at individual 
concentrations difference is able to be demonstrated at the higher test flow rate.  The 
effect of solute concentration used at the point of spray drying upon emitted dose is 
noticeably less marked than that observed for droplet size, with difference only proven 
at the higher flow rate for particles formed from 40 m droplets. 
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Table 5.4 Significance probability (p) values for Emitted Dose differences 
Droplet size (m) Concentration (%w/w) Emitted Dose 
20 L min-1 60 L min-1 
80 vs. 40 All 0.0172 <0.001 
0.375 0.143 0.003 
0.75 0.236 <0.001 
1.0 0.976 0.037 
1.25 0.771 0.630 
80 0.375 vs. 0.75 0.528 0.161 
40 0.375 vs. 0.75 0.691 0.044 
 
The combination of solvent and spray drying conditions was observed to have a direct 
impact upon the texture of output particles at the 80 m droplet size, as discussed in 
Section 4.3.3.1.  A comparison of the emitted dose differences for relevant batches is 
presented as Table 5.5.   
Table 5.5 Significance probability (p) values for Emitted Dose difference, 80 
micron droplet size batches 
Droplet size 
(m) 
Concentration 
(%w/w) 
Batches compared Emitted Dose 
20 L min-1 60 L min-1 
80 0.75 EE758544/4 EE758544/7 0.162 0.007 
EE758544/4 EE758544/6 0.034 0.044 
EE758544/6 EE758544/7 0.432 0.650 
0.375 EE758544/5 EE758544/13 0.064 0.073 
0.375 vs. 0.75 EE758544/4 EE758544/13 0.979 0.003 
EE758544/5 EE758544/7 0.848 0.787 
0.75 vs. 1.0 EE758544/7 EE758544/9 0.323 0.093 
1.0 vs. 1.25 EE758544/9 EE758544/11 0.148 0.240 
 
Higher emitted dose values are seen for batches containing particles with a larger 
median particle size where significant emitted dose differences exist, consistent with the 
overall trends observed in Table 5.4.  Particle size differences also exist however for the 
inter-batch comparisons shown in Table 5.5 where significant differences are not 
observed, and in the case of batches EE758544/7 and EE758544/9 the X50 difference is of 
the same order as that for EE758544/4 and EE758544/7, where a difference in ED was 
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demonstrated. It is arguable that the difference in texture between the open crumpled 
particles of EE758544/4 and the tightly crumpled particles of EE758544/7 and 
EE758544/9 is to some extent responsible for the emitted dose differences – a difference 
in emitted dose between corrugated and spherical particles was observed by Chew & 
Chan (2001) with corrugated bovine serum albumin particles responsible for lower 
device deposition.  The surface texture will have an influence on the geometric particle 
size for particles of equivalent mass, as a greater deviation from sphericity will result in a 
larger geometric size, hence the X50 differences observed between the various batches 
compared here may not completely describe absolute differences in mean diameter by 
mass.  Insufficient material was generated during spray drying to allow specific surface 
area and density measurements to be conducted, hence it has not been possible to 
deconvolute the effects of particle mass and texture.  Blend structure may also have an 
influence upon the emitted dose, particularly at the lower test air flow rate.  The 
electron micrographs presented as Appendix 7 show an increased prevalence of 
adhesion to carrier particles for the three batches containing API particles with X50 below 
10 m. 
The effect of particle size upon deposition is clearly evident from the inter-batch 
comparison of RM and ISM.   Greater amounts are deposited in the case of batches 
containing particles with an X50 below 10 m particles (batches EE758544/2, 3, 8, 12 and 
13) than for batches with larger X50 values, and the expected correlation between X50 
and mass deposited is observed for the sub-10 m X50 batches.  Students T-test was used 
to determine the significance (at 95% confidence) of the differences between the 
deposition masses attributable to droplet sizes and concentrations over the twelve 
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formulated batches; significance probability (p) values are presented in Table 5.6 with 
significant differences highlighted in red.  The droplet size used to produce mometasone 
furoate particles has a highly significant impact upon ISM and RM at both 20 and 60 L 
min-1 when considering the entire range of mometasone furoate concentrations 
employed.  Significant differences in impactor sized mass between batches containing 
particles formed at  the two droplet sizes are also observed at individual concentrations 
with the exception of particles formed at 1.25 %w/w solution concentration, where 
similar particle sizes were unexpectedly obtained during spray drying.  Respirable mass 
shows a similar trend with no significant difference observed at 1.25 %w/w; statistical 
significance between droplet sizes was also unable to be demonstrated at the 0.375 
%w/w solution concentration.  The effect of solution concentration used to produce the 
API particles upon APSD is demonstrated for blends containing API generated at 80 m 
droplet size, with significant differences for both ISM and RM.  No significant difference 
is observed at 40 m droplet diameter however, unsurprisingly given the similarity in 
mometasone furoate particle size and morphology between the input API batches. 
Table 5.6: Significance probability (p) values for effect of experimental parameters 
on APSD 
Droplet size 
(m) 
Concentration 
(%w/w) 
ISM RM 
20 L min-1 60 L min-1 20 L min-1 60 L min-1 
80 vs. 40 All <0.001 <0.001 0.001 0.001 
0.375 0.018 0.029 0.0743 0.0644 
0.75 0.001 <0.001 <0.001 <0.001 
1.0 0.008 0.010 0.001 0.001 
1.25 0.212 0.716 0.588 0.658 
80 0.375 vs. 0.75 0.024 0.029 0.021 0.032 
40 0.375 vs. 0.75 0.904 0.132 0.817 0.180 
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A batch-wise comparison of results was undertaken to assess the possible impact of 
particle morphology and surface texture upon aerosolisation performance, as presented 
in Table 5.7.  Statistically significant differences in APSD results between batches are 
denoted using red text. 
Table 5.7: Significance probability (p) values for batch-wise comparison of 
morphology on APSD 
Droplet 
size 
(m) 
Concentration 
(%w/w) 
Batches compared ISM RM 
20 L min-1 60 L min-1 20 L min-1 60 L min-1 
80 0.75 EE758544/4 EE758544/7 0.827 0.412 0.827 0.878 
EE758544/4 EE758544/6 0.574 0.101 0.470 0.050 
EE758544/6 EE758544/7 0.575 0.079 0.549 0.007 
0.375 EE758544/5 EE758544/13 0.056 0.315 0.034 0.027 
0.375 vs. 0.75 EE758544/4 EE758544/13 0.043 0.128 0.018 0.023 
EE758544/5 EE758544/7 0.772 0.025 0.062 0.042 
0.75 vs. 1.0 EE758544/7 EE758544/9 0.179 0.127 0.058 0.019 
1.0 vs. 1.25 EE758544/9 EE758544/11 0.40 0.151 0.592 0.018 
40 0.5 vs. 0.75 EE758544/2 EE758544/12 0.063 0.001 0.063 <0.001 
0.375 vs. 0.5 EE758544/3 EE758544/12 0.020 0.002 0.002 0.0004 
0.375 vs. 0.75 EE758544/2 EE758544/3 0.904 0.132 0.816 0.180 
Differences in the mass of API impacted when comparing concentrations within a droplet 
size can be identified.  At the 40 m droplet size differences in ISM and RM exist 
between 0.5 and 0.375 %w/w or 0.75 %w/w concentrations at 60 L min-1; significant 
difference is also observed at 20 L min-1 between 0.5 and 0.375 %w/w.  The particles 
generated at 0.5 %w/w concentration produced a larger ISM and RM than those 
generated at either 0.375 or 0.75 %w/w, however this is unsurprising given that a 
smaller particle size was produced by the 0.5 %w/w run than for 0.375 %w/w.  Some 
variability between atomization runs at nominally identical conditions was noted in 
Section 3.2.3, and may be the cause of the unexpectedly smaller particle size percentiles 
measured for the API used in formulated blend EE758544/12 compared to that used in 
EE758544/3. 
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A number of batches manufactured using mometasone furoate particles generated at 
the larger droplet size have been compared where operating parameters other than 
concentration are kept constant.  Significant differences in RM at 60 L min-1 are evident 
for the three groups of batches compared, with the difference also observed at 20 L min-
1 between batches EE758544/4 and EE758544/13, which showed the greatest divergence 
in result for the batches produced using a target droplet size of 80 m batches.  The RM 
differences between the batches compared are intuitive for all concentrations with the 
exception of the comparison between 1.0 and 1.25 %w/w.  Inspection of the particle size 
determination results reveals a similar geometric size for particles produced using 1.0 
and 1.25 %w/w concentrations, again possibly due to subtle differences in droplet size 
distributions between runs at the same atomizer operating parameters. 
Comparison of batches containing particles generated at the same droplet size and 
concentration show significant differences.  Two of the batches, EE758544/5 and 
EE758544/13, contained mometasone furoate particles with distinctly different 
morphologies as shown in the electron micrographs presented in Table 4.4.  The 
resulting differences in respirable mass between the two batches is similar to that seen 
between either batch and the RM for batch EE758544/3 containing API produced using 
40 m droplets.  Similar arguments on the relative impact of geometric size and particle 
texture can be made as for the emitted dose differences between batches EE758544/4 
and 7; notable differences in particle texture are present but the difference in geometric 
size is consistent with the relative difference in ISM and RM. 
Three formulations (EE758544/4, 6 and 7) utilised particles produced using nominally 70 
m droplets at a solute concentration of 0.75 %w/w.  Differences in aerosolisation 
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performance, assuming similarity in geometric PSD, can be attributed to mometasone 
furoate particle property differences resulting from the use of different solvent and 
changes to the inlet temperature and drying gas flow rate of the spray dryer.  Visual 
inspection of the electron micrographs presented as Table 4.4 reveals pronounced 
differences in particle morphology produced upon drying – particles spray dried from 
ethanol are corrugated, the degree of which appears related to the drying temperature.  
In contrast particles produced using propanol as solvent exhibit corrugation to a much 
lower extent with smooth, spherical particles being prevalent.  Differences in 
aerosolisation behaviour were identified at 60 L min-1 with emitted dose for EE758544/4 
being significantly higher than EE758544/6 and EE758544/7, and respirable mass for 
EE758544/6 being greater than that for EE758544/4 and EE758544/7.  The trends RM 
results also correspond to the average particle mass trends that would be expected from 
the measured diameters presented in Table 4.5, however the generation of corrugated 
particles is likely to result in a larger characteristic particle dimension than for a solid 
sphere of the same mass of material, similarly to the ED results as discussed earlier. 
5.4. Conclusion 
The differences in particle properties able to be obtained for mometasone furoate by 
spray drying with the flow focusing nozzle have had a direct impact upon the 
performance of formulated product. Statistically-significant differences in both the 
emitted dose and respirable fraction have been determined during this study, indicating 
that atomization using controlled droplet distribution is a viable method for optimising 
the API particle size distribution for use in an inhaled dosage form.  A direct relationship 
between respirable mass and the droplet size used to produce the mometasone furoate 
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particles has been demonstrated, with respirable masses of 28.7 to 109.3 mcg obtained 
for particles from 35 m droplets, compared to 4.7 to 10.5 mcg for 70 m droplets (for 
blends containing particles generated from 0.375 to 1.0 %w/w solution concentration, 
tested at 60 L min-1).  The absolute effect of size upon delivery efficiency is illustrated 
with reference to the API particles produced using 40 m droplets – a 13 % decrease in 
MF particle diameter from 6.2 to 5.4 m has resulted in a three-fold increase in 
respirable mass from 29.9 to 109.3 mcg. 
Emitted doses were also dependent upon the droplet size used to form particles, with 
lower emitted doses (341.7 to 593.1 mcg) determined at 60 L min-1 for 35 m droplets 
compared to 70 m droplets (615.4 to 819.7 mcg) at solution concentrations at or below 
1.0% w/w.  Flow dependency of cascade impaction results is clearly evident, with 
impactor sized masses and respirable masses all greater at 60 L min-1 compared to 20 L 
min-1.  The relationship between emitted dose and flow rate is similar, additionally 
divergence in the relationship between mometasone furoate size and emitted dose was 
noted with a change in flow: smaller mometasone furoate particles produced a 
comparatively larger emitted dose at 20 L min-1, however at 60 L min-1 larger particles 
were seen to increase the emitted dose. 
The cascade impaction results suggest particle texture may play a role in the differences 
in respirable mass observed - three API particle batches generated at the same nominal 
droplet size and concentration under different drying conditions yielded different 
particle textures which subsequently produced subtle but significant differences in 
device performance.  A respirable mass of 10.3mcg was determined for the smooth 
mometasone furoate particles within formulation EE758544/6, compared with 6.3 and 
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6.5 mcg for the open crumpled particles within EE758544/4 and tight crumpled particles 
in EE758544/7. 
The mometasone furoate particles used in this study were generated with the intention 
of studying the energetic impact of spray drying with controlled droplet sizes, as 
described in Chapter 3, hence were not optimised for exploring inhaled delivery.  The 
optimal batch produced, containing mometasone furoate particles of 5.4 m X50, 
however compares well in terms of respirable fraction to those described by Donovan et 
al for micronized budesonide from a Cyclohaler using similar lactose – 19.3% of emitted 
dose for spray dried mometasone furoate versus 15.2 for budesonide. 
The data presented here therefore provide only a small insight into what is achievable 
via narrow droplet distribution spray drying using flow-focusing, and the univariate 
approach taken to formulation necessitated by the small quantities of API available 
leaves much scope for optimising the formulation approach.  Similarly the use of single 
device did not fully explore the interplay between deagglomeration potential and API 
particle properties in respirable dose generation. 
Further studies targeted at producing particles within the respirable range, particularly 
those employing a range of solvents capable of inducing varying texture, will provide 
additional information regarding the utility of this technique and the potential for 
subsequent performance gains for inhaled formulations.
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6. CONCLUSION AND FURTHER WORK 
The studies described in this thesis have highlighted the effectiveness of simple flow-
focussing technology in improving the uniformity of output from an industrially-
representative spray dryer.  Regulation of target droplet size and the associated droplet 
size variance using two control parameters, gas pressure and liquid flow rate, has been 
successful in delivering meaningful differences in the particle size, morphology and 
molecular arrangement of a representative active pharmaceutical ingredient.  The use of 
two droplet sizes and multiple solute concentrations allowed sodium chloride particles 
across the X50 range 3 – 13 m to be produced; amorphous mometasone furoate 
particles were generated within the X50 range 5 – 17 m with a variety of textures.  
Drying of 40 m diameter mometasone furoate solution droplets led to the formation of 
smooth particles, except when using ethanol as a solvent and drying at 100C inlet 
temperature which yielded corrugated particles.  At 80 m droplet size the depth of the 
corrugations was observed to increase with decreasing concentration and 100C inlet 
temperature; increasing the concentration or use of 160C inlet temperature increased 
the number of corrugations and reduced the corrugation depth, with some instances of 
spherical particles when using 2-propanol as the solvent.  The formation of spherical 
particles is indicative of a mechanically robust layer being formed during initial 
precipitation of solid, hence the generation of corrugations would appear to indicate a 
greater degree of flexibility resulting in deformation upon further drying.  Deep 
corrugations are consistent with increased flexibility given their formation when using 
low solute concentrations, with increased corrugation frequency and smaller amplitude 
being observed upon concentration increase. 
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The differences in the texture able to be produced during spray drying with narrow 
droplet distributions further exemplify the particle characterisation differences possible 
by careful control of the spray drying operation, without always having to resort to the 
inclusion of excipients. 
A comparison to experiments employing the standard two-fluid nozzle supplied with the 
Buchi B-290 demonstrates a reduced span. The flow-focusing atomizer produced particle 
size distributions with an average span (range in parentheses) of 1.1 (0.8 – 1.6) 
compared to 1.7 (1.2 – 1.9) (Paluch et al., 2012).  Perhaps more important is the range of 
average particle size the flow-focusing atomizer is capable of generating; minimum and 
maximum X50 values of 4.5 to 16.9 m were able to be produced compared to 1.6 to 3.4 
m for the Buchi two-fluid atomizer (Paluch et al., 2012). 
Flow rates within the experimental equipment configuration used were modest, 
however multiplexing of atomizers would offer a route to scale-up and commercial 
viability.  The technology has been observed to be robust to use in the demanding 
environment within the spray dryer, and is not believed to be subject to the limitations 
presented by the full range of solution systems encountered with more complex 
systems.  An inability to process fluticasone propionate, one of the APIs selected for 
evaluation was observed however; further work has been suggested using a similar API 
with modified ester groupings to attempt to elucidate the root cause for the processing 
difficulties experienced. 
Valuable insights into the thermodynamic and kinetic properties of mometasone furoate 
in the amorphous state were also able to be gained by use of the flow-focusing 
technology within the spray drying configuration.  A relationship was defined between 
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the enthalpy observed as the spray dried mometasone furoate passed the glass 
transition temperature, attributed to latent heat of crystallization, and drying conditions. 
The correlation between the enthalpy range (8 – 40 J g-1) and processing conditions 
suggests a link between the free energy of the particles and the kinetics of drying.  The 
in-vivo dissolution and so bioavailability may therefore be able to be improved whilst 
maintaining a stable product, given that suitably high glass transition temperatures (109 
– 150C) were determined across the processing ranges used.  Some counterintuitive 
relationships between variables and enthalpy have been identified, with increased gas 
flow and solute concentration giving unexpected reductions in enthalpy perhaps 
associated with retained solvent upon drying.  Further investigation of these variables 
would help establish the validity of these relationships and explore whether, if 
confirmed, they are generic or specific to mometasone furoate.  The possible impact of 
residual solvent on the mometasone glass transition has also been noted; complete 
drying will be required to ensure no suppression in this attribute and so lend stability to 
the particles generated.   
Formulation experiments using the mometasone furoate particles have demonstrated a 
meaningful difference in the delivery of API from a pharmaceutical dosage form.  The 
systematic variation in impaction profile with mometasone particle size, spanning the 
respirable mass range 5 – 109 mcg when tested at 60 L min-1, indicates a difference in 
clinical dosing performance should be expected across the range of particles produced 
by flow-focusing spray drying, and if the differing thermodynamic properties of the 
particles translate to dissolution and transport differences, an additional dimension in 
efficacy change may be available. 
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The work performed has also identified some topics that would benefit from further 
research.  The understanding of flow focusing continues to develop, and the systematic 
offset from predicted droplet size with varying flow and pressure identified in Section 
3.2.3 indicates the current theory based predominantly upon Weber number may 
require augmentation.  The increased variance and decreased reproducibility associated 
with aqueous solutions compared to those encountered when using alcohols suggests 
additional attributes in addition to surface tension are impactful and should be 
accounted for.  X50 coefficient of variation values of 4.5 % for sodium chloride solutions 
and 2.8 % for mometasone furoate were apparent within runs.  The discrepancy for 
between run variability is greater: 5.3 and 3.5 % for 40 and 80 m mometasone furoate 
solution droplets versus 26.9 and 10% for 35 and 70 m sodium chloride solution 
droplets. 
From a processing perspective the over-prediction of output sodium chloride particle 
diameter (approximately 65 % of predicted) when flow focussing within a high-velocity 
gas stream indicates the external environment directly effects the formation of droplets, 
possibly by increasing the degree of extension of the liquid thread initially formed 
leading to reduced droplet size.  Additional investigational work into the influence of 
external gas flows upon the average droplet size and variance would be of benefit to the 
successful implementation of the technology. 
Insights gained into the behaviour of the two corticosteroid molecules selected for 
experimentation during practical work also highlights further area of study from a 
physicochemical perspective.  The substantial difference in ability to spray dry the two 
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APIs was unexpected given their structural similarity, and is indicative of potentially large 
differences in transport properties that extend beyond their use in spray drying.  
Finally, additional work can be identified that would add to the current knowledge of dry 
powder inhalation formulations.  The variation in texture observed is likely to change the 
adhesion and aerodynamic properties of the particles compared to an equivalent sphere, 
however decoupling this factor from size has been difficult in the present study.  A more 
complete understanding of the range of textures possible, and verification of these being 
produced at similar aerodynamic size would be an important development.  The 
thermodynamic differences indicated by the range of enthalpies and varying textures 
obtained during experiments may translate into differences in transport across the lung; 
studies using cultured cell lines are likely to provide an understanding of the efficacy 
differences attributable to these attribute changes.
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7. APPENDICES 
Appendix 1 Images of droplet break-up 
Water 
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Ethanol 
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2-Propanol 
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Appendix 2 SEM images of spray dried NaCl 
Magnification 
Batch number, predicted diameter (microns) 
EE686926/2, 20 microns EE686926/5, 7 microns EE686926/7, 9 microns 
250 
   
1000 
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Magnification 
Batch number, predicted diameter (microns) 
EE686926/10, 9 microns EE686926/11, 17 microns EE686926/12, 12 microns 
250 
   
1000 
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Magnification 
Batch number, predicted diameter (microns) 
EE686926/13, 5 microns EE686926/14, 7 microns EE686926/16, 16 microns 
250 
   
1000 
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Magnification 
Batch number, predicted diameter (microns) 
EE686926/17, 20 microns EE686926/19, 5 microns EE686926/20, 12 microns 
250 
   
1000 
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Appendix 3 SEM images of spray dried MF 
Batch number 
Magnification 
250 500 1000 
EE686926/31C 
   
EE686926/31E 
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Batch number 
Magnification 
250 500 1000 
EE686926/31F 
   
EE686926/31G* 
   
* - Note: a 20 micron scale bar has been used for one image of EE696926/31G; the magnification (500x) is the same as for the images of compared batches 
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Batch number 
Magnification 
250 500 1000 
EE686926/31H 
   
EE686926/31I 
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Batch number 
Magnification 
250 500 1000 
EE686926/31J* 
   
EE686926/31K 
   
* - Note: a 20 micron scale bar has been used for one image of EE696926/31J; the magnification (500x) is the same as for the images of compared batches 
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Batch number 
Magnification 
250 500 1000 
EE686926/31L 
   
EE686926/31M 
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Batch number 
Magnification 
250 500 1000 
EE686926/31N 
   
EE686926/31P 
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Batch number 
Magnification 
250 500 1000 
EE686926/31Q 
   
EE686926/31R 
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Batch number 
Magnification 
250 500 1000 
EE686926/31S 
   
EE686926/31T 
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Batch number 
Magnification 
250 500 1000 
EE686926/31U 
   
EE686926/32J 
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Batch number 
Magnification 
250 500 1000 
EE686926/32K 
   
EE686926/32I 
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Batch number 
Magnification 
250 500 1000 
EE686926/31V 
   
EE686926/31W 
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Batch number 
Magnification 
250 500 1000 
EE686926/31X 
   
EE686926/31Y 
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Batch number 
Magnification 
250 500 1000 
EE686926/31Z 
   
EE686926/32A 
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Appendix 4 Thermal analysis results 
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Temperature (°C)
Sample: GR226838X EE686926/31C
Size:  3.1000 mg
Method: M7501-250
DSC
File: C:...\Inital DoE runs\31C run 1
Operator: CAB/AS
Run Date: 22-Apr-2013 02:07
Instrument: DSC Q2000 V24.4 Build 116
Exo Up Universal V4.7A TA Instruments
131.19°C
122.09°C
11.34J/g
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Temperature (°C)
Sample: GR226838X EE686926/31C
Size:  1.9890 mg
Method: M7501-250
DSC
File: C:...\Inital DoE runs\31C run 2
Operator: CAB/AS
Run Date: 22-Apr-2013 02:37
Instrument: DSC Q2000 V24.4 Build 116
Exo Up Universal V4.7A TA Instruments
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6.588J/g
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Sample: GR226838X EE686926/31E
Size:  3.5650 mg
Method: M7501-250
DSC
File: C:...\Inital DoE runs\31E run 1
Operator: CAB/AS
Run Date: 22-Apr-2013 04:09
Instrument: DSC Q2000 V24.4 Build 116
Exo Up Universal V4.7A TA Instruments
114.15°C
108.59°C
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Sample: GR226838X EE686926/31E
Size:  3.6620 mg
Method: M7501-250
DSC
File: C:...\Inital DoE runs\31E run 2
Operator: CAB/AS
Run Date: 22-Apr-2013 04:40
Instrument: DSC Q2000 V24.4 Build 116
Exo Up Universal V4.7A TA Instruments
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Sample: GR226838X EE686926/31F
Size:  2.2910 mg
Method: M7501-250
DSC
File: C:...\Inital DoE runs\31F run 1
Operator: CAB/AS
Run Date: 22-Apr-2013 00:05
Instrument: DSC Q2000 V24.4 Build 116
Exo Up Universal V4.7A TA Instruments
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Size:  2.1100 mg
Method: M7501-250
DSC
File: C:...\Inital DoE runs\31F run 2
Operator: CAB/AS
Run Date: 22-Apr-2013 00:35
Instrument: DSC Q2000 V24.4 Build 116
Exo Up Universal V4.7A TA Instruments
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Sample: DSC EE686926-31G r1 GR226838X
Size:  2.2170 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31G run 1
Operator: CAB/AS
Run Date: 19-May-2013 21:41
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  3.1370 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31G run 2
Operator: CAB/AS
Run Date: 19-May-2013 22:09
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Sample: DSC EE686926-31H r1 GR226838X
Size:  2.3060 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31H run 1
Operator: CAB/AS
Run Date: 19-May-2013 22:37
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  2.0760 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31H run 2
Operator: CAB/AS
Run Date: 19-May-2013 23:05
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Sample: DSC EE686926-31I r1 GR226838X
Size:  3.4790 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31I run 1
Operator: CAB/AS
Run Date: 19-May-2013 23:33
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Sample: DSC EE686926-31I r2 GR226838X
Size:  3.5720 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31I run 2
Operator: CAB/AS
Run Date: 20-May-2013 00:01
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  2.2140 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31J run 1
Operator: CAB/AS
Run Date: 20-May-2013 00:29
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  3.3250 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31J run 2
Operator: CAB/AS
Run Date: 20-May-2013 00:57
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Sample: DSC EE686926/31L r1 GR226838X
Size:  2.8930 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31L run 1
Operator: CAB/AS
Run Date: 27-May-2013 14:48
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  3.0800 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31L run 2
Operator: CAB/AS
Run Date: 27-May-2013 15:16
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
134.99°C
130.64°C
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Size:  2.2060 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31M run 1
Operator: CAB/AS
Run Date: 27-May-2013 15:44
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  2.7200 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31M run 2
Operator: CAB/AS
Run Date: 27-May-2013 16:12
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Sample: DSC EE686926/31N r1 GR226838X
Size:  2.0440 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31N run 1
Operator: CAB/AS
Run Date: 27-May-2013 16:40
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  2.6540 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31N run 2
Operator: CAB/AS
Run Date: 27-May-2013 17:08
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  2.4740 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31P run 1
Operator: CAB/AS
Run Date: 27-May-2013 18:32
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  2.4190 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31P run 2
Operator: CAB/AS
Run Date: 27-May-2013 19:00
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  2.0370 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31Q run 1
Operator: CAB/AS
Run Date: 19-May-2013 20:45
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  2.2440 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31Q run 2
Operator: CAB/AS
Run Date: 19-May-2013 21:13
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  2.0630 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31R run 1
Operator: CAB/AS
Run Date: 27-May-2013 19:28
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  1.4900 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31R run 2
Operator: CAB/AS
Run Date: 27-May-2013 19:56
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  1.8600 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31S run 1
Operator: CAB/AS
Run Date: 27-May-2013 20:23
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Sample: DSC EE686926/31S r2 GR226838X
Size:  2.5970 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31S run 2
Operator: CAB/AS
Run Date: 27-May-2013 20:51
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  2.4240 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31T run 1
Operator: CAB/AS
Run Date: 27-May-2013 21:19
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
159.17°C
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Size:  2.5260 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31T run 2
Operator: CAB/AS
Run Date: 27-May-2013 21:47
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Sample: DSC EE686926/31U r1 GR226838X
Size:  1.9510 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31U run 1
Operator: CAB/AS
Run Date: 27-May-2013 22:15
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
183.84°C
170.71°C
34.19J/g
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Sample: DSC EE686926/31U r2 GR226838X
Size:  2.3130 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\31U run 2
Operator: CAB/AS
Run Date: 27-May-2013 22:43
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
182.42°C
162.34°C
39.97J/g144.80°C
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Sample: DSC EE686926/32J r1 GR226838X
Size:  2.9520 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance 502862
DSC
File: C:...\Inital DoE runs\32J run 1
Operator: CAB/AS
Run Date: 11-Aug-2013 18:57
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
181.75°C
160.23°C
40.62J/g
153.99°C
147.90°C
1.121J/g
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Sample: DSC EE686926/32J r2 GR226838X
Size:  4.2040 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance 502862
DSC
File: C:...\Inital DoE runs\32J run 2
Operator: CAB/AS
Run Date: 11-Aug-2013 19:20
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Sample: DSC EE686926/32K r1 GR226838X
Size:  2.6980 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance 502862
DSC
File: C:...\Inital DoE runs\32K run 1
Operator: CAB/AS
Run Date: 11-Aug-2013 19:43
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  2.5070 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance 502862
DSC
File: C:...\Inital DoE runs\32K run 2
Operator: CAB/AS
Run Date: 11-Aug-2013 20:07
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\32I run 1
Operator: CAB/AS
Run Date: 16-Jun-2013 21:07
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Inital DoE runs\32I run 2
Operator: CAB/AS
Run Date: 16-Jun-2013 21:36
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Additional runs – 0.56, 1.00 and 1.25%w/w mometasone furoate and 0.375%w/w fluticasone propionate 
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Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\DSC\Thesis thermograms\31V run 1
Operator: CAB/AS
Run Date: 09-Jun-2013 18:26
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\DSC\Thesis thermograms\31V run 2
Operator: CAB/AS
Run Date: 09-Jun-2013 18:54
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Sample: DSC EE686926/31W r1 GR226838X
Size:  2.0290 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\DSC\Thesis thermograms\31W run 1
Operator: CAB/AS
Run Date: 09-Jun-2013 19:22
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Sample: DSC EE686926/31W r2 GR226838X
Size:  2.8620 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\DSC\Thesis thermograms\31W run 2
Operator: CAB/AS
Run Date: 09-Jun-2013 19:50
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  2.7320 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\DSC\Thesis thermograms\31X run 1
Operator: CAB/AS
Run Date: 09-Jun-2013 21:16
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  2.9680 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\DSC\Thesis thermograms\31X run 2
Operator: CAB/AS
Run Date: 09-Jun-2013 21:44
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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171.25°C
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Sample: DSC EE686926/31Y r1 GR226838X
Size:  3.7560 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\DSC\Thesis thermograms\31Y run 1
Operator: CAB/AS
Run Date: 09-Jun-2013 20:19
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
171.27°C
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Size:  3.8670 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\DSC\Thesis thermograms\31Y run 2
Operator: CAB/AS
Run Date: 09-Jun-2013 20:47
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
139.76°C
131.37°C
30.28J/g
-0.2
0.0
0.2
0.4
H
e
a
t 
F
lo
w
 (
W
/g
)
-50 0 50 100 150 200 250
Temperature (°C)
Sample: DSC EE686926/31Z r1 GR226838X
Size:  1.9900 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\DSC\Thesis thermograms\31Z run 1
Operator: CAB/AS
Run Date: 09-Jun-2013 22:13
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
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File: C:...\DSC\Thesis thermograms\31Z run 2
Operator: CAB/AS
Run Date: 09-Jun-2013 22:41
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Size:  1.7150 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Crystalline MF run 1
Operator: CAB/AS
Run Date: 27-May-2013 23:11
Instrument: DSC Q2000 V24.10 Build 122
Exo Down Universal V4.7A TA Instruments
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Size:  2.1300 mg
Method: M0011383
Comment: DSC Biomax 065496 Balance Biomax 502862.
DSC
File: C:...\Crystalline MF run 2
Operator: CAB/AS
Run Date: 27-May-2013 23:39
Instrument: DSC Q2000 V24.10 Build 122
Exo Down Universal V4.7A TA Instruments
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Method: M0011383
Comment: DSC Biomax 065496 Balance 502862
DSC
File: C:...\DSC EE686926_32A r1 CCI18781.001
Operator: CAB/AS
Run Date: 11-Aug-2013 20:30
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Comment: DSC Biomax 065496 Balance 502862
DSC
File: C:...\DSC EE686926_32A r2 CCI18781.001
Operator: CAB/AS
Run Date: 11-Aug-2013 20:54
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.7A TA Instruments
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Appendix 5 X-ray powder diffractograms 
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Appendix 6 Thermogravimetric analysis data 
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Appendix 7 SEM images of MF-lactose blends 
Batch 
number 
Image 1 Image 2 
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Appendix 8 Droplet size, flow rate and pressure drop 
relationships for flow focusing atomization 
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Ethanol, 25C 
 
 
Ethanol, 50C 
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